<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Immunol</journal-id><journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id><journal-id journal-id-type="pmc-domain-id">1754</journal-id><journal-id journal-id-type="pmc-domain">frontimmu</journal-id><journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id><journal-title-group><journal-title>Frontiers in Immunology</journal-title></journal-title-group><issn pub-type="epub">1664-3224</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC7775495</article-id><article-id pub-id-type="pmcid-ver">PMC7775495.1</article-id><article-id pub-id-type="pmcaid">7775495</article-id><article-id pub-id-type="pmcaiid">7775495</article-id><article-id pub-id-type="pmid">33391283</article-id><article-id pub-id-type="doi">10.3389/fimmu.2020.613170</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Immunology</subject><subj-group><subject>Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Alternative Pathways of IL-1 Activation, and Its Role in Health and Disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Pyrillou</surname><given-names initials="K">Katerina</given-names></name><xref ref-type="author-notes" rid="fn002">
<sup>&#8224;</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Burzynski</surname><given-names initials="LC">Laura C.</given-names></name><xref ref-type="author-notes" rid="fn002">
<sup>&#8224;</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/957887"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Clarke</surname><given-names initials="MCH">Murray C. H.</given-names></name><xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://loop.frontiersin.org/people/1046815"/></contrib></contrib-group><aff id="aff1">
<institution>Division of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Addenbrooke&#8217;s Hospital</institution>, <addr-line>Cambridge</addr-line>, <country>United Kingdom</country>
</aff><author-notes><fn fn-type="edited-by"><p>Edited by: Kuo-Feng Hua, National Ilan University, Taiwan</p></fn><fn fn-type="edited-by"><p>Reviewed by: Luiz Eduardo Baggio Savio, Federal University of Rio de Janeiro, Brazil; David Brough, The University of Manchester, United Kingdom; Sampsa Matikainen, University of Helsinki, Finland</p></fn><corresp id="fn001">*Correspondence: Murray C. H. Clarke, <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:mchc2@cam.ac.uk">mchc2@cam.ac.uk</email></corresp><fn fn-type="equal" id="fn002"><p>&#8224;These authors have contributed equally to this work</p></fn><fn fn-type="other" id="fn003"><p>This article was submitted to Inflammation, a section of the journal Frontiers in Immunology</p></fn></author-notes><pub-date pub-type="epub"><day>18</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><issue-id pub-id-type="pmc-issue-id">351098</issue-id><elocation-id>613170</elocation-id><history><date date-type="received"><day>01</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>11</month><year>2020</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2020</year></date></event><event event-type="pmc-live"><date><day>02</day><month>01</month><year>2021</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-11-09 20:25:10.530"><day>09</day><month>11</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2020 Pyrillou, Burzynski and Clarke</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Pyrillou, Burzynski and Clarke</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="fimmu-11-613170.pdf"/><abstract><p>Cytokines activate or inhibit immune cell behavior and are thus integral to all immune responses. IL-1&#945; and IL-1&#946; are powerful apical cytokines that instigate multiple downstream processes to affect both innate and adaptive immunity. Multiple studies show that IL-1&#946; is typically activated in macrophages after inflammasome sensing of infection or danger, leading to caspase-1 processing of IL-1&#946; and its release. However, many alternative mechanisms activate IL-1&#945; and IL-1&#946; in atypical cell types, and IL-1 function is also important for homeostatic processes that maintain a physiological state. This review focuses on the less studied, yet arguably more interesting biology of IL-1. We detail the production by, and effects of IL-1 on specific innate and adaptive immune cells, report how IL-1 is required for barrier function at multiple sites, and discuss how perturbation of IL-1 pathways can drive disease. Thus, although IL-1 is primarily studied for driving inflammation after release from macrophages, it is clear that it has a multifaceted role that extends far beyond this, with various unconventional effects of IL-1 vital for health. However, much is still unknown, and a detailed understanding of cell-type and context-dependent actions of IL-1 is required to truly understand this enigmatic cytokine, and safely deploy therapeutics for the betterment of human health.</p></abstract><kwd-group><kwd>cytokines</kwd><kwd>interleukin-1</kwd><kwd>inflammasome</kwd><kwd>innate immunity</kwd><kwd>inflammation</kwd><kwd>adaptive immunity</kwd></kwd-group><funding-group><award-group><funding-source id="cn001">British Heart Foundation<named-content content-type="fundref-id">10.13039/501100000274</named-content></funding-source><award-id rid="cn001">FS/09/005/26845, FS/13/3/30038, FS/18/19/33371, RG/16/8/32388, RE/13/6/30180</award-id></award-group><award-group><funding-source id="cn002">National Institute for Health Research<named-content content-type="fundref-id">10.13039/501100000272</named-content></funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="289"/><page-count count="19"/><word-count count="8773"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1"><title>Part 1&#8212;IL-1 Is Activated by Proteolysis</title><p>IL-1&#945; and IL-1&#946; are the most studied members of the IL-1 superfamily, and although both ligate the same receptor (IL-1R1), and therefore induce identical downstream signaling, activation pathways of the two cytokines differ. Both IL-1&#945; and IL-1&#946; are expressed as proforms that require proteolytic processing for maximum cytokine activity (<xref rid="B1" ref-type="bibr">1</xref>), with removal of the N-terminus (N-term) leading to unmasking of key residues and/or a conformational change that enables the signature C-terminal beta-trefoil motif to interact with the receptor. The study of IL-1 activation has historically focused on processing of IL-1&#946; by caspase-1 (casp-1) (<xref rid="B2" ref-type="bibr">2</xref>) and IL-1&#945; by calpain (<xref rid="B3" ref-type="bibr">3</xref>). However, as summarized in <xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>, pro-IL-1 processing and activation can be mediated by caspases other than casp-1 and a range of other tissue and/or cell-type specific proteases. Together, this allows IL-1 activation to be controlled in specialized environments across the body (<xref rid="B1" ref-type="bibr">1</xref>). This review focuses on alternative modes of IL-1 activation and the more unconventional effects IL-1 can have in health and disease. Throughout the review use of the term &#8220;IL-1&#8221; relates to effects that can be driven by either IL-1&#945; or IL-1&#946;, or where experiments could not determine the form responsible (e.g. use of an <italic toggle="yes">Il1r1</italic> knockout), whilst use of &#8220;IL-1&#945;&#8221; or &#8220;IL-1&#946;&#8221; refers to processes that were driven by a specific form.</p><fig id="f1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>IL-1 is activated after proteolysis and has a variety of cell-specific roles that maintain homeostasis. <bold>(A)</bold> Pro-IL-1&#945;/&#946; is activated after cleavage by a diverse range of proteases. Active IL-1 binds to its signalling receptor IL-1R1 and elicits downstream signalling. IL-1 signalling is inhibited by binding to soluble or cell surface decoy receptor IL-1R2, or by competition from the IL-1 receptor antagonist (IL-1RA) for IL-1R1. <bold>(B&#8211;E)</bold> The production and response to IL-1 by specific cell types is important for the maintenance of cell function and homeostasis. <bold>(F, G)</bold> Dysregulation of IL-1 signalling can exacerbate or drive development of disease.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-11-613170-g001.jpg"/></fig><sec id="s1_1"><title>IL-1 Activation <italic toggle="yes">via</italic> Canonical NLRP3 Inflammasomes</title><p>Typical IL-1&#946; activation is mediated by casp-1 cleavage after inflammasome formation. Activation of inflammasomes is extensively reviewed elsewhere (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B4" ref-type="bibr">4</xref>). Briefly, inflammasomes are intracellular multiprotein complexes that assemble in response to pathogen-associated molecular patterns (PAMPs) (e.g. bacterial LPS, viral dsRNA) or danger-associated molecular patterns (DAMPs) (e.g. uric acid crystals, ATP), as well as other environmental factors (<xref rid="B5" ref-type="bibr">5</xref>). The NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome is the best studied and unique in its ability to form in response to a wide range of stimuli. Canonical activation occurs after the sensing of factors by NLRP3, causing assembly of NLRP3, ASC and casp-1 into a complex that results in the activation of casp-1. Active casp-1 cleaves pro-IL-1&#946; and pro-IL-18 to active cytokines and cleaves Gasdermin D (GSDMD) to a form able to generate pores in the plasma membrane, both releasing cytokines and inducing pyroptotic cell death by loss of plasma membrane integrity (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B7" ref-type="bibr">7</xref>). Furthermore, IL-1&#945; is also able to be released from cells <italic toggle="yes">via</italic> GSDMD pores (<xref rid="B8" ref-type="bibr">8</xref>), but it is unclear if proteolytic processing of pro-IL-1&#945; is required prior to release.</p></sec><sec id="s1_2"><title>Non-Canonical Activation of NLRP3 Inflammasomes</title><p>Non-canonical inflammasome activation typically occurs in response to intracellular bacteria or internalized LPS. Depending on the cell type, non-canonical activation of inflammasomes occurs <italic toggle="yes">via</italic> a one- or two-step process. Macrophages require two-steps, with an initial engagement of a pathogen recognition receptor by PAMPs (e.g. LPS binding to toll-like receptor 4 (TLR4)) leading to NF-&#954;B-mediated upregulation of inflammasome components (e.g. NLRP3 and pro-casp-1) and type I interferon (IFN) signaling-mediated upregulation of pro-casp-5 (in humans) or casp-11 (in mice), complementing the constitutively expressed human pro-casp-4. In the second step, these non-canonical caspases bind to intracellular LPS <italic toggle="yes">via</italic> the Lipid A domain, leading to their activation (<xref rid="B9" ref-type="bibr">9</xref>&#8211;<xref rid="B11" ref-type="bibr">11</xref>) and the subsequent cleavage of GSDMD. The now active N-term of GSDMD forms pores in the plasma membrane, to drive pyroptosis, and in turn triggers NLRP3 inflammasome activation (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B12" ref-type="bibr">12</xref>). In the event of infection with cytosol-invading bacteria such as <italic toggle="yes">Salmonella typhimurium</italic> or <italic toggle="yes">Shigella flexneri</italic>, where the Lipid A moiety is not accessible, interferon-induced guanylate-binding proteins (GBPs) are critical for LPS recognition and activation of non-canonical caspases, due to their association with the vacuole containing the phagocytosed pathogen. The GBPs coating the vacuole either recruit the caspase to the vacuole to create a platform for LPS detection and casp-4 activation (<xref rid="B13" ref-type="bibr">13</xref>), or mediate vacuolar rupture that exposes LPS to the cytosol (<xref rid="B14" ref-type="bibr">14</xref>). GBP1 initiates the formation of the platform, followed by GBP2, GBP4 and GBP3, eventually controlling casp-4 recruitment and activation (<xref rid="B15" ref-type="bibr">15</xref>). In contrast, non-canonical inflammasome activation in human monocytes occurs in a single step, with internalized free LPS directly activating ready-made casp-4/5 (<xref rid="B16" ref-type="bibr">16</xref>), negating the need for IFN signaling.</p><p>Recent developments identified an alternative pathway of non-canonical inflammasome activation involving caspase-8 (casp-8). Casp-8 is best known for transmitting pro-apoptotic signals downstream of death receptor signaling during extrinsic apoptosis (<xref rid="B17" ref-type="bibr">17</xref>). However, casp-8 is also able to promote both the upregulation of pro-IL-1&#946; and its activation by direct processing at the same site targeted by casp-1 (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). This occurs in dendritic cells (DCs) exposed to fungi, with Dectin-1 signaling causing formation of a non-canonical casp-8 inflammasome that upregulates and matures IL-1&#946; (<xref rid="B20" ref-type="bibr">20</xref>). Similarly, bacterial infection inside macrophages also induces casp-8-dependent IL-1&#946; secretion (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>). However, as casp-8 can also mediate casp-1 activation (<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>), it is likely that pro-IL-1&#946; is processed by both casp-1 and casp-8. Stimulation of DCs and macrophages with cellular stressors (e.g. chemotherapeutics) also causes direct cleavage of pro-IL-1&#946; by casp-8, and casp-8-mediated NLRP3 inflammasome activation (<xref rid="B23" ref-type="bibr">23</xref>). However, casp-8 can also induce IL-1&#946; maturation completely independent of casp-1. In DCs where casp-1 proteolytic activity is inhibited by casp-1 mutation, resulting in no GSDMD activation or pyroptosis, casp-8 is recruited to the NLRP3 inflammasome, which enhances casp-8 activity and drives IL-1&#946; release, albeit in a delayed fashion due to either reduced processing or release (<xref rid="B24" ref-type="bibr">24</xref>). Casp-8 can also mediate IL-1&#946; release completely independent of the NLRP3 inflammasome after engagement of DC Fas with Fas ligand (FasL) on invariant natural killer (NK) T cells (<xref rid="B25" ref-type="bibr">25</xref>). Finally, casp-8 can mediate an alternative form of NLRP3-dependent cell death coined incomplete pyroptosis, which is driven by gasdermin E pores in the absence of casp-1/11 (<xref rid="B26" ref-type="bibr">26</xref>). Although activation of these non-canonical pathways is often accompanied by pyroptosis and IL-1&#945; release <italic toggle="yes">via</italic> GSDMD (<xref rid="B4" ref-type="bibr">4</xref>) or GSDME (<xref rid="B26" ref-type="bibr">26</xref>) pores, the exact mechanism for IL-1&#945; release remains unclear.</p></sec><sec id="s1_3"><title>IL-1&#945; Activation by Proteolysis</title><p>The historic view is that IL-1&#945; does not require proteolytic cleavage for full activity. However, these conclusions were drawn from studies that did not directly compare the activity of pro- and cleaved IL-1&#945; (<xref rid="B27" ref-type="bibr">27</xref>), or used recombinant forms of IL-1&#945; that were likely denatured during the purification process (i.e. by using HPLC) (<xref rid="B28" ref-type="bibr">28</xref>). Further work has shown that mature IL-1&#945; has much higher cytokine activity than pro-IL-1&#945; (<xref rid="B29" ref-type="bibr">29</xref>&#8211;<xref rid="B31" ref-type="bibr">31</xref>), with the calpain cleaved form having a ~50-fold higher affinity for IL-1R1 than the pro-form (<xref rid="B30" ref-type="bibr">30</xref>). In addition, cleavage of pro-IL-1&#945; is regulated by its binding to a cytosolic form of the decoy receptor IL-1R2, which prevents calpain cleavage. However, after inflammasome activation casp-1 cleaves IL-1R2, which releases pro-IL-1&#945; and allows calpain cleavage to the mature form (<xref rid="B30" ref-type="bibr">30</xref>).</p><p>Pro-IL-1&#945; can also be cleaved by granzyme B (a cytotoxic T and NK cell protease), neutrophil elastase and mast-cell chymase, which confers bioactivity similar to calpain and up to a ~10-fold increase in activity over pro-IL-1&#945; (<xref rid="B29" ref-type="bibr">29</xref>). This was found to be important in persistent inflammatory lung conditions such as cystic fibrosis, as patient bronchoalveolar lavage fluids could process IL-1&#945; to a mature form. Interestingly, neutrophil elastase and mast cell chymase can also cleave IL-1&#946;, IL-18, and IL-33 (<xref rid="B32" ref-type="bibr">32</xref>&#8211;<xref rid="B34" ref-type="bibr">34</xref>), perhaps revealing historic processes that could activate the ancestral IL-1 ligand before gene duplications formed the IL-1 family (<xref rid="B35" ref-type="bibr">35</xref>).</p><p>Thrombin, the key protease of coagulation, is also able to directly cleave and activate pro-IL-1&#945; (<xref rid="B36" ref-type="bibr">36</xref>). Pro-IL-1&#945; is cleaved by thrombin at a (K)PRS motif that is highly conserved across disparate mammalian species, suggesting functional importance. IL-1&#945; cytokine activity after cleavage by either thrombin or calpain is equivalent, suggesting that removal of the N-term is critical for IL-1&#945; activity, as is seen for IL-1&#946;. The co-localization of tissue factor (TF) (a thrombin activator) and pro-IL-1&#945; in the epidermis means that following injury thrombin generated during hemostasis can rapidly activate IL-1&#945;, leading to inflammation and recruitment of immune cells that can safeguard against potential infection.</p><p>In addition to responding to intracellular LPS, casp-5 and -11 can also directly process and activate IL-1&#945; (<xref rid="B31" ref-type="bibr">31</xref>). Again, pro-IL-1&#945; cleavage occurs at an Asp residue that is highly conserved between different species, and this processing partially controls the release of mature IL-1&#945; from macrophages after both canonical and non-canonical inflammasome activation (<xref rid="B31" ref-type="bibr">31</xref>). Importantly, <italic toggle="yes">CASP5</italic> expression is increased in senescent human fibroblasts, and release of IL-1&#945;, which drives the senescence-associated secretory phenotype (SASP), and SASP factors (e.g. IL-6/8, monocyte chemoattractant protein-1) is reduced without casp-5 (<xref rid="B31" ref-type="bibr">31</xref>). Furthermore, in an <italic toggle="yes">in vivo</italic> model of hepatocyte senescence, reducing casp-11 in senescent cells leads to their accumulation, which is caused by a reduced SASP failing to recruit immune cells. Together this suggests that casp-5/11 plays a key role in regulating IL-1&#945; activation and release in both myeloid and senescent cells.</p><p>All the proteases described above cleave pro-IL-1&#945; within the same target region located between the N-term propiece and the C-term cytokine domain. Together, this means that cleavage of IL-1&#945; by any protease results in an active cytokine that only differs by a few amino acids and has comparable biologically activity. IL-1&#945; activation can therefore be affected in a broad range of scenarios, allowing it to act as a versatile universal danger signal.</p></sec></sec><sec id="s2"><title>Part 2&#8212;IL-1 Production and Responses by Specific Cell Types</title><p>IL-1 was historically studied under many names, including leukocyte endogenous mediator, hematopoietin 1, endogenous pyrogen, lymphocyte activating factor, catabolin and osteoclast activating factor (<xref rid="B37" ref-type="bibr">37</xref>)&#8212;underscoring the pleiotropic effects of this widely expressed cytokine. In multi-cellular organisms cells exist in specialized niches that require distinct environmental cues to maintain homeostasis and functionality, much of which is controlled by soluble signaling factors such as cytokines and growth factors. Both IL-1&#945; and IL-1&#946; are active at very low concentrations, are tightly regulated and have important roles that extend beyond typical inflammation. Cell type-specific examples of both IL-1&#945; and IL-1&#946; production and response are discussed in this section.</p><sec id="s2_1"><title>IL-1 Performs Key Roles in Controlling Innate Immune Cell Function</title><p>IL-1 signaling is vital for effective innate immunity, with most innate immune cells able to produce IL-1 and almost all mesenchymal/tissue cells able to respond to it (<xref rid="B38" ref-type="bibr">38</xref>). Innate responses typically occur after sensing of DAMPs or PAMPs by tissue resident immune cells (e.g. macrophages), which leads to upregulation of pro-IL-1&#945;/&#946; and other cytokines (e.g. TNF&#945;). If the insult is severe enough, leaked factors such as ATP drive inflammasome activation and large-scale release of mature IL-1&#945;/&#946;. Importantly, as pro-IL-1&#945; is constitutively expressed by many tissue cells, necrosis can release fully active IL-1&#945; that may instigate a low level responses able to resolve an insult before full inflammasome activation and potential collateral tissue damage. IL-1-mediated processes important for innate responses include cytokine secretion, upregulation of adhesion, MHC and/or co-stimulatory molecules and induction of vascular leakage, ultimately leading to the recruitment, activation and instruction of immune cells (<xref rid="B39" ref-type="bibr">39</xref>).</p><sec id="s2_1_1"><title>Neutrophils</title><p>Neutrophils are the most abundant white blood cell in the circulation. They are rapidly recruited to sites of injury or infection where they phagocytose microbes and undergo degranulation to release bactericidal reactive oxygen species and proteases (<xref rid="B40" ref-type="bibr">40</xref>). Because of a short life span (~23&#8211;38 h), neutrophils require continuous replacement and robust mechanisms to control circulating numbers (<xref rid="B41" ref-type="bibr">41</xref>). Granulopoiesis and release of mature neutrophils from the bone marrow can be driven by IL-17 from Th17 cells (<xref rid="B42" ref-type="bibr">42</xref>), <italic toggle="yes">via</italic> granulocyte-colony stimulating factor. As Th17 differentiation is regulated by IL-1 (<xref rid="B43" ref-type="bibr">43</xref>) and Th17 cells produce IL-17 after exposure to IL-1 and IL-23, this gives IL-1 an indirect role in granulopoiesis (<xref ref-type="fig" rid="f1">
<bold>Figure 1B</bold>
</xref>) (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B45" ref-type="bibr">45</xref>). More generally, infection and inflammation trigger neutrophilia <italic toggle="yes">via</italic> IL-1-induced proliferation of hematopoietic stem cells, a process known as emergency granulopoiesis (<xref rid="B46" ref-type="bibr">46</xref>).</p><p>IL-1 does not directly recruit neutrophils (<xref rid="B47" ref-type="bibr">47</xref>), rather it causes recruitment to sites of inflammation by upregulating neutrophil chemoattractants such as CXC- and CCL- chemokines in other cell types (<xref rid="B48" ref-type="bibr">48</xref>). For example, IL-1-dependent production of the chemokine IL-8 (CXCL8) occurs in endothelial cells (<xref rid="B49" ref-type="bibr">49</xref>), fibroblasts, and keratinocytes (<xref rid="B50" ref-type="bibr">50</xref>). IL-1 can also induce production of neutrophil chemotactic lipids including leukotriene B4 (<xref rid="B51" ref-type="bibr">51</xref>) and platelet activating factor (<xref rid="B52" ref-type="bibr">52</xref>). Recruitment of mature neutrophils to sites of infection or injury can also be driven by Th17 cell IL-17, which induces release of the neutrophil chemokines CXCL1, CXCL2, CXCL5, and CXCL8 from local endothelial and epithelial cells (<xref rid="B53" ref-type="bibr">53</xref>). Th17 cells also directly recruit neutrophils by production of CXCL8 (<xref rid="B54" ref-type="bibr">54</xref>). After administration of hydrocarbon oils to the peritoneal cavity, locally released IL-1&#945; drives production of CXCL5 that recruits neutrophils (<xref rid="B55" ref-type="bibr">55</xref>).</p><p>IL-1 also drives calcium-dependent degranulation of neutrophils (<xref rid="B56" ref-type="bibr">56</xref>), with the exteriorized proteases (e.g. cathepsin G, elastase, and proteinase 3) subsequently able to cleave and activate multiple IL-1 family members (e.g. IL-1&#945;, IL-1&#946;, IL-33, IL-36) (<xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B58" ref-type="bibr">58</xref>). Indeed, it has been suggested that neutrophil proteases may be more effective at processing IL-1 family members than directly killing microbes (<xref rid="B58" ref-type="bibr">58</xref>), suggesting the ancestral purpose of these proteases was to activate cytokines. Proteinase 3 can also process IL-1&#946; inside neutrophils lacking NF-&#954;B signaling (<xref rid="B59" ref-type="bibr">59</xref>), which could serve as a host defense mechanism against pathogens able to evade NF-&#954;B dependent innate immunity (<xref rid="B60" ref-type="bibr">60</xref>). Activated neutrophils release a meshwork of chromatin and proteases that form extracellular fibers, known as neutrophil extracellular traps (NETs), which trap and kill bacteria (<xref rid="B61" ref-type="bibr">61</xref>). Formation of NETs often leads to a lytic form of cell death called NETosis, but NETs can be released without cell death, known as vital NETosis (<xref rid="B62" ref-type="bibr">62</xref>). Interestingly, NET extrusion and NETosis are dependent on GSDMD pore formation that occurs during non-canonical inflammasome activation by intracellular LPS or bacteria (<xref rid="B63" ref-type="bibr">63</xref>, <xref rid="B64" ref-type="bibr">64</xref>). NET formation also occurs in response to exogenous IL-1 (<xref rid="B65" ref-type="bibr">65</xref>, <xref rid="B66" ref-type="bibr">66</xref>). In atherosclerotic plaques, cholesterol efflux-driven NLRP3 inflammasome activation in myeloid cells induces subsequent IL-1R1-dependent neutrophil accumulation and NET formation (<xref rid="B67" ref-type="bibr">67</xref>). Conversely, NET formation can also elicit IL-1 signaling, with the NET-associated proteases elastase and cathepsin G able to cleave and activate IL-1&#945; (<xref rid="B68" ref-type="bibr">68</xref>, <xref rid="B69" ref-type="bibr">69</xref>). Indeed, in diabetic wounds NET overproduction triggers macrophage NLRP3 inflammasome activation and IL-1&#946; release, which sustains inflammation and impairs healing (<xref rid="B70" ref-type="bibr">70</xref>).</p><p>Finally, myelopoiesis following myocardial infarction is driven by neutrophil-derived IL-1&#946;. Neutrophils recruited to the infarcted tissue release the alarmins S100A8 and S100A9 that bind to TLR4 on na&#239;ve neutrophils and induce NLRP3 inflammasome-dependent IL-1&#946; secretion, which subsequently drives IL-1R1-dependent granulopoiesis in the bone marrow (<xref rid="B71" ref-type="bibr">71</xref>). Together, IL-1 signaling is either directly or indirectly capable of inducing neutrophil production, recruitment, degranulation, and NETosis. In turn, neutrophil proteases are able to activate IL-1 family members, which could act as a means to rapidly amplify inflammation at sites of injury or infection.</p></sec><sec id="s2_1_2"><title>Macrophages</title><p>The main functions of a macrophage are to phagocytose cell debris and foreign bodies and release cytokines that orchestrate immune responses. Phagocytosis is fundamental for host defense, as it combines microbial killing with innate immune activation and the presentation of antigens to T cells. Macrophage phagosome maturation depends on progressive acidification, which activates pH-dependent proteases (e.g. cathepsins) that degrade the contents (<xref rid="B72" ref-type="bibr">72</xref>). Interestingly, mechanisms for macrophage cytokine release and phagocytosis overlap, with gram-positive bacteria within phagosomes inducing NLRP3 inflammasome activation. This leads to active casp-1 accumulation on phagosomes, where it controls acidification <italic toggle="yes">via</italic> the NADPH oxidase NOX2 (<xref rid="B73" ref-type="bibr">73</xref>, <xref rid="B74" ref-type="bibr">74</xref>). To evade digestion in the phagosome, <italic toggle="yes">Staphylococcus aureus</italic> has evolved a mechanism that allows it to sequester mitochondria away from phagosomes, thereby preventing mitochondrial reactive oxygen species generation, local casp-1 activation, and subsequent phagosome acidification (<xref rid="B75" ref-type="bibr">75</xref>).</p><p>Macrophages can produce IL-1 in a variety of ways, as detailed above. However, macrophages appear unique in their ability to present IL-1&#945; on the cell surface (<xref ref-type="fig" rid="f1">
<bold>Figure 1C</bold>
</xref>) (<xref rid="B76" ref-type="bibr">76</xref>, <xref rid="B77" ref-type="bibr">77</xref>). Cell surface (csIL-1&#945;) is induced de-novo after TLR ligation and associates with the membrane <italic toggle="yes">via</italic> IL-1R2 and a glycosylphosphatidylinositol (GPI)-anchored protein, with trafficking to the membrane specifically inhibited by IFN&#947; (<xref rid="B77" ref-type="bibr">77</xref>). Because csIL-1&#945; is the less active pro-form tethered <italic toggle="yes">via</italic> the N-term (<xref rid="B77" ref-type="bibr">77</xref>), it is both activated and released after cleavage, for example by thrombin (<xref rid="B36" ref-type="bibr">36</xref>), permitting wider ranging effects. However, because IL-33 causes macrophage activation and differentiation and IL-33 signaling <italic toggle="yes">via</italic> ST2 needs IL-1 receptor accessory protein (IL-1AcP) as a co-receptor (<xref rid="B78" ref-type="bibr">78</xref>, <xref rid="B79" ref-type="bibr">79</xref>), this signaling complex likely sequesters IL-1AcP away from any IL-1R1 and reduces the potential for IL-1 signaling by macrophages.</p><p>Macrophages change phenotype in response to the microenvironment, typically becoming polarized to M1 (classically activated) or M2 (alternatively activated) subtypes. NLRP3 and IL-1&#946; expression is reduced in M2 cells (<xref rid="B80" ref-type="bibr">80</xref>), and inhibition of NLRP3 inflammasome activation drives M2 polarization (<xref rid="B81" ref-type="bibr">81</xref>, <xref rid="B82" ref-type="bibr">82</xref>). In keeping with this, NLRP3 inflammasome activation in <italic toggle="yes">Treponema pallidum</italic> infected macrophages induces M1 polarization and IL-1&#946; release (<xref rid="B83" ref-type="bibr">83</xref>). In contrast, NLRP3 activation can also cause M2 polarization <italic toggle="yes">via</italic> upregulation of IL-4 in an inflammasome-independent process (<xref rid="B84" ref-type="bibr">84</xref>). Together, although NLRP3-controlled M1/M2 polarization is clearly important, the exact picture is yet to be elucidated.</p></sec><sec id="s2_1_3"><title>Platelets</title><p>Platelets are key for hemostasis in response to vascular injury, but also form pathogenic thrombi. Activated platelets change shape, aggregate, degranulate, and upregulate receptors (<xref rid="B85" ref-type="bibr">85</xref>), but also release bioactive molecules that cause inflammation and modulate immune responses. Activation of platelets increases cell surface IL-1&#945; (<xref rid="B86" ref-type="bibr">86</xref>, <xref rid="B87" ref-type="bibr">87</xref>), which can be cleaved and released from the surface by thrombin (<xref rid="B36" ref-type="bibr">36</xref>). During stroke or brain injury, IL-1&#945; released from activated platelets is important for driving cerebrovascular inflammation <italic toggle="yes">via</italic> activation of the brain endothelium, which enhances adhesion molecule and CXCL1 expression (<xref ref-type="fig" rid="f1">
<bold>Figure 1D</bold>
</xref>) (<xref rid="B88" ref-type="bibr">88</xref>). Platelet microparticle-associated IL-1&#946; also promotes platelet-neutrophil aggregation in injured lung microvasculature during sickle cell disease (<xref rid="B89" ref-type="bibr">89</xref>). Additionally, platelets are able to license NLRP3 inflammasome activation and IL-1 production in innate immune cells, particularly monocytes. This licensing is <italic toggle="yes">via</italic> an unknown soluble platelet factor, independent of contact, and is not IL-1 or an inflammasome component (<xref rid="B90" ref-type="bibr">90</xref>). Platelets also express IL-1R1, and treatment with exogenous IL-1&#946; can activate platelets and enhance adhesion to substrates (<xref rid="B91" ref-type="bibr">91</xref>). Platelets can also respond to the IL-1&#946; they release in an autocrine signaling loop after LPS stimulation (<xref rid="B92" ref-type="bibr">92</xref>).</p><p>Platelet count and thrombopoiesis are both tightly regulated. Normal thrombopoiesis occurs after thrombopoietin induces caspase activation in megakaryocytes, causing compartmentalized apoptosis and pro-platelet formation (<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>). However, emergency thrombopoiesis also occurs after acute platelet loss, with IL-1&#945; signaling causing alternative platelet production <italic toggle="yes">via</italic> megakaryocyte rupture (<xref rid="B95" ref-type="bibr">95</xref>). Indeed, mice with thrombin-resistant pro-IL-1&#945; do not rapidly recover platelet count after platelet depletion, suggesting thrombin activation of IL-1&#945; is the critical mechanism for this form of emergency thrombopoiesis (<xref rid="B36" ref-type="bibr">36</xref>). Platelets are at the interplay of hemostasis and inflammation and together it is clear that their role in host defense goes much deeper than their ability to cross link fibrin during hemostasis.</p></sec></sec><sec id="s2_2"><title>IL-1 Is Vital for Adaptive Immunity</title><p>An appreciation of the effects of IL-1 on the adaptive immune system dates to the 1970s, when IL-1 was originally named lymphocyte activating factor) to account for its lymphoproliferative activity (<xref rid="B96" ref-type="bibr">96</xref>&#8211;<xref rid="B98" ref-type="bibr">98</xref>). Indeed, T cell expansion under the influence of either IL-1&#945; or IL-1&#946; is demonstrated for a variety of T helper (Th) cell subsets such as Th1 (<xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>), Th2 (<xref rid="B100" ref-type="bibr">100</xref>, <xref rid="B101" ref-type="bibr">101</xref>), and Th17 (<xref rid="B100" ref-type="bibr">100</xref>), in a process that is antigen and/or T cell receptor (TCR)-dependent. These observations are partly explained by a pro-survival role of IL-1 on the cells (<xref rid="B100" ref-type="bibr">100</xref>); however, other studies show no pro-survival effects of IL-1 downstream signaling on CD4 T cells (<xref rid="B102" ref-type="bibr">102</xref>). Similar observations were noted with Granzyme B+ CD8+ T cells, where IL-1&#946; regulates expansion and effector function (<xref rid="B103" ref-type="bibr">103</xref>). IL-1&#945; also drives Th cell differentiation, in particular Th17, but also synergizes with TNF to enable IL-12-driven Th1 differentiation (<xref rid="B99" ref-type="bibr">99</xref>). Th17 lineage commitment in both human (<xref rid="B104" ref-type="bibr">104</xref>, <xref rid="B105" ref-type="bibr">105</xref>) and mouse systems (<xref rid="B43" ref-type="bibr">43</xref>) is conferred by IL-1-driven upregulation of the transcription factor <italic toggle="yes">Rorc</italic> (<xref rid="B106" ref-type="bibr">106</xref>). Production of signature cytokines by the majority of CD4 effector T cells is also augmented by other IL-1 family members (e.g. IL-18, IL-33 and IL-36), with Th9 (<xref rid="B107" ref-type="bibr">107</xref>, <xref rid="B108" ref-type="bibr">108</xref>) and Th17 (<xref rid="B106" ref-type="bibr">106</xref>) cells directly responding to IL-1, which bypasses the requirement for TCR engagement and CD28 co-stimulation (<xref rid="B100" ref-type="bibr">100</xref>). Indeed, the tri-fold effects of IL-1 on T cell proliferation, differentiation and cytokine secretion in the absence of TCR stimulation is suggestive of the negative effects dysregulated IL-1 might have on adaptive immunity (as summarized in <xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). This is further compounded by the inability of Tregs to effectively suppress IL-1-driven T cell proliferation and cytokine production (<xref rid="B102" ref-type="bibr">102</xref>). Thus, IL-1-driven activation of effector T cells with reduced Treg suppression could breach tolerance and drive autoimmunity.</p><fig id="f2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>IL-1 influences adaptive immunity by multiple mechanisms, with dysregulation leading to disease. <bold>(A)</bold> IL-1 can shape T cell responses either by direct binding to T cell IL-1R1 or indirectly via IL-1-primed DCs. <bold>(B)</bold> Amplified B cell responses are driven by IL-1-activated Tfh cells. <bold>(C)</bold> Maturation, activation and cytokine secretion by DCs is directly driven by IL-1 signalling. <bold>(D)</bold> Uncontrolled IL-1 amplifies T cell responses and can break self-tolerance to drive autoimmunity, while its non-immunological role in tissue damage and remodelling can exacerbate these conditions.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="fimmu-11-613170-g002.jpg"/></fig><sec id="s2_2_1"><title>Direct Effects of IL-1 on T Cells</title><p>It is not totally clear whether the effects of IL-1 on T cells are direct or indirect. Direct regulation implies expression of IL-1 receptor 1 (IL-1R1) on T cells, and although some evidence supports this it is not currently conclusive. Competitive binding experiments using radiolabeled IL-1 demonstrates that Th2 cells, but not Th1, bind IL-1 (<xref rid="B109" ref-type="bibr">109</xref>), which is supported by flow cytometry for IL-1R1 expression on murine Th2 cells (<xref rid="B110" ref-type="bibr">110</xref>). However, circulating human Th17 precursor cells (CCR6+ CD161+ CD4+) do not express <italic toggle="yes">Il1r1</italic> mRNA (<xref rid="B111" ref-type="bibr">111</xref>), and a subset of Th2 cells with the ability to express IL-17 (CRTH2+ CD4+) contain very low levels of IL-1R1 protein (<xref rid="B112" ref-type="bibr">112</xref>). In contrast, <italic toggle="yes">bona fide</italic> Th17 cells show clear <italic toggle="yes">Il1r1</italic> transcription (<xref rid="B43" ref-type="bibr">43</xref>) and expression of functional IL-1R1 on the cell surface (<xref rid="B106" ref-type="bibr">106</xref>). Furthermore, the presence of IL-1R1 on naive or memory CD4 T cells isolated from human blood determines Th17 fate and subsequent secretion of IL-17, with or without TCR triggering (<xref rid="B113" ref-type="bibr">113</xref>). Importantly, formation of an active IL-1 signaling complex requires IL-1R accessory protein (IL-1RAcP), and therefore the expression pattern of this co-receptor in conjunction with IL-1R1 is required to determine which T cells respond to IL-1 (<xref rid="B114" ref-type="bibr">114</xref>, <xref rid="B115" ref-type="bibr">115</xref>). CD4 and CD8 T cells express cell surface IL-1RAcP, with higher abundance on regulatory CD4+ CD127<sup>low</sup> CD25<sup>hi</sup> cells that also express high levels of forkhead box P3 (FoxP3) (<xref rid="B116" ref-type="bibr">116</xref>). IL-1RAcP is also stably expressed on Th2 cells, where it acts as a co-receptor for ST2 that mediates T helper type 2 reactions in response to IL-33 (<xref rid="B117" ref-type="bibr">117</xref>, <xref rid="B118" ref-type="bibr">118</xref>), suggesting that Th2 cells would respond to IL-1 if IL-1R1 is co-expressed.</p><p>T follicular helper (Tfh) cells also express IL-1R1 transcript and protein, and functionally respond to IL-1 (<xref rid="B119" ref-type="bibr">119</xref>), suggesting they must also express IL-1RAcP. Tfh cells provide growth and differentiation signals (i.e. IL-4, IL-21 and ICOS) to germinal center (GC) B cells, which drives affinity maturation, somatic hypermutation and long-lived humoral immunity (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>) (<xref rid="B120" ref-type="bibr">120</xref>&#8211;<xref rid="B122" ref-type="bibr">122</xref>). Indeed, administration of IL-1&#946; during immunization substitutes for adjuvant-induced Tfh expansion and cytokine release (specifically IL-4 and IL-21). Moreover, IL-1&#946; augments adjuvant-driven immunization by enhancing antigen-specific antibody production. In contrast, IL-1RA (Anakinra) inhibits these responses, showing the importance of IL-1 signaling in Tfh cells (<xref rid="B119" ref-type="bibr">119</xref>). The need of IL-1&#946; for a productive GC and antibody response after immunization (<xref rid="B123" ref-type="bibr">123</xref>) suggests that driving IL-1-dependent Tfh-mediated B cell activation might be beneficial for enhancing vaccine efficacy, either by direct IL-1 administration or by using agents that induce or release IL-1 (e.g. alum and necrotic cell death, respectively). However, GC activation has to be tightly regulated, because loss of control could breach B cell tolerance and allow self-reactive clones to escape the GC, ultimately causing systemic autoimmune disease (<xref rid="B124" ref-type="bibr">124</xref>, <xref rid="B125" ref-type="bibr">125</xref>).</p><p>Tregs maintain immune homeostasis by suppressing unwanted immune responses <italic toggle="yes">via</italic> multiple mechanisms (<xref rid="B126" ref-type="bibr">126</xref>, <xref rid="B127" ref-type="bibr">127</xref>), including regulation of IL-1 availability <italic toggle="yes">via</italic> expression of IL-1 antagonists. Within the GC, Treg subtypes can restrain humoral responses by inhibiting secretion of the B cell activating cytokines IL-4 and IL-21 from activated Tfh (<xref rid="B128" ref-type="bibr">128</xref>, <xref rid="B129" ref-type="bibr">129</xref>). T follicular regulatory (Tfr) cells in particular express high levels of IL-1R2 and IL-1RA, which suppresses IL-1-driven GC activation by inhibiting Tfh activation and secretion of IL-4 and IL-21 (<xref rid="B119" ref-type="bibr">119</xref>). Thus, in cases of IL-1-mediated GC dysregulation, IL-1 antagonists may be useful in controlling these responses and restoring protective immunity. However, non-physiological upregulation of IL-1R2 represents a maladaptive mechanism utilized by Tregs infiltrating colorectal, non-small cell lung or breast cancers that are more aggressive with poor prognosis (<xref rid="B130" ref-type="bibr">130</xref>, <xref rid="B131" ref-type="bibr">131</xref>). Supported by evidence showing that DC-derived IL-1&#946;-dependent priming of CD8+ T cells augments their tumoricidal properties and that <italic toggle="yes">Nlrp3<sup>-/-</sup></italic> or <italic toggle="yes">Casp-1<sup>-/-</sup></italic> DCs sub-optimally prime T cells (<xref rid="B132" ref-type="bibr">132</xref>), these data suggest that IL-1&#946; (or potentially IL-1&#945;) depletion from the tumor microenvironment could confer immunosuppression and poor tumor control, and thus IL-1R2 expression on intra-tumoral Tregs could be utilized as a prognostic marker.</p></sec><sec id="s2_2_2"><title>Indirect Effects of IL-1 on T Cells <italic toggle="yes">via</italic> Dendritic Cell Activation</title><p>In addition to the direct effects of IL-1 on T cells, their function can also be indirectly influenced by interaction with IL-1-primed DCs (<xref ref-type="fig" rid="f2">
<bold>Figure 2C</bold>
</xref>). Both IL-1&#945; or IL-1&#946;-pulsed DCs enhance T cell-dependent cytokine secretion from CD4 and CD8 T cells, with IFN-&#947; secretion being consistently augmented (<xref rid="B133" ref-type="bibr">133</xref>&#8211;<xref rid="B135" ref-type="bibr">135</xref>). Although IL-1&#946; is not as strong an inducer of DC maturation as LPS, it still potently upregulates activation markers (e.g. CD40, CD80 and CD83) and induces secretion of pro-inflammatory mediators (e.g. CXCL8 and CXCL12) (<xref rid="B133" ref-type="bibr">133</xref>). In contrast, IL-1&#946; induces minimal secretion of the major polarizing cytokine IL-12p70, but in combination with CD40L both expression of <italic toggle="yes">Il12b</italic> and release of IL-12p70 is increased (<xref rid="B134" ref-type="bibr">134</xref>, <xref rid="B136" ref-type="bibr">136</xref>). In addition, antigen endocytosis, which is diminished during DC maturation, is decreased by IL-1&#946; to a similar degree as LPS (<xref rid="B137" ref-type="bibr">137</xref>). What is clear is that the role of IL-1 on adaptive immunity is multifaceted and cannot be summarized in a single conclusion. A multitude of normal immune responses depend on IL-1 signaling, including T cell proliferation, expansion and differentiation, as well as humoral responses to T cell-dependent antigens. Moreover, IL-1 synergizes with CD40L to potentiate activation and maturation of DCs, and the subsequent adaptive immune response. Together, these processes are critical for host defense, and dysregulation of the equilibrium leads to either an ineffective adaptive reaction or an overwrought maladaptive response that drives autoimmune pathology.</p></sec></sec><sec id="s2_3"><title>IL-1 Is Important for Maintenance of Epithelial Barriers</title><p>Epithelial cells form a highly specialized physical barrier against the external environment, and thus are exposed to a myriad of PAMPs, damage-associated molecular patterns (DAMPs), and other environmental factors that induce inflammation. Although inflammasomes are primarily studied in myeloid cells they are also essential for barrier defense in non-myeloid cells, including specialized epithelial cells. Indeed, IL-1 is constitutively expressed in many epithelial cells, where it helps defend against pathogens and injury (<xref ref-type="fig" rid="f1">
<bold>Figure 1E</bold>
</xref>) (<xref rid="B138" ref-type="bibr">138</xref>). However, loss of control can lead to inappropriate activation, chronic inflammation and disease (<xref rid="B139" ref-type="bibr">139</xref>).</p><sec id="s2_3_1"><title>Keratinocytes</title><p>Keratinocytes secrete pro-IL-1&#945; that can be processed by thrombin activated during hemostasis after wounding. This connection between the coagulation and immune systems allows rapid IL-1&#945; activation and immune cell recruitment that can safeguard against potential infection after breach of the epidermal barrier (<xref rid="B36" ref-type="bibr">36</xref>). In response to UVB irradiation (<xref rid="B140" ref-type="bibr">140</xref>) or analogs of viral double stranded RNA (<xref rid="B141" ref-type="bibr">141</xref>) keratinocytes activate the NLRP3 inflammasome and secrete IL-1&#946;. The IL-1 released from keratinocytes after viral infection induces expression of anti-viral interferon-stimulated genes in local fibroblasts and endothelial cells. However, this is not observed in mouse models, suggesting human skin has an alternative IL-1-driven anti-viral system to prevent viruses that can evade detection by pattern recognition receptors (<xref rid="B142" ref-type="bibr">142</xref>).</p></sec><sec id="s2_3_2"><title>Gastrointestinal Epithelium</title><p>The gastrointestinal tract epithelium is highly specialized throughout its length and must respond appropriately to its local environment to maintain homeostasis. In the stomach, IL-1-mediated reduction of gastric acid production (<xref rid="B143" ref-type="bibr">143</xref>&#8211;<xref rid="B145" ref-type="bibr">145</xref>) and prostaglandin synthesis (<xref rid="B146" ref-type="bibr">146</xref>) by parietal epithelial cells inhibits neutrophil infiltration, which protects the gastric lining from non-steroidal anti-inflammatory drug-induced gastropathy (<xref rid="B146" ref-type="bibr">146</xref>) and ulceration (<xref rid="B147" ref-type="bibr">147</xref>). In the duodenum, IL-1 signaling causes epithelial goblet cells to increase mucus secretion (<xref rid="B148" ref-type="bibr">148</xref>, <xref rid="B149" ref-type="bibr">149</xref>), and IL-1 can also confer protection to disrupted mucosal layers during <italic toggle="yes">Helicobacter pylori</italic> infection (<xref rid="B150" ref-type="bibr">150</xref>). In contrast, elevated IL-1 signaling can also contribute to gut epithelium dysfunction by increasing tight junction permeability (<xref rid="B151" ref-type="bibr">151</xref>, <xref rid="B152" ref-type="bibr">152</xref>) and inhibiting effective absorption (<xref rid="B153" ref-type="bibr">153</xref>&#8211;<xref rid="B155" ref-type="bibr">155</xref>). Finally, IL-1 signaling in colonic epithelial cells plays a direct pro-tumorigenic role by regulating the early proliferation and survival of colorectal cancer cells, independent of inflammation (<xref rid="B156" ref-type="bibr">156</xref>).</p></sec><sec id="s2_3_3"><title>Respiratory Epithelium</title><p>The respiratory epithelium comprises basal, ciliated, and secretory epithelial cells responsible for homeostatic regulation of lung fluid, clearance of inhaled agents, recruitment of immune cells, and regulation of airway smooth muscle function (<xref rid="B157" ref-type="bibr">157</xref>). Epithelial IL-1 signaling regulates mucin secretion and airway surface liquid metabolism, resulting in enhanced mucociliary clearance during inflammation (<xref rid="B158" ref-type="bibr">158</xref>). In cystic fibrosis, where CFTR-mediated fluid secretion is impaired, IL-1 drives secretion of epithelial mucin, but not fluid, causing mucus hyperconcentration (<xref rid="B159" ref-type="bibr">159</xref>). IL-1 and TNF&#945; also promote the regeneration of alveolar epithelial cells by stimulating proliferation of type 2 epithelial progenitor cells (<xref rid="B160" ref-type="bibr">160</xref>). Indeed, IL-1 and TNF&#945; released during influenza infection promotes repair of damaged alveoli (<xref rid="B161" ref-type="bibr">161</xref>).</p></sec><sec id="s2_3_4"><title>Endothelial Cells</title><p>Endothelial cells are critical for blood vessel formation, coagulation, regulation of vascular tone, and inflammation (<xref rid="B162" ref-type="bibr">162</xref>). Heme from ruptured red blood cells can activate the NLRP3 inflammasome and cause IL-1&#946; release from endothelial cells, and thus inflammation can occur in response to sterile hemolysis (<xref rid="B163" ref-type="bibr">163</xref>). Endothelial cells activated by IL-1 express TF on their surface, which initiates the coagulation cascade (<xref rid="B69" ref-type="bibr">69</xref>, <xref rid="B164" ref-type="bibr">164</xref>, <xref rid="B165" ref-type="bibr">165</xref>). IL-1 also causes endothelial cells to reduce tight junction integrity (<xref rid="B166" ref-type="bibr">166</xref>&#8211;<xref rid="B168" ref-type="bibr">168</xref>) and increase expression of adhesion molecules, such as ICAM (<xref rid="B169" ref-type="bibr">169</xref>) and PECAM1 (<xref rid="B170" ref-type="bibr">170</xref>), facilitating diapedesis of leukocytes. In contrast, IL-1 reduces transcellular diapedesis through endothelial cells (<xref rid="B167" ref-type="bibr">167</xref>). Finally, IL-1 also acts as a potent proangiogenic signal <italic toggle="yes">via</italic> endothelial cell-derived vascular endothelial growth factor (VEGF) (<xref rid="B171" ref-type="bibr">171</xref>). For example, during tumorigenesis, IL-1 from recruited myeloid cells causes endothelial cells to upregulate VEGF and other proangiogenic factors, which promotes an inflammatory microenvironment that supports tumor angiogenesis (<xref rid="B172" ref-type="bibr">172</xref>, <xref rid="B173" ref-type="bibr">173</xref>). In these models IL-1 inhibition restricted tumor growth and angiogenesis (<xref rid="B174" ref-type="bibr">174</xref>). Together, IL-1 signaling is essential to many specialized epithelial cell processes and is vital for effective barrier defense; however, dysregulation can lead to excessive inflammation and tumorigenesis.</p></sec></sec></sec><sec id="s3"><title>Part 3&#8212;Alternative Roles of IL-1 in Health and Disease</title><p>Immune responses are necessary for the maintenance of homeostasis; for example, to maintain an environment that is inhospitable for invading pathogens (e.g. mucous membranes), or in contrast, training the immune system to tolerate bacteria (e.g. gut microbiota). However, balance is everything, with loss of homeostasis leading to chronic inflammation and/or inappropriate adaptive immunity, which both exacerbates existing disease and drives emergence of new pathology. IL-1 signaling is central to many immune responses, and thus blocking IL-1 therapeutically is important in a wide spectrum of diseases (<xref rid="B175" ref-type="bibr">175</xref>). This section focuses on some of the more unconventional effects of IL-1 in health and disease.</p><sec id="s3_1"><title>IL-1 Signaling Is Important During Wounding and Thrombosis</title><p>Skin wounding occurs when the epidermal barrier is disrupted by cutting, excessive force, chemicals, or extreme temperature. Wounding triggers a series of events critical to the healing process: hemostasis, inflammation, proliferation, and remodeling (<xref rid="B176" ref-type="bibr">176</xref>). Initially, hemostasis is activated after vessel wall injury to allow local thrombus formation that stymies blood loss (<xref rid="B177" ref-type="bibr">177</xref>). Subsequent inflammation at the wound site is integral for removal of damaged tissue and recruitment of immune cells that coordinate repair (<xref rid="B176" ref-type="bibr">176</xref>).</p><p>Epidermal IL-1&#945; colocalizes with TF, a potent thrombin activator. Thus, epidermal injury results in generation of active thrombin, which cleaves and activates pro-IL-1&#945; (<xref rid="B36" ref-type="bibr">36</xref>). Indeed, genetically modified mice with thrombin-resistant pro-IL-1&#945; recruit fewer neutrophils and macrophages to the granulation tissue under the wound and show&#160;delayed healing (<xref rid="B36" ref-type="bibr">36</xref>). Furthermore, excisional wounds in <italic toggle="yes">Nlrp3</italic>
<sup>-/-</sup> and <italic toggle="yes">Casp1</italic>
<sup>-/-</sup> mice contain less IL-1&#946; and TNF&#945;, recruit fewer neutrophils and macrophages, and also show delayed healing that can be partially rescued by addition of exogenous IL-1&#946; (<xref rid="B178" ref-type="bibr">178</xref>). In keeping with this, application of the NLRP3 activator ATP accelerates wound closure in wild type mice (<xref rid="B179" ref-type="bibr">179</xref>)<italic toggle="yes">. Staphylococcus aureus</italic> infection of wounds upregulates keratinocyte IL-1 that drives neutrophil recruitment <italic toggle="yes">via</italic> IL-1R1 signaling (<xref rid="B180" ref-type="bibr">180</xref>), while NLRP3 activation is also seen after sterile burn injuries, with Nlrp3-/- mice showing reduced macrophage infiltration and impaired healing after chemical burns (<xref rid="B181" ref-type="bibr">181</xref>). In contrast, excessive IL-1 can lead to chronic non-resolving wounds (<xref ref-type="fig" rid="f1">
<bold>Figure 1F</bold>
</xref>). For example, sustained NLRP3 activation and elevated IL-1&#946; is found in non-healing diabetic wounds (<xref rid="B182" ref-type="bibr">182</xref>), with inflammasome inhibition improving healing <italic toggle="yes">via</italic> increased angiogenesis and reduced inflammatory macrophages (<xref rid="B182" ref-type="bibr">182</xref>, <xref rid="B183" ref-type="bibr">183</xref>). Additionally, excessive neutrophil NETs cause NLRP3-dependent IL-1&#946; release from macrophages (<xref rid="B70" ref-type="bibr">70</xref>), with NET digestion reducing inflammasome activation and macrophage infiltration, leading to diabetic wound healing (<xref rid="B70" ref-type="bibr">70</xref>). IL-1 signaling also promotes fibrosis in the wound, with IL-1 inhibition reducing scarring and improving healing in deep tissue (<xref rid="B184" ref-type="bibr">184</xref>) and diabetic wounds (<xref rid="B185" ref-type="bibr">185</xref>). Together, this shows that while IL-1 signaling in the wound is necessary for effective wound healing, it must be tightly regulated to prevent pathological chronic inflammation and/or scarring.</p><p>Hemostasis is essential to prevent injury-related blood loss; however pathological thrombosis occurs when anticoagulant mechanisms are unable to limit excessive activation of the hemostatic pathway, leading to vessel occlusion and downstream ischemia. Excessive IL-1 signaling can cause thrombosis (<xref ref-type="fig" rid="f1">
<bold>Figure 1F</bold>
</xref>), with the CANTOS study finding that IL-1&#946; inhibition with Canakinumab reduces secondary atherothrombotic events in patients with residual inflammatory risk, which was likely due to modulation of procoagulant factors and reduced leukocyte recruitment to the plaque (<xref rid="B186" ref-type="bibr">186</xref>). Additionally, increased NLRP3-dependent IL-1&#946; maturation and venous thrombosis is seen in mice deficient for the vasculoprotective enzyme CD39, which is reversed by IL-1 inhibition (<xref rid="B187" ref-type="bibr">187</xref>). Thrombosis relies on the interplay between blood cells, plasma proteins and the vessel wall. Neutrophils drive thrombosis by producing TF and NETs, which act as scaffolds for thrombus stabilization (<xref rid="B188" ref-type="bibr">188</xref>, <xref rid="B189" ref-type="bibr">189</xref>), which can induce coagulopathy during sepsis (<xref rid="B190" ref-type="bibr">190</xref>), acute respiratory distress syndrome (ARDS) (<xref rid="B191" ref-type="bibr">191</xref>), and coronary artery thrombosis (<xref rid="B192" ref-type="bibr">192</xref>). ST-elevation myocardial infarction (STEMI) patients with elevated inflammatory markers (e.g. hsCRP) have increased circulating IL-1&#946; and NET-associated TF, while mouse models of thrombosis have reduced NET-associated TF and delayed thrombotic occlusion when IL-1&#946; is blocked (<xref rid="B193" ref-type="bibr">193</xref>). Similarly, IL-1&#946; or NLRP3 inhibition attenuates NET-associated thrombosis in mouse models of breast cancer, supporting IL-1&#946; as the driver of this mechanism (<xref rid="B194" ref-type="bibr">194</xref>). Additionally, as NET-associated proteases can activate IL-1&#945;, this can also promote IL-1R1-dependent TF expression on the endothelial cell surface (<xref rid="B69" ref-type="bibr">69</xref>). Macrophages can also release TF after inflammasome activation by bacteria during sepsis, with GSDMD-dependent pyroptosis and pore formation allowing externalization of TF that triggers systemic coagulation and lethality (<xref rid="B195" ref-type="bibr">195</xref>, <xref rid="B196" ref-type="bibr">196</xref>). Overall, wounding is a complex mechanism that requires rapid, tightly controlled, hemostasis and inflammation for effective healing. IL-1 is widely expressed in the epidermis and the vessel wall and can be activated by many proteases, and is therefore integral to the wounding response.</p></sec><sec id="s3_2"><title>Innate Immune Training Can Be Mediated by IL-1&#946;</title><p>Trained immunity refers to a response in innate immune cells after encountering a pathogen that is more adaptive-like and confers a degree of protection against secondary exposure to an un-related infection (<xref rid="B197" ref-type="bibr">197</xref>). Establishment of trained immunity is mostly driven by epigenetic remodeling and metabolic changes that occur after the first exposure (<xref rid="B198" ref-type="bibr">198</xref>, <xref rid="B199" ref-type="bibr">199</xref>). Because the epigenetic imprinting is locus-specific and allows access to transcription factors, it can alter cell identity and prime specific functions. Similarly, changes in cell metabolism also establish new cell functions (<xref rid="B199" ref-type="bibr">199</xref>). However, cell metabolism can affect epigenetic reprogramming that further alters the cells metabolic status, and thus these processes are inter-dependent. IL-1 family agonists are implicated in trained innate immunity, with macrophage-derived IL-18 playing a non-redundant role in training NK cells&#8217; anti-tumor activity <italic toggle="yes">via</italic> secretion of IFN-&#947; (<xref rid="B200" ref-type="bibr">200</xref>&#8211;<xref rid="B202" ref-type="bibr">202</xref>). Moreover, IL-1&#946; participates in induction of trained immunity in response to Bacille Calmette-Guerin (BCG) vaccination, where increased IL-1&#946; and TNF&#945; from peripheral monocytes correlates with enriched histone H3K4 tri-methylation at <italic toggle="yes">Il6</italic>, <italic toggle="yes">Tnf</italic>, and <italic toggle="yes">Tlr4</italic> promoters after <italic toggle="yes">in vitro</italic> re-stimulation with <italic toggle="yes">M. tuberculosis</italic>, heat-killed <italic toggle="yes">S. aureus</italic> or <italic toggle="yes">C. albicans</italic> (<xref rid="B203" ref-type="bibr">203</xref>).</p><p>Epigenetic changes after training <italic toggle="yes">via</italic> cytokines can be mediated by altered metabolism that leads to accumulation of metabolic products such as glucose, lactate (<xref rid="B204" ref-type="bibr">204</xref>), succinate, itaconate (<xref rid="B205" ref-type="bibr">205</xref>), mevalonate (<xref rid="B206" ref-type="bibr">206</xref>) and fumarate (<xref rid="B207" ref-type="bibr">207</xref>). In particular, the transition from oxidative phosphorylation to aerobic glycolysis is a determining step towards trained immunity, and is associated with H3K4me3 and H3K27Ac modifications in the presence of glucose, lactate (<xref rid="B204" ref-type="bibr">204</xref>) and mevalonate (<xref rid="B206" ref-type="bibr">206</xref>). Interestingly, mevalonate accumulation in patients with hyper IgD syndrome (HIDS) that lack mevalonate kinase is associated with increased IL-1&#946; production by LPS-stimulated monocytes (<xref rid="B206" ref-type="bibr">206</xref>). Similarly, glycolysis-driven accumulation of succinate in response to LPS induces macrophage IL-1&#946; expression, which occurs <italic toggle="yes">via</italic> HIF-1&#945; binding to the <italic toggle="yes">Il1b</italic> promoter (<xref rid="B208" ref-type="bibr">208</xref>).</p><p>Trained immunity is also established at a systemic/central level after exposure of bone marrow hemopoietic stem and progenitor cells (HSPCs) to pathogen-derived products, such as &#946;-glucan, BCG, or Western diet (WD) feeding. &#946;-glucan induces bone marrow IL-1&#946; production that acts on HSPCs, leading to preferential myelopoiesis and metabolism that favors glycolysis and cholesterol synthesis (<xref rid="B209" ref-type="bibr">209</xref>). BCG vaccination also causes HSPCs to skew toward myelopoiesis and epigenetic reprogramming of macrophages, such that they upregulate <italic toggle="yes">Ifng</italic>, <italic toggle="yes">Tnf</italic>, and <italic toggle="yes">Il1b</italic> upon re-stimulation with <italic toggle="yes">M. tuberculosis</italic> (<xref rid="B210" ref-type="bibr">210</xref>). Indeed, BCG vaccination increases circulating IL-1&#946;, which inversely correlates with viremia after a secondary yellow fever vaccination (<xref rid="B211" ref-type="bibr">211</xref>). Together, this suggests that IL-1&#946; contributes to both training process and direct anti-mycobacterial response. Interestingly, diet can also drive trained immunity, with WD fed mice exhibiting myelopoiesis skewed towards the monocytic lineage and upregulation of genes associated with hematopoiesis, metabolism, immune cell differentiation and leukocyte activation. This WD-dependent reprogramming was long lasting (4 weeks) and was dependent on NLRP3 (<xref rid="B212" ref-type="bibr">212</xref>).</p><p>However, despite beneficial effects of trained immunity on host defense, the long-lasting reprogramming of innate immune cells can become maladaptive and contribute to pathology. Human monocytes trained <italic toggle="yes">ex vivo</italic> with oxidized low density lipoprotein (oxLDL) or &#946;-glucan produce pro-atherogenic cytokines and increase foam cell formation upon re-stimulation (<xref rid="B213" ref-type="bibr">213</xref>). Furthermore, chronic systemic exposure to IL-1 can lead to haematopoietic stem cell exhaustion that compromises blood cell homeostasis and reduces the ability to endure replicative challenges such as transplantation (<xref rid="B214" ref-type="bibr">214</xref>). Under such circumstances metabolites such as itaconate, which limits aerobic glycolysis and induces anti-inflammatory and anti-oxidative programs (<xref rid="B215" ref-type="bibr">215</xref>&#8211;<xref rid="B217" ref-type="bibr">217</xref>), might be utilized to counteract innate training and re-instate immune tolerance (<xref rid="B205" ref-type="bibr">205</xref>).</p><p>In the brain, microglia are able to undergo priming in response to injury similar to immune training seen in macrophages in the peripheral immune system (<xref rid="B218" ref-type="bibr">218</xref>). IL-1 is constitutively expressed at very low levels in the normal brain but appears to have a role in some physiological processes, including regulation of sleep and synaptic plasticity (<xref rid="B219" ref-type="bibr">219</xref>, <xref rid="B220" ref-type="bibr">220</xref>). Following neurotoxic injury, upregulation of IL-1&#945; and IL-1&#946; occurs rapidly in the brain (<xref rid="B219" ref-type="bibr">219</xref>), and facilitates recruitment of leukocytes across the blood brain barrier (<xref rid="B221" ref-type="bibr">221</xref>). Microglia are able to retain memory of an inflammatory state <italic toggle="yes">via</italic> histone H3 modifications, which may contribute to hyper-reactive IL-1 expression in response to subsequent inflammatory stimuli, which is seen in many neurodegenerative pathologies (<xref rid="B218" ref-type="bibr">218</xref>).</p></sec><sec id="s3_3"><title>Autoimmunity Can Be Driven by Aberrant IL-1 Signaling</title><p>Although IL-1 is critical for host defense, it can also contribute to autoimmune disease <italic toggle="yes">via</italic> its ability to amplify T cell responses, shift the balance for immune tolerance and its direct action on non-immune cells that induces inflammation and tissue damage (<xref rid="B102" ref-type="bibr">102</xref>, <xref rid="B222" ref-type="bibr">222</xref>) (<xref ref-type="fig" rid="f2">
<bold>Figure 2D</bold>
</xref>). Indeed, each of the above mechanisms, either alone or in combination, underlie the pathophysiology of common autoimmune diseases.</p><sec id="s3_3_1"><title>Amplification of T Cell Response in IL-17-Producing T Cells</title><p>IL-17-producing Th17 and &#947;&#948; T cells are causal of several mouse autoimmune syndromes, such as experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B223" ref-type="bibr">223</xref>, <xref rid="B224" ref-type="bibr">224</xref>). IL-17 production in these cell types is stimulated by IL-1, suggesting that excess IL-1 would exacerbate these conditions. Indeed, both <italic toggle="yes">Il1r1<sup>-/-</sup></italic> and <italic toggle="yes">Il1a/b<sup>-/-</sup></italic> mice are resistant to the development of EAE due to lower Th17 cell proliferation, less IL-17 and lower self-reactive T cell activation, leading to less autoantibodies (<xref rid="B44" ref-type="bibr">44</xref>, <xref rid="B225" ref-type="bibr">225</xref>). Similarly, IL-1&#946; and IL-23-treated &#947;&#948; T cells drive EAE by increased secretion of IL-17 directly into the brain milieu and by indirect augmentation of IL-17 production by &#945;&#946; T cells (<xref rid="B223" ref-type="bibr">223</xref>).</p><p>As demonstrated in the Deficiency of Interleukin-1 Receptor antagonist (DIRA) syndrome, IL-1 antagonism is critical for the amelioration of IL-17-driven diseases. DIRA is an autoinflammatory condition associated with hyperactivation of IL-1 signaling due to loss-of-function mutations in IL-1RA, with severe manifestations in skin and bone. As such, DIRA is very responsive to IL-1 blockade by administration of recombinant IL-1RA (Anakinra) (<xref rid="B226" ref-type="bibr">226</xref>). Furthermore, IL-1 antagonists (i.e. IL-1RA and SIGIRR) delay onset and reduce severity of mouse EAE (<xref rid="B225" ref-type="bibr">225</xref>, <xref rid="B227" ref-type="bibr">227</xref>). Interestingly, classic drugs used to manage multiple sclerosis (MS) (i.e. IFN&#946;) and its clinical relapse (i.e. steroids) associate with increased systemic levels of IL-1RA and IL-1R2 (<xref rid="B228" ref-type="bibr">228</xref>&#8211;<xref rid="B230" ref-type="bibr">230</xref>). In addition, monitoring the IL-1 to IL-1RA ratio in cerebrospinal fluid and/or lesions in MS patients may predict susceptibility of relapse-onset MS, hinting towards the use of IL-1 as a biomarker (<xref rid="B231" ref-type="bibr">231</xref>).</p><p>In keeping, loss of NLRP3 inflammasome components (i.e. NLRP3, ASC, caspases-1 or -11) confers some protection from EAE (<xref rid="B232" ref-type="bibr">232</xref>&#8211;<xref rid="B235" ref-type="bibr">235</xref>). However, inflammasome-independent IL-1&#946; production has also been demonstrated as a result of trans-cellular interactions between effector CD4 T cells and DCs. Thus, CD4 T cell-derived TNF induces DC expression of pro-IL-1&#946;, which is subsequently activated by casp-8 after T cell FasL ligation of DC Fas, leading to IL-1&#946; release and induction of EAE (<xref rid="B236" ref-type="bibr">236</xref>).</p></sec><sec id="s3_3_2"><title>Stability of Tregs and Break of Self-Tolerance</title><p>Tregs are critical for maintenance of peripheral tolerance through their ability to suppress inappropriate activation of effector T cells. Foxp3 is essential for the suppressive functions of Tregs, and thus its expression maintains physiological T cell responses. Foxp3 expression can be reduced in highly inflammatory tissue microenvironments, especially in the presence of IL-1 and IL-6, which can convert Tregs into effector T cells that produce IFN-&#947; and IL-17 (<xref rid="B237" ref-type="bibr">237</xref>&#8211;<xref rid="B239" ref-type="bibr">239</xref>). Indeed, this confirms observations that IL-1&#946; reduces susceptibility of CD4 effector/memory T cells to Treg suppression due to expansion of IFN-&#947; producing effector CD25+ cells (<xref rid="B240" ref-type="bibr">240</xref>). This is more pronounced in the autoimmune-prone NOD mice, where splenocyte IL-1&#946; production is enhanced and IL-1&#946; neutralization restores Treg suppression and normalizes IFN-&#947; secretion, altogether suggesting that breach of tolerance can be driven by IL-1&#946; (<xref rid="B240" ref-type="bibr">240</xref>).</p></sec></sec><sec id="s3_4"><title>The Action of IL-1 on Non-Immune Cells Contributes to Autoimmunity</title><p>Besides its direct immunomodulatory effects, IL-1 can also act on non-immune cells to either alter their function or direct them towards apoptosis, thus contributing to the progression of several autoimmune and metabolic syndromes. Tissue damaging effects of IL-1 have been identified in the development of Type 1 and Type 2 Diabetes Mellitus (T1/T2DM) as well as rheumatoid arthritis (RA), while in systemic sclerosis (SSc) IL-1 has been shown to mediate pathological tissue remodeling.</p><sec id="s3_4_1"><title>IL-1-Mediated &#946;-Cell Apoptosis in Metabolic Syndromes</title><p>Pancreatic inflammation and &#946;-cell deregulation and loss are determining factors in the pathogenesis of both T1/T2DM (<xref rid="B241" ref-type="bibr">241</xref>, <xref rid="B242" ref-type="bibr">242</xref>), and IL-1 can interfere with all these processes. Pancreatic &#946;-cells express high levels or IL-1R1 and respond to IL-1 by upregulating inflammatory cytokines and chemokines (<xref rid="B243" ref-type="bibr">243</xref>, <xref rid="B244" ref-type="bibr">244</xref>), which in turn recruit macrophages (<xref rid="B245" ref-type="bibr">245</xref>) and T cells (<xref rid="B246" ref-type="bibr">246</xref>). In addition, IL-1&#946; has direct cytotoxic effects on &#946;-cells (<xref rid="B247" ref-type="bibr">247</xref>) <italic toggle="yes">via</italic> canonical NF-&#954;B activation and upregulation of Fas, in response to glucose, ultimately contributing to insulin resistance and development of T2DM (<xref rid="B248" ref-type="bibr">248</xref>). This IL-1&#946;-mediated glucotoxicity is also relevant to T1DM, where islet resident macrophages secrete IL-1&#946; upon stimulation with LPS and TNF (<xref rid="B249" ref-type="bibr">249</xref>), leading to &#946;-cell production of cytotoxic molecules (e.g. inducible nitric oxide synthase) (<xref rid="B250" ref-type="bibr">250</xref>). In addition, &#946;-cell apoptosis can also be triggered by IL-1&#946; and IFN-&#947; activation of the non-canonical NF-&#954;B pathway (<xref rid="B251" ref-type="bibr">251</xref>). Indeed, glucotoxicity and cell loss is abrogated by IL-1RA, improving &#946;-cell secretory function and glycemic control (<xref rid="B248" ref-type="bibr">248</xref>, <xref rid="B252" ref-type="bibr">252</xref>).</p></sec><sec id="s3_4_2"><title>IL-1-Dependent Degradation of Bone and Cartilage in Rheumatoid Arthritis</title><p>RA is characterized by progressive destruction of the articular joints due to IL-1&#946;-dependent degradation of both bone and cartilage (<xref rid="B253" ref-type="bibr">253</xref>). BALB/c mice lacking IL-1RA spontaneously develop an inflammatory arthropathy that shares features with human RA, such as inflammatory cell infiltrates, fibrin clots, bone erosion, increased IL-1&#946; in the affected joints and autoantibodies in serum (<xref rid="B254" ref-type="bibr">254</xref>). IL-1 signaling in synovial cells and chondrocytes causes upregulation and secretion of matrix metalloproteinases that degrade cartilage (<xref rid="B255" ref-type="bibr">255</xref>&#8211;<xref rid="B257" ref-type="bibr">257</xref>). In addition, IL-1 and TNF, when in the presence of T cell-derived RANKL, exert pro-osteoclastogenic effects that result in bone erosion and further joint damage (<xref rid="B258" ref-type="bibr">258</xref>), suggesting that IL-1 could be a druggable target for ameliorating symptoms and impeding disease progression. Indeed, neutralization of IL-1 with antibodies or natural antagonists (i.e. IL-1RA or IL-1R2) diminish local inflammation and protect the joint from bone erosion, which led to the approval of Anakinra (IL-1RA) as an effective therapeutic for management of RA (<xref rid="B259" ref-type="bibr">259</xref>&#8211;<xref rid="B261" ref-type="bibr">261</xref>).</p></sec><sec id="s3_4_3"><title>IL-1 Regulates Fibroblast Differentiation in Systemic Sclerosis</title><p>SSc is an idiopathic autoimmune syndrome that exhibits fibrosis in the skin and other organs like the heart and lungs, due to fibroblast activation and deposition of extracellular matrix (<xref rid="B262" ref-type="bibr">262</xref>). IL-1&#945; and IL-1&#946; regulate IL-6 and PDGF-A expression on SSc fibroblasts, promoting collagen deposition and proliferation (<xref rid="B263" ref-type="bibr">263</xref>, <xref rid="B264" ref-type="bibr">264</xref>) and differentiation into myofibroblasts (<xref rid="B265" ref-type="bibr">265</xref>&#8211;<xref rid="B267" ref-type="bibr">267</xref>). In addition, inflammasome activation in fibroblasts leading to IL-1&#946; production acts in an autocrine manner to trigger expression of mIR-155, which in turn regulates collagen deposition in SSc (<xref rid="B268" ref-type="bibr">268</xref>&#8211;<xref rid="B270" ref-type="bibr">270</xref>).</p></sec></sec><sec id="s3_5"><title>IL-1 Signaling May Be Important in the Pathogenesis of COVID-19</title><p>The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has caused a global pandemic (<xref rid="B271" ref-type="bibr">271</xref>). Symptoms of COVID-19 range from mild to severe, with viral pneumonia leading to ARDS, sepsis/disseminated intravascular coagulation (DIC) and/or multi-organ failure identified as the major causes of death (<xref rid="B272" ref-type="bibr">272</xref>). A key stage of the virus lifecycle is release of newly replicated virons (<xref rid="B273" ref-type="bibr">273</xref>), which escape <italic toggle="yes">via</italic> the host cell&#8217;s secretory pathways or by cell lysis (<xref rid="B274" ref-type="bibr">274</xref>). Egress of coronaviruses depends on the coronavirus envelope (E) protein, which acts as a viroporin that forms pores in the plasma membrane, causing lysis and subsequent release of DAMPs (<xref rid="B275" ref-type="bibr">275</xref>&#8211;<xref rid="B277" ref-type="bibr">277</xref>). For example, respiratory syncytial virus-infected cells release IL-1&#945; that activates neighboring cells to promote leukocyte recruitment (<xref rid="B278" ref-type="bibr">278</xref>) and interferon-mediated anti-viral mechanisms (<xref ref-type="fig" rid="f1">
<bold>Figure 1G</bold>
</xref>) (<xref rid="B142" ref-type="bibr">142</xref>). However, excessive cell lysis and DAMP release can trigger an over-the-top innate immune response and overt production of cytokines, known as a cytokine storm, which can spill over into the circulation and cause sepsis (<xref rid="B279" ref-type="bibr">279</xref>). Severe SARS-CoV-2 infection causes a systemic cytokine storm and ARDS, with accompanying thrombosis (<xref rid="B271" ref-type="bibr">271</xref>, <xref rid="B280" ref-type="bibr">280</xref>, <xref rid="B281" ref-type="bibr">281</xref>). IL-1 inhibition improves pathologies associated with cytokine storms, including sepsis and DIC (<xref rid="B282" ref-type="bibr">282</xref>&#8211;<xref rid="B284" ref-type="bibr">284</xref>), and thus maybe beneficial for treating COVID-19. Indeed, Anakinra (IL-1RA) appears to dampen markers of systemic inflammation and improve ARDS in COVID-19 patients. Importantly, Anakinra has a short half-life (3h) that allows rapid discontinuation of treatment if needed, in contrast to Canakinumab (half-life 26&#160;d) (<xref rid="B284" ref-type="bibr">284</xref>, <xref rid="B285" ref-type="bibr">285</xref>). At the time of writing there were 15 registered clinical trials examining IL-1 blockade by Anakinra for COVID-19. However, patient selection, dosing, and outcome measures are not harmonized between studies (<xref rid="B286" ref-type="bibr">286</xref>), and only 11 were randomized control trials. Finally, the multi-center RECOVERY trial has recently shown that the corticosteroid dexamethasone reduces deaths by one-third in ventilated COVID-19 patients (<xref rid="B287" ref-type="bibr">287</xref>), reinforcing the use of anti-inflammatory agents. Interestingly, dexamethasone is long known to profoundly inhibit IL-1 production (<xref rid="B288" ref-type="bibr">288</xref>, <xref rid="B289" ref-type="bibr">289</xref>), again signifying a likely role for this apical cytokine in human health and disease. Together, there is existing evidence that blockade of inflammatory pathways, including IL-1, is beneficial for reducing symptoms of cytokine storm in COVID-19. Further clinical trials will be essential to determine the full extent of this benefit.</p></sec></sec><sec id="s4"><title>Author Contributions</title><p>KP and LB contributed equally. KP, LB, and MC conceived and wrote the review. All authors contributed to the article and approved the submitted version.</p></sec><sec sec-type="funding-information" id="s5"><title>Funding</title><p>This work was funded by British Heart Foundation Grants FS/09/005/26845, FS/13/3/30038, FS/18/19/33371, and RG/16/8/32388 to MC, the BHF Cambridge Centre for Research Excellence RE/13/6/30180, and the Cambridge NIHR Biomedical Research Centre.</p></sec><sec sec-type="COI-statement" id="s6"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afonina</surname><given-names>IS</given-names></name><name name-style="western"><surname>M&#252;ller</surname><given-names>C</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Beyaert</surname><given-names>R</given-names></name></person-group><article-title>Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme</article-title>. <source>Immunity</source> (<year>2015</year>) <volume>42</volume>:<fpage>991</fpage>&#8211;<lpage>1004</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.003</pub-id><pub-id pub-id-type="pmid">26084020</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornberry</surname><given-names>NA</given-names></name><name name-style="western"><surname>Bull</surname><given-names>HG</given-names></name><name name-style="western"><surname>Calaycay</surname><given-names>JR</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>KT</given-names></name><name name-style="western"><surname>Howard</surname><given-names>AD</given-names></name><name name-style="western"><surname>Kostura</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes</article-title>. <source>Nature</source> (<year>1992</year>) <volume>356</volume>:<page-range>768&#8211;74</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/356768a0</pub-id><pub-id pub-id-type="pmid">1574116</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yamamoto</surname><given-names>K</given-names></name><name name-style="western"><surname>Saido</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawasaki</surname><given-names>H</given-names></name><name name-style="western"><surname>Oppenheim</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>K</given-names></name></person-group><article-title>Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1990</year>) <volume>87</volume>:<page-range>5548&#8211;52</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.87.14.5548</pub-id><pub-id pub-id-type="pmcid">PMC54362</pub-id><pub-id pub-id-type="pmid">2115174</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>K</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Huang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death</article-title>. <source>Nature</source> (<year>2015</year>) <volume>526</volume>:<page-range>660&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature15514</pub-id><pub-id pub-id-type="pmid">26375003</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>J</given-names></name><name name-style="western"><surname>Pan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Magupalli</surname><given-names>VG</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores</article-title>. <source>Nature</source> (<year>2016</year>) <volume>535</volume>:<page-range>153&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature18629</pub-id><pub-id pub-id-type="pmcid">PMC5539988</pub-id><pub-id pub-id-type="pmid">27383986</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aglietti</surname><given-names>RA</given-names></name><name name-style="western"><surname>Estevez</surname><given-names>A</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>A</given-names></name><name name-style="western"><surname>Ramirez</surname><given-names>MG</given-names></name><name name-style="western"><surname>Liu</surname><given-names>PS</given-names></name><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><etal/></person-group><article-title>GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2016</year>) <volume>113</volume>:<page-range>7858&#8211;63</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1607769113</pub-id><pub-id pub-id-type="pmcid">PMC4948338</pub-id><pub-id pub-id-type="pmid">27339137</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gaidt</surname><given-names>MM</given-names></name><name name-style="western"><surname>Ebert</surname><given-names>TS</given-names></name><name name-style="western"><surname>Chauhan</surname><given-names>D</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>T</given-names></name><name name-style="western"><surname>Schmid-Burgk</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rapino</surname><given-names>F</given-names></name><etal/></person-group><article-title>Human Monocytes Engage an Alternative Inflammasome Pathway</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>:<page-range>833&#8211;46</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.01.012</pub-id><pub-id pub-id-type="pmid">27037191</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Evavold</surname><given-names>CL</given-names></name><name name-style="western"><surname>Ruan</surname><given-names>J</given-names></name><name name-style="western"><surname>Tan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xia</surname><given-names>S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>H</given-names></name><name name-style="western"><surname>Kagan</surname><given-names>JC</given-names></name></person-group><article-title>The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages</article-title>. <source>Immunity</source> (<year>2018</year>) <volume>48</volume>:<fpage>35</fpage>&#8211;<lpage>44.e6</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2017.11.013</pub-id><pub-id pub-id-type="pmid">29195811</pub-id><pub-id pub-id-type="pmcid">PMC5773350</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hagar</surname><given-names>JA</given-names></name><name name-style="western"><surname>Powell</surname><given-names>DA</given-names></name><name name-style="western"><surname>Aachoui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ernst</surname><given-names>RK</given-names></name><name name-style="western"><surname>Miao</surname><given-names>EA</given-names></name></person-group><article-title>Cytoplasmic LPS activates caspase-11: Implications in TLR4-independent endotoxic shock</article-title>. <source>Science (80)</source> (<year>2013</year>) <volume>341</volume>:<page-range>1250&#8211;3</page-range>. &#160;<pub-id pub-id-type="doi">10.1126/science.1240988</pub-id><pub-id pub-id-type="pmcid">PMC3931427</pub-id><pub-id pub-id-type="pmid">24031018</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>W</given-names></name><name name-style="western"><surname>Ding</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>P</given-names></name><etal/></person-group><article-title>Inflammatory caspases are innate immune receptors for intracellular LPS</article-title>. <source>Nature</source> (<year>2014</year>) <volume>514</volume>:<page-range>187&#8211;92</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature13683</pub-id><pub-id pub-id-type="pmid">25119034</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baker</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>D</given-names></name><name name-style="western"><surname>Bierschenk</surname><given-names>D</given-names></name><name name-style="western"><surname>Tebartz</surname><given-names>C</given-names></name><name name-style="western"><surname>Whitney</surname><given-names>PG</given-names></name><name name-style="western"><surname>D&#8217;Silva</surname><given-names>DB</given-names></name><etal/></person-group><article-title>NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase-4 and caspase-5</article-title>. <source>Eur J Immunol</source> (<year>2015</year>) <volume>45</volume>:<page-range>2918&#8211;26</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/eji.201545655</pub-id><pub-id pub-id-type="pmid">26173988</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kayagaki</surname><given-names>N</given-names></name><name name-style="western"><surname>Stowe</surname><given-names>IB</given-names></name><name name-style="western"><surname>Lee</surname><given-names>BL</given-names></name><name name-style="western"><surname>O&#8217;Rourke</surname><given-names>K</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>K</given-names></name><name name-style="western"><surname>Warming</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling</article-title>. <source>Nature</source> (<year>2015</year>) <volume>526</volume>:<page-range>666&#8211;71</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature15541</pub-id><pub-id pub-id-type="pmid">26375259</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santos</surname><given-names>JC</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>D</given-names></name><name name-style="western"><surname>Schneider</surname><given-names>LK</given-names></name><name name-style="western"><surname>Demarco</surname><given-names>B</given-names></name><name name-style="western"><surname>Dilucca</surname><given-names>M</given-names></name><name name-style="western"><surname>Shkarina</surname><given-names>K</given-names></name><etal/></person-group><article-title>Human GBP1 binds LPS to initiate assembly of a caspase-4 activating platform on cytosolic bacteria</article-title>. <source>Nat Commun</source> (<year>2020</year>) <volume>11</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41467-020-16889-z</pub-id><pub-id pub-id-type="pmid">32581219</pub-id><pub-id pub-id-type="pmcid">PMC7314798</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meunier</surname><given-names>E</given-names></name><name name-style="western"><surname>Dick</surname><given-names>MS</given-names></name><name name-style="western"><surname>Dreier</surname><given-names>RF</given-names></name><name name-style="western"><surname>Sch&#252;rmann</surname><given-names>N</given-names></name><name name-style="western"><surname>Broz</surname><given-names>DK</given-names></name><name name-style="western"><surname>Warming</surname><given-names>S</given-names></name><etal/></person-group><article-title>Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases</article-title>. <source>Nature</source> (<year>2014</year>) <volume>509</volume>:<page-range>366&#8211;70</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature13157</pub-id><pub-id pub-id-type="pmid">24739961</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wandel</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kim</surname><given-names>BH</given-names></name><name name-style="western"><surname>Park</surname><given-names>ES</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>KB</given-names></name><name name-style="western"><surname>Nayak</surname><given-names>K</given-names></name><name name-style="western"><surname>Lagrange</surname><given-names>B</given-names></name><etal/></person-group><article-title>Guanylate-binding proteins convert cytosolic bacteria into caspase-4 signaling platforms</article-title>. <source>Nat Immunol</source> (<year>2020</year>) <volume>21</volume>:<page-range>880&#8211;91</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/s41590-020-0697-2</pub-id><pub-id pub-id-type="pmcid">PMC7381384</pub-id><pub-id pub-id-type="pmid">32541830</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vigan&#242;</surname><given-names>E</given-names></name><name name-style="western"><surname>Diamond</surname><given-names>CE</given-names></name><name name-style="western"><surname>Spreafico</surname><given-names>R</given-names></name><name name-style="western"><surname>Balachander</surname><given-names>A</given-names></name><name name-style="western"><surname>Sobota</surname><given-names>RM</given-names></name><name name-style="western"><surname>Mortellaro</surname><given-names>A</given-names></name></person-group><article-title>Human caspase-4 and caspase-5 regulate the one-step non-canonical inflammasome activation in monocytes</article-title>. <source>Nat Commun</source> (<year>2015</year>) <volume>6</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/ncomms9761</pub-id><pub-id pub-id-type="pmcid">PMC4640152</pub-id><pub-id pub-id-type="pmid">26508369</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Raam</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Salvesen</surname><given-names>GS</given-names></name></person-group><article-title>Proliferative versus apoptotic functions of caspase-8 Hetero or homo: the caspase-8 dimer controls cell fate</article-title>. <source>Biochim Biophys Acta</source> (<year>2012</year>) <volume>1824</volume>:<page-range>113&#8211;22</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.bbapap.2011.06.005</pub-id><pub-id pub-id-type="pmcid">PMC3993904</pub-id><pub-id pub-id-type="pmid">21704196</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maelfait</surname><given-names>J</given-names></name><name name-style="western"><surname>Beyaert</surname><given-names>R</given-names></name></person-group><article-title>Non-apoptotic functions of caspase-8</article-title>. <source>Biochem Pharmacol</source> (<year>2008</year>) <volume>76</volume>:<page-range>1365&#8211;73</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.bcp.2008.07.034</pub-id><pub-id pub-id-type="pmid">18761323</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feltham</surname><given-names>R</given-names></name><name name-style="western"><surname>Vince</surname><given-names>JE</given-names></name><name name-style="western"><surname>Lawlor</surname><given-names>KE</given-names></name></person-group><article-title>Caspase-8: Not so silently deadly</article-title>. <source>Clin Transl Immunol</source> (<year>2017</year>) <volume>6</volume>:<fpage>e124</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/cti.2016.83</pub-id><pub-id pub-id-type="pmcid">PMC5292560</pub-id><pub-id pub-id-type="pmid">28197335</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gringhuis</surname><given-names>SI</given-names></name><name name-style="western"><surname>Kaptein</surname><given-names>TM</given-names></name><name name-style="western"><surname>Wevers</surname><given-names>BA</given-names></name><name name-style="western"><surname>Theelen</surname><given-names>B</given-names></name><name name-style="western"><surname>Van Der Vlist</surname><given-names>M</given-names></name><name name-style="western"><surname>Boekhout</surname><given-names>T</given-names></name><etal/></person-group><article-title>Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1&#946; via a noncanonical caspase-8 inflammasome</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>:<page-range>246&#8211;54</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni.2222</pub-id><pub-id pub-id-type="pmid">22267217</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Man</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tourlomousis</surname><given-names>P</given-names></name><name name-style="western"><surname>Hopkins</surname><given-names>L</given-names></name><name name-style="western"><surname>Monie</surname><given-names>TP</given-names></name><name name-style="western"><surname>Fitzgerald</surname><given-names>KA</given-names></name><name name-style="western"><surname>Bryant</surname><given-names>CE</given-names></name></person-group><article-title>Salmonella Infection Induces Recruitment of Caspase-8 to the Inflammasome To Modulate IL-1&#946; Production</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<page-range>5239&#8211;46</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1301581</pub-id><pub-id pub-id-type="pmcid">PMC3835177</pub-id><pub-id pub-id-type="pmid">24123685</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weng</surname><given-names>D</given-names></name><name name-style="western"><surname>Marty-Roix</surname><given-names>R</given-names></name><name name-style="western"><surname>Ganesan</surname><given-names>S</given-names></name><name name-style="western"><surname>Proulx</surname><given-names>MK</given-names></name><name name-style="western"><surname>Vladimer</surname><given-names>GI</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><etal/></person-group><article-title>Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2014</year>) <volume>111</volume>:<page-range>7391&#8211;6</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1403477111</pub-id><pub-id pub-id-type="pmcid">PMC4034196</pub-id><pub-id pub-id-type="pmid">24799678</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Antonopoulos</surname><given-names>C</given-names></name><name name-style="western"><surname>El Sanadi</surname><given-names>C</given-names></name><name name-style="western"><surname>Kaiser</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Mocarski</surname><given-names>ES</given-names></name><name name-style="western"><surname>Dubyak</surname><given-names>GR</given-names></name></person-group><article-title>Proapoptotic Chemotherapeutic Drugs Induce Noncanonical Processing and Release of IL-1&#946; via Caspase-8 in Dendritic Cells</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<page-range>4789&#8211;803</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1300645</pub-id><pub-id pub-id-type="pmcid">PMC3870469</pub-id><pub-id pub-id-type="pmid">24078693</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>KS</given-names></name><name name-style="western"><surname>Gro&#223;</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Dreier</surname><given-names>RF</given-names></name><name name-style="western"><surname>Saller</surname><given-names>BS</given-names></name><name name-style="western"><surname>Mishra</surname><given-names>R</given-names></name><name name-style="western"><surname>Gorka</surname><given-names>O</given-names></name><etal/></person-group><article-title>The Inflammasome Drives GSDMD-Independent Secondary Pyroptosis and IL-1 Release in the Absence of Caspase-1 Protease Activity</article-title>. <source>Cell Rep</source> (<year>2017</year>) <volume>21</volume>:<page-range>3846&#8211;59</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.celrep.2017.12.018</pub-id><pub-id pub-id-type="pmcid">PMC5750195</pub-id><pub-id pub-id-type="pmid">29281832</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donado</surname><given-names>CA</given-names></name><name name-style="western"><surname>Cao</surname><given-names>AB</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>DP</given-names></name><name name-style="western"><surname>Croker</surname><given-names>BA</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>A Two-Cell Model for IL-1&#946; Release Mediated by Death-Receptor Signaling</article-title>. <source>Cell Rep</source> (<year>2020</year>) <volume>31</volume>:<fpage>107466</fpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.celrep.2020.03.030</pub-id><pub-id pub-id-type="pmid">32268091</pub-id><pub-id pub-id-type="pmcid">PMC7192215</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aizawa</surname><given-names>E</given-names></name><name name-style="western"><surname>Karasawa</surname><given-names>T</given-names></name><name name-style="western"><surname>Watanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Komada</surname><given-names>T</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>H</given-names></name><name name-style="western"><surname>Kamata</surname><given-names>R</given-names></name><etal/></person-group><article-title>GSDME-Dependent Incomplete Pyroptosis Permits Selective IL-1&#945; Release under Caspase-1 Inhibition</article-title>. <source>iScience</source> (<year>2020</year>) <volume>23</volume>:<elocation-id>101070</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1016/j.isci.2020.101070</pub-id><pub-id pub-id-type="pmid">32361594</pub-id><pub-id pub-id-type="pmcid">PMC7200307</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>March</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Mosley</surname><given-names>B</given-names></name><name name-style="western"><surname>Larsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Cerretti</surname><given-names>DP</given-names></name><name name-style="western"><surname>Braedt</surname><given-names>G</given-names></name><name name-style="western"><surname>Price</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs</article-title>. <source>Nature</source> (<year>1985</year>) <volume>315</volume>:<page-range>641&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/315641a0</pub-id><pub-id pub-id-type="pmid">2989698</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>B</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kim</surname><given-names>E</given-names></name><name name-style="western"><surname>Kwak</surname><given-names>A</given-names></name><name name-style="western"><surname>Ryoo</surname><given-names>S</given-names></name><name name-style="western"><surname>Bae</surname><given-names>SH</given-names></name><etal/></person-group><article-title>The Interleukin-1alpha Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines</article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<elocation-id>391</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fimmu.2013.00391</pub-id><pub-id pub-id-type="pmid">24312098</pub-id><pub-id pub-id-type="pmcid">PMC3834611</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Afonina</surname><given-names>IS</given-names></name><name name-style="western"><surname>Tynan</surname><given-names>GA</given-names></name><name name-style="western"><surname>Logue</surname><given-names>SE</given-names></name><name name-style="western"><surname>Cullen</surname><given-names>SP</given-names></name><name name-style="western"><surname>Bots</surname><given-names>M</given-names></name><name name-style="western"><surname>L&#252;thi</surname><given-names>AU</given-names></name><etal/></person-group><article-title>Granzyme B-dependent proteolysis acts as a switch to enhance the proinflammatory activity of IL-1&#945;</article-title>. <source>Mol Cell</source> (<year>2011</year>) <volume>44</volume>:<page-range>265&#8211;78</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.molcel.2011.07.037</pub-id><pub-id pub-id-type="pmcid">PMC3319689</pub-id><pub-id pub-id-type="pmid">22017873</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Humphry</surname><given-names>M</given-names></name><name name-style="western"><surname>Maguire</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>MR</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>MC</given-names></name></person-group><article-title>Intracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1alpha, controlling necrosis-induced sterile inflammation</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<page-range>285&#8211;95</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.01.008</pub-id><pub-id pub-id-type="pmcid">PMC3659285</pub-id><pub-id pub-id-type="pmid">23395675</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wiggins</surname><given-names>KA</given-names></name><name name-style="western"><surname>Parry</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Cassidy</surname><given-names>LD</given-names></name><name name-style="western"><surname>Humphry</surname><given-names>M</given-names></name><name name-style="western"><surname>Webster</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Goodall</surname><given-names>JC</given-names></name><etal/></person-group><article-title>IL-1&#945; cleavage by inflammatory caspases of the noncanonical inflammasome controls the senescence-associated secretory phenotype</article-title>. <source>Aging Cell</source> (<year>2019</year>) <volume>18</volume>:<fpage>e12946</fpage>. &#160;<pub-id pub-id-type="doi">10.1111/acel.12946</pub-id><pub-id pub-id-type="pmid">30916891</pub-id><pub-id pub-id-type="pmcid">PMC6516163</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizutani</surname><given-names>H</given-names></name><name name-style="western"><surname>Schechter</surname><given-names>N</given-names></name><name name-style="western"><surname>Lazarus</surname><given-names>G</given-names></name><name name-style="western"><surname>Black</surname><given-names>RA</given-names></name><name name-style="western"><surname>Kupper</surname><given-names>TS</given-names></name></person-group><article-title>Rapid and specific conversion of precursor interleukin 1 beta (IL-1 beta) to an active IL-1 species by human mast cell chymase</article-title>. <source>J Exp Med</source> (<year>1991</year>) <volume>174</volume>:<page-range>821&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.174.4.821</pub-id><pub-id pub-id-type="pmcid">PMC2118970</pub-id><pub-id pub-id-type="pmid">1919436</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefran&#231;ais</surname><given-names>E</given-names></name><name name-style="western"><surname>Roga</surname><given-names>S</given-names></name><name name-style="western"><surname>Gautier</surname><given-names>V</given-names></name><name name-style="western"><surname>Gonzalez-de-Peredo</surname><given-names>A</given-names></name><name name-style="western"><surname>Monsarrat</surname><given-names>B</given-names></name><name name-style="western"><surname>Girard</surname><given-names>J-P</given-names></name><etal/></person-group><article-title>IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>:<page-range>1673&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1115884109</pub-id><pub-id pub-id-type="pmcid">PMC3277172</pub-id><pub-id pub-id-type="pmid">22307629</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tokime</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamanaka</surname><given-names>K</given-names></name><name name-style="western"><surname>Habe</surname><given-names>K</given-names></name><name name-style="western"><surname>Morioka</surname><given-names>T</given-names></name><name name-style="western"><surname>Kurokawa</surname><given-names>I</given-names></name><etal/></person-group><article-title>Human mast cell chymase cleaves pro-IL-18 and generates a novel and biologically active IL-18 fragment</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<page-range>8315&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.177.12.8315</pub-id><pub-id pub-id-type="pmid">17142727</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rivers-Auty</surname><given-names>J</given-names></name><name name-style="western"><surname>Daniels</surname><given-names>MJD</given-names></name><name name-style="western"><surname>Colliver</surname><given-names>I</given-names></name><name name-style="western"><surname>Robertson</surname><given-names>DL</given-names></name><name name-style="western"><surname>Brough</surname><given-names>D</given-names></name></person-group><article-title>Redefining the ancestral origins of the interleukin-1 superfamily</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>1156</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41467-018-03362-1</pub-id><pub-id pub-id-type="pmid">29559685</pub-id><pub-id pub-id-type="pmcid">PMC5861070</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burzynski</surname><given-names>LC</given-names></name><name name-style="western"><surname>Humphry</surname><given-names>M</given-names></name><name name-style="western"><surname>Pyrillou</surname><given-names>K</given-names></name><name name-style="western"><surname>Wiggins</surname><given-names>KA</given-names></name><name name-style="western"><surname>Chan</surname><given-names>JNE</given-names></name><name name-style="western"><surname>Figg</surname><given-names>N</given-names></name><etal/></person-group><article-title>The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1&#945; by Thrombin</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>:<fpage>1033</fpage>&#8211;<lpage>1042.e6</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.03.003</pub-id><pub-id pub-id-type="pmid">30926232</pub-id><pub-id pub-id-type="pmcid">PMC6476404</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sims</surname><given-names>JE</given-names></name><name name-style="western"><surname>Smith</surname><given-names>DE</given-names></name></person-group><article-title>The IL-1 family: Regulators of immunity</article-title>. <source>Nat Rev Immunol</source> (<year>2010</year>) <volume>10</volume>:<fpage>89</fpage>&#8211;<lpage>102</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/nri2691</pub-id><pub-id pub-id-type="pmid">20081871</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garlanda</surname><given-names>C</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name></person-group><article-title>The Interleukin-1 Family: Back to the Future</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<page-range>1003&#8211;18</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.11.010</pub-id><pub-id pub-id-type="pmcid">PMC3933951</pub-id><pub-id pub-id-type="pmid">24332029</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Janeway</surname></name></person-group><article-title>CA. How the immune system works to protect the host from infection: a personal view</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2001</year>) <volume>98</volume>:<page-range>7461&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.131202998</pub-id><pub-id pub-id-type="pmcid">PMC34691</pub-id><pub-id pub-id-type="pmid">11390983</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Summers</surname><given-names>C</given-names></name><name name-style="western"><surname>Rankin</surname><given-names>SM</given-names></name><name name-style="western"><surname>Condliffe</surname><given-names>AM</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Peters</surname><given-names>AM</given-names></name><name name-style="western"><surname>Chilvers</surname><given-names>ER</given-names></name></person-group><article-title>Neutrophil kinetics in health and disease</article-title>. <source>Trends Immunol</source> (<year>2010</year>) <volume>31</volume>:<page-range>318&#8211;24</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.it.2010.05.006</pub-id><pub-id pub-id-type="pmcid">PMC2930213</pub-id><pub-id pub-id-type="pmid">20620114</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lahoz-Beneytez</surname><given-names>J</given-names></name><name name-style="western"><surname>Elemans</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ahmed</surname><given-names>R</given-names></name><name name-style="western"><surname>Salam</surname><given-names>A</given-names></name><name name-style="western"><surname>Block</surname><given-names>M</given-names></name><etal/></person-group><article-title>Human neutrophil kinetics: modeling of stable isotope labeling data supports short blood neutrophil half-lives</article-title>. <source>Blood</source> (<year>2016</year>) <volume>127</volume>:<page-range>3431&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2016-03-700336</pub-id><pub-id pub-id-type="pmcid">PMC4929930</pub-id><pub-id pub-id-type="pmid">27136946</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Vietinghoff</surname><given-names>S</given-names></name><name name-style="western"><surname>Ley</surname><given-names>K</given-names></name></person-group><article-title>IL-17A controls IL-17F production and maintains blood neutrophil counts in mice</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>:<fpage>4136</fpage>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.0990072</pub-id><pub-id pub-id-type="pmcid">PMC2759196</pub-id><pub-id pub-id-type="pmid">19542376</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chang</surname><given-names>SH</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Yang</surname><given-names>XO</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><etal/></person-group><article-title>Critical regulation of early Th17 cell differentiation by interleukin-1 signaling</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>30</volume>:<page-range>576&#8211;87</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.02.007</pub-id><pub-id pub-id-type="pmcid">PMC2705871</pub-id><pub-id pub-id-type="pmid">19362022</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>C</given-names></name><name name-style="western"><surname>Brereton</surname><given-names>C</given-names></name><name name-style="western"><surname>Keogh</surname><given-names>B</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KHGG</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name></person-group><article-title>A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis</article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>:<page-range>1685&#8211;91</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20060285</pub-id><pub-id pub-id-type="pmcid">PMC2118338</pub-id><pub-id pub-id-type="pmid">16818675</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>KH</given-names></name><name name-style="western"><surname>Dungan</surname><given-names>LS</given-names></name><name name-style="western"><surname>Jones</surname><given-names>SA</given-names></name><name name-style="western"><surname>Harris</surname><given-names>J</given-names></name></person-group><article-title>The role of inflammasome-derived IL-1 in driving IL-17 responses</article-title>. <source>J Leukoc Biol</source> (<year>2013</year>) <volume>93</volume>:<page-range>489&#8211;97</page-range>. &#160;<pub-id pub-id-type="doi">10.1189/jlb.1012543</pub-id><pub-id pub-id-type="pmid">23271701</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ueda</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cain</surname><given-names>DW</given-names></name><name name-style="western"><surname>Kuraoka</surname><given-names>M</given-names></name><name name-style="western"><surname>Kondo</surname><given-names>M</given-names></name><name name-style="western"><surname>Kelsoe</surname><given-names>G</given-names></name></person-group><article-title>IL-1R Type I-Dependent Hemopoietic Stem Cell Proliferation Is Necessary for Inflammatory Granulopoiesis and Reactive Neutrophilia</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>6477</fpage>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.0803961</pub-id><pub-id pub-id-type="pmid">19414802</pub-id><pub-id pub-id-type="pmcid">PMC2780360</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshimura</surname><given-names>T</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>K</given-names></name><name name-style="western"><surname>Oppenheim</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>EJ</given-names></name></person-group><article-title>Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1)</article-title>. <source>J Immunol</source> (<year>1987</year>) <volume>139</volume>:<fpage>788</fpage>.<pub-id pub-id-type="pmid">3298433</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sadik</surname><given-names>CD</given-names></name><name name-style="western"><surname>Kim</surname><given-names>ND</given-names></name><name name-style="western"><surname>Luster</surname><given-names>AD</given-names></name></person-group><article-title>Neutrophils cascading their way to inflammation</article-title>. <source>Trends Immunol</source> (<year>2011</year>) <volume>32</volume>:<page-range>452&#8211;60</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.it.2011.06.008</pub-id><pub-id pub-id-type="pmcid">PMC3470857</pub-id><pub-id pub-id-type="pmid">21839682</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sica</surname><given-names>A</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>K</given-names></name><name name-style="western"><surname>Van Damme</surname><given-names>J</given-names></name><name name-style="western"><surname>Wang</surname><given-names>JM</given-names></name><name name-style="western"><surname>Polentarutti</surname><given-names>N</given-names></name><name name-style="western"><surname>Dejana</surname><given-names>E</given-names></name><etal/></person-group><article-title>IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells</article-title>. <source>Immunology</source> (<year>1990</year>) <volume>69</volume>:<page-range>548&#8211;53</page-range>.<pub-id pub-id-type="pmcid">PMC1385627</pub-id><pub-id pub-id-type="pmid">2185985</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>CG</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>AO</given-names></name><name name-style="western"><surname>Oppenheim</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>K</given-names></name></person-group><article-title>Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor</article-title>. <source>Immunology</source> (<year>1989</year>) <volume>68</volume>:<page-range>31&#8211;6</page-range>.<pub-id pub-id-type="pmcid">PMC1385501</pub-id><pub-id pub-id-type="pmid">2478449</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oliveira</surname><given-names>SH</given-names></name><name name-style="western"><surname>Canetti</surname><given-names>C</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>RA</given-names></name><name name-style="western"><surname>Cunha</surname><given-names>FQ</given-names></name></person-group><article-title>Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells</article-title>. <source>Inflammation</source> (<year>2008</year>) <volume>31</volume>:<fpage>36</fpage>&#8211;<lpage>46</lpage>. &#160;<pub-id pub-id-type="doi">10.1007/s10753-007-9047-x</pub-id><pub-id pub-id-type="pmid">17874178</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biancone</surname><given-names>L</given-names></name><name name-style="western"><surname>Tetta</surname><given-names>C</given-names></name><name name-style="western"><surname>Turello</surname><given-names>E</given-names></name><name name-style="western"><surname>Montrucchio</surname><given-names>G</given-names></name><name name-style="western"><surname>Iorio</surname><given-names>EL</given-names></name><name name-style="western"><surname>Servillo</surname><given-names>L</given-names></name><etal/></person-group><article-title>Platelet-activating factor biosynthesis by cultured mesangial cells is modulated by proteinase inhibitors</article-title>. <source>J Am Soc Nephrol</source> (<year>1992</year>) <volume>2</volume>:<fpage>1251</fpage>.<pub-id pub-id-type="pmid">1591364</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zenobia</surname><given-names>C</given-names></name><name name-style="western"><surname>Hajishengallis</surname><given-names>G</given-names></name></person-group><article-title>Basic biology and role of interleukin-17 in immunity and inflammation</article-title>. <source>Periodontol 2000</source> (<year>2015</year>) <volume>69</volume>:<page-range>142&#8211;59</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/prd.12083</pub-id><pub-id pub-id-type="pmcid">PMC4530463</pub-id><pub-id pub-id-type="pmid">26252407</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pelletier</surname><given-names>M</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>L</given-names></name><name name-style="western"><surname>Micheletti</surname><given-names>A</given-names></name><name name-style="western"><surname>Lazzeri</surname><given-names>E</given-names></name><name name-style="western"><surname>Tamassia</surname><given-names>N</given-names></name><name name-style="western"><surname>Costantini</surname><given-names>C</given-names></name><etal/></person-group><article-title>Evidence for a cross-talk between human neutrophils and Th17 cells</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>:<page-range>335&#8211;43</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2009-04-216085</pub-id><pub-id pub-id-type="pmid">19890092</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>PY</given-names></name><name name-style="western"><surname>Kumagai</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Barker</surname><given-names>T</given-names></name><name name-style="western"><surname>Liu</surname><given-names>C</given-names></name><etal/></person-group><article-title>IL-1&#945; Modulates Neutrophil Recruitment in Chronic Inflammation Induced by Hydrocarbon Oil</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>1747</fpage>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1001328</pub-id><pub-id pub-id-type="pmid">21191074</pub-id><pub-id pub-id-type="pmcid">PMC3607541</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Bowman</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Speziale</surname><given-names>SC</given-names></name></person-group><article-title>Interleukin-1 stimulates granule exocytosis from human neutrophils</article-title>. <source>Int J Immunopharmacol</source> (<year>1986</year>) <volume>8</volume>:<fpage>33</fpage>&#8211;<lpage>40</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/0192-0561(86)90070-6</pub-id><pub-id pub-id-type="pmid">2420732</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coeshott</surname><given-names>C</given-names></name><name name-style="western"><surname>Ohnemus</surname><given-names>C</given-names></name><name name-style="western"><surname>Pilyavskaya</surname><given-names>A</given-names></name><name name-style="western"><surname>Ross</surname><given-names>S</given-names></name><name name-style="western"><surname>Wieczorek</surname><given-names>M</given-names></name><name name-style="western"><surname>Kroona</surname><given-names>H</given-names></name><etal/></person-group><article-title>Converting enzyme-independent release of tumor necrosis factor &#945; and IL-1&#946; from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3</article-title>. <source>Proc Natl Acad Sci</source> (<year>1999</year>) <volume>96</volume>:<elocation-id>6261</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.96.11.6261</pub-id><pub-id pub-id-type="pmid">10339575</pub-id><pub-id pub-id-type="pmcid">PMC26869</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clancy</surname><given-names>DM</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>GP</given-names></name><name name-style="western"><surname>Moran</surname><given-names>HBT</given-names></name><name name-style="western"><surname>Henry</surname><given-names>CM</given-names></name><name name-style="western"><surname>Reeves</surname><given-names>EP</given-names></name><name name-style="western"><surname>McElvaney</surname><given-names>NG</given-names></name><etal/></person-group><article-title>Extracellular Neutrophil Proteases Are Efficient Regulators of IL-1, IL-33, and IL-36 Cytokine Activity but Poor Effectors of Microbial Killing</article-title>. <source>Cell Rep</source> (<year>2018</year>) <volume>22</volume>:<page-range>2937&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.062</pub-id><pub-id pub-id-type="pmid">29539422</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Greten</surname><given-names>FR</given-names></name><name name-style="western"><surname>Arkan</surname><given-names>MC</given-names></name><name name-style="western"><surname>Bollrath</surname><given-names>J</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>LC</given-names></name><name name-style="western"><surname>Goode</surname><given-names>J</given-names></name><name name-style="western"><surname>Miething</surname><given-names>C</given-names></name><etal/></person-group><article-title>NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta</article-title>. <source>Cell</source> (<year>2007</year>) <volume>130</volume>:<page-range>918&#8211;31</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.cell.2007.07.009</pub-id><pub-id pub-id-type="pmcid">PMC2134986</pub-id><pub-id pub-id-type="pmid">17803913</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orth</surname><given-names>K</given-names></name><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Mudgett</surname><given-names>MB</given-names></name><name name-style="western"><surname>Bao</surname><given-names>ZQ</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>LE</given-names></name><name name-style="western"><surname>Bliska</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Disruption of signaling by Yersinia effector YopJ, a ubiquitin-like protein protease</article-title>. <source>Science (80)</source> (<year>2000</year>) <volume>290</volume>:<page-range>1594&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1126/science.290.5496.1594</pub-id><pub-id pub-id-type="pmid">11090361</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brinkmann</surname><given-names>V</given-names></name><name name-style="western"><surname>Reichard</surname><given-names>U</given-names></name><name name-style="western"><surname>Goosmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Fauler</surname><given-names>B</given-names></name><name name-style="western"><surname>Uhlemann</surname><given-names>Y</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Neutrophil Extracellular Traps Kill Bacteria</article-title>. <source>Science (80)</source> (<year>2004</year>) <volume>303</volume>:<fpage>1532</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/science.1092385</pub-id><pub-id pub-id-type="pmid">15001782</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yipp</surname><given-names>BG</given-names></name><name name-style="western"><surname>Kubes</surname><given-names>P</given-names></name></person-group><article-title>NETosis: how vital is it</article-title>? <source>Blood</source> (<year>2013</year>) <volume>122</volume>:<page-range>2784&#8211;94</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2013-04-457671</pub-id><pub-id pub-id-type="pmid">24009232</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>KW</given-names></name><name name-style="western"><surname>Monteleone</surname><given-names>M</given-names></name><name name-style="western"><surname>Boucher</surname><given-names>D</given-names></name><name name-style="western"><surname>Sollberger</surname><given-names>G</given-names></name><name name-style="western"><surname>Ramnath</surname><given-names>D</given-names></name><name name-style="western"><surname>Condon</surname><given-names>ND</given-names></name><etal/></person-group><article-title>Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps</article-title>. <source>Sci Immunol</source> (<year>2018</year>) <volume>3</volume>:<fpage>eaar6676</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/sciimmunol.aar6676</pub-id><pub-id pub-id-type="pmid">30143554</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sollberger</surname><given-names>G</given-names></name><name name-style="western"><surname>Choidas</surname><given-names>A</given-names></name><name name-style="western"><surname>Burn</surname><given-names>GL</given-names></name><name name-style="western"><surname>Habenberger</surname><given-names>P</given-names></name><name name-style="western"><surname>Di Lucrezia</surname><given-names>R</given-names></name><name name-style="western"><surname>Kordes</surname><given-names>S</given-names></name><etal/></person-group><article-title>Gasdermin D plays a vital role in the generation of neutrophil extracellular traps</article-title>. <source>Sci Immunol</source> (<year>2018</year>) <volume>3</volume>:<fpage>eaar6689</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/sciimmunol.aar6689</pub-id><pub-id pub-id-type="pmid">30143555</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meher</surname><given-names>AK</given-names></name><name name-style="western"><surname>Spinosa</surname><given-names>M</given-names></name><name name-style="western"><surname>Davis</surname><given-names>JP</given-names></name><name name-style="western"><surname>Pope</surname><given-names>N</given-names></name><name name-style="western"><surname>Laubach</surname><given-names>VE</given-names></name><name name-style="western"><surname>Su</surname><given-names>G</given-names></name><etal/></person-group><article-title>Novel Role of IL (Interleukin)-1&#946; in Neutrophil Extracellular Trap Formation and Abdominal Aortic Aneurysms</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2018</year>) <volume>38</volume>:<page-range>843&#8211;53</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/ATVBAHA.117.309897</pub-id><pub-id pub-id-type="pmcid">PMC5864548</pub-id><pub-id pub-id-type="pmid">29472233</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitroulis</surname><given-names>I</given-names></name><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Chrysanthopoulou</surname><given-names>A</given-names></name><name name-style="western"><surname>Skendros</surname><given-names>P</given-names></name><name name-style="western"><surname>Apostolidou</surname><given-names>E</given-names></name><name name-style="western"><surname>Kourtzelis</surname><given-names>I</given-names></name><etal/></person-group><article-title>Neutrophil extracellular trap formation is associated with IL-1&#946; and autophagy-related signaling in gout</article-title>. <source>PLoS One</source> (<year>2011</year>) <volume>6</volume>:<page-range>e29318&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0029318</pub-id><pub-id pub-id-type="pmcid">PMC3241704</pub-id><pub-id pub-id-type="pmid">22195044</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Westerterp</surname><given-names>M</given-names></name><name name-style="western"><surname>Fotakis</surname><given-names>P</given-names></name><name name-style="western"><surname>Ouimet</surname><given-names>M</given-names></name><name name-style="western"><surname>Bochem</surname><given-names>AE</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Molusky</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis</article-title>. <source>Circulation</source> (<year>2018</year>) <volume>138</volume>:<fpage>898</fpage>&#8211;<lpage>912</lpage>. &#160;<pub-id pub-id-type="doi">10.1161/circulationaha.117.032636</pub-id><pub-id pub-id-type="pmid">29588315</pub-id><pub-id pub-id-type="pmcid">PMC6160368</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clancy</surname><given-names>DM</given-names></name><name name-style="western"><surname>Henry</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>GP</given-names></name><name name-style="western"><surname>Martin</surname><given-names>SJ</given-names></name></person-group><article-title>Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines</article-title>. <source>FEBS J</source> (<year>2017</year>) <volume>284</volume>:<page-range>1712&#8211;25</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/febs.14075</pub-id><pub-id pub-id-type="pmid">28374518</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Folco</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Mawson</surname><given-names>TL</given-names></name><name name-style="western"><surname>Vromman</surname><given-names>A</given-names></name><name name-style="western"><surname>Bernardes-Souza</surname><given-names>B</given-names></name><name name-style="western"><surname>Franck</surname><given-names>G</given-names></name><name name-style="western"><surname>Persson</surname><given-names>O</given-names></name><etal/></person-group><article-title>Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1&#945; and Cathepsin G</article-title>. <source>Arter Thromb Vasc Biol</source> (<year>2018</year>) <volume>38</volume>:<page-range>1901&#8211;12</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/atvbaha.118.311150</pub-id><pub-id pub-id-type="pmcid">PMC6202190</pub-id><pub-id pub-id-type="pmid">29976772</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Yang</surname><given-names>P</given-names></name><name name-style="western"><surname>Gao</surname><given-names>M</given-names></name><name name-style="western"><surname>Yu</surname><given-names>T</given-names></name><name name-style="western"><surname>Shi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>M</given-names></name><etal/></person-group><article-title>NLRP3 activation induced by neutrophil extracellular traps sustains inflammatory response in the diabetic wound</article-title>. <source>Clin Sci</source> (<year>2019</year>) <volume>133</volume>:<page-range>565&#8211;82</page-range>. &#160;<pub-id pub-id-type="doi">10.1042/cs20180600</pub-id><pub-id pub-id-type="pmid">30626731</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sreejit</surname><given-names>G</given-names></name><name name-style="western"><surname>Abdel-Latif</surname><given-names>A</given-names></name><name name-style="western"><surname>Athmanathan</surname><given-names>B</given-names></name><name name-style="western"><surname>Annabathula</surname><given-names>R</given-names></name><name name-style="western"><surname>Dhyani</surname><given-names>A</given-names></name><name name-style="western"><surname>Noothi</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Neutrophil-Derived S100A8/A9 Amplify Granulopoiesis After Myocardial Infarction</article-title>. <source>Circulation</source> (<year>2020</year>) <volume>141</volume>:<page-range>1080&#8211;94</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/circulationaha.119.043833</pub-id><pub-id pub-id-type="pmcid">PMC7122461</pub-id><pub-id pub-id-type="pmid">31941367</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aderem</surname><given-names>A</given-names></name><name name-style="western"><surname>Underhill</surname><given-names>DM</given-names></name></person-group><article-title>Mechanisms of phagocytosis in macrophages</article-title>. <source>Annu Rev Immunol</source> (<year>1999</year>) <volume>17</volume>:<fpage>593</fpage>&#8211;<lpage>623</lpage>. &#160;<pub-id pub-id-type="doi">10.1146/annurev.immunol.17.1.593</pub-id><pub-id pub-id-type="pmid">10358769</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sokolovska</surname><given-names>A</given-names></name><name name-style="western"><surname>Becker</surname><given-names>CE</given-names></name><name name-style="western"><surname>Ip</surname><given-names>WK</given-names></name><name name-style="western"><surname>Rathinam</surname><given-names>VA</given-names></name><name name-style="western"><surname>Brudner</surname><given-names>M</given-names></name><name name-style="western"><surname>Paquette</surname><given-names>N</given-names></name><etal/></person-group><article-title>Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function</article-title>. <source>Nat Immunol</source> (<year>2013</year>) <volume>14</volume>:<page-range>543&#8211;53</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni.2595</pub-id><pub-id pub-id-type="pmcid">PMC3708594</pub-id><pub-id pub-id-type="pmid">23644505</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoon</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Jo</surname><given-names>DH</given-names></name><name name-style="western"><surname>Park</surname><given-names>SH</given-names></name><name name-style="western"><surname>Park</surname><given-names>JY</given-names></name><name name-style="western"><surname>Lee</surname><given-names>YK</given-names></name><name name-style="western"><surname>Lee</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Thioredoxin-Interacting Protein Promotes Phagosomal Acidification Upon Exposure to Escherichia coli Through Inflammasome-Mediated Caspase-1 Activation in Macrophages</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>2636</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02636</pub-id><pub-id pub-id-type="pmid">31781121</pub-id><pub-id pub-id-type="pmcid">PMC6861186</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>TS</given-names></name><name name-style="western"><surname>Boland</surname><given-names>ML</given-names></name><name name-style="western"><surname>Boland</surname><given-names>BB</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>V</given-names></name><name name-style="western"><surname>Tovchigrechko</surname><given-names>A</given-names></name><name name-style="western"><surname>Lee</surname><given-names>Y</given-names></name><etal/></person-group><article-title>S.&#160;aureus Evades Macrophage Killing through NLRP3-Dependent Effects on Mitochondrial Trafficking</article-title>. <source>Cell Rep</source> (<year>2018</year>) <volume>22</volume>:<page-range>2431&#8211;41</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.celrep.2018.02.027</pub-id><pub-id pub-id-type="pmcid">PMC7160668</pub-id><pub-id pub-id-type="pmid">29490278</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurt-Jones</surname><given-names>EA</given-names></name><name name-style="western"><surname>Beller</surname><given-names>DI</given-names></name><name name-style="western"><surname>Mizel</surname><given-names>SB</given-names></name><name name-style="western"><surname>Unanue</surname><given-names>ER</given-names></name></person-group><article-title>Identification of a membrane-associated interleukin 1 in macrophages</article-title>. <source>Proc Natl Acad Sci</source> (<year>1985</year>) <volume>82</volume>:<elocation-id>1204</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.82.4.1204</pub-id><pub-id pub-id-type="pmid">3919388</pub-id><pub-id pub-id-type="pmcid">PMC397223</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>JNE</given-names></name><name name-style="western"><surname>Humphry</surname><given-names>M</given-names></name><name name-style="western"><surname>Kitt</surname><given-names>L</given-names></name><name name-style="western"><surname>Krzyzanska</surname><given-names>D</given-names></name><name name-style="western"><surname>Filbey</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Cell surface IL-1&#945; trafficking is specifically inhibited by interferon-&#947;, and associates with the membrane via IL-1R2 and GPI anchors</article-title>. <source>Eur J Immunol</source> (<year>2020</year>) <volume>50</volume>:<page-range>1663&#8211;75</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/eji.201948521</pub-id><pub-id pub-id-type="pmid">32447774</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurowska-Stolarska</surname><given-names>M</given-names></name><name name-style="western"><surname>Stolarski</surname><given-names>B</given-names></name><name name-style="western"><surname>Kewin</surname><given-names>P</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>G</given-names></name><name name-style="western"><surname>Corrigan</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Ying</surname><given-names>S</given-names></name><etal/></person-group><article-title>IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>:<page-range>6469&#8211;77</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.0901575</pub-id><pub-id pub-id-type="pmid">19841166</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmer</surname><given-names>G</given-names></name><name name-style="western"><surname>Lipsky</surname><given-names>BP</given-names></name><name name-style="western"><surname>Smithgall</surname><given-names>MD</given-names></name><name name-style="western"><surname>Meininger</surname><given-names>D</given-names></name><name name-style="western"><surname>Siu</surname><given-names>S</given-names></name><name name-style="western"><surname>Talabot-Ayer</surname><given-names>D</given-names></name><etal/></person-group><article-title>The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33</article-title>. <source>Cytokine</source> (<year>2008</year>) <volume>42</volume>:<page-range>358&#8211;64</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.cyto.2008.03.008</pub-id><pub-id pub-id-type="pmid">18450470</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Awad</surname><given-names>F</given-names></name><name name-style="western"><surname>Assrawi</surname><given-names>E</given-names></name><name name-style="western"><surname>Jumeau</surname><given-names>C</given-names></name><name name-style="western"><surname>Georgin-Lavialle</surname><given-names>S</given-names></name><name name-style="western"><surname>Cobret</surname><given-names>L</given-names></name><name name-style="western"><surname>Duquesnoy</surname><given-names>P</given-names></name><etal/></person-group><article-title>Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation</article-title>. <source>PLoS One</source> (<year>2017</year>) <volume>12</volume>:<fpage>e0175336</fpage>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0175336</pub-id><pub-id pub-id-type="pmid">28403163</pub-id><pub-id pub-id-type="pmcid">PMC5389804</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qing</surname><given-names>L</given-names></name><name name-style="western"><surname>Fu</surname><given-names>J</given-names></name><name name-style="western"><surname>Wu</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z</given-names></name><name name-style="western"><surname>Yu</surname><given-names>F</given-names></name><name name-style="western"><surname>Tang</surname><given-names>J</given-names></name></person-group><article-title>Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK/mTOR/NLRP3 inflammasome singling pathway</article-title>. <source>Am J Transl Res</source> (<year>2019</year>) <volume>11</volume>:<page-range>655&#8211;68</page-range>.<pub-id pub-id-type="pmcid">PMC6413292</pub-id><pub-id pub-id-type="pmid">30899369</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pan</surname><given-names>L</given-names></name><etal/></person-group><article-title>Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice</article-title>. <source>J Cell Mol Med</source> (<year>2020</year>) <volume>24</volume>:<page-range>2593&#8211;609</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/jcmm.14972</pub-id><pub-id pub-id-type="pmcid">PMC7028849</pub-id><pub-id pub-id-type="pmid">31930778</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>LR</given-names></name><name name-style="western"><surname>Liu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>XZ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>YY</given-names></name><name name-style="western"><surname>Gao</surname><given-names>ZX</given-names></name><name name-style="western"><surname>Gao</surname><given-names>K</given-names></name><etal/></person-group><article-title>Treponema pallidum promotes macrophage polarization and activates the NLRP3 inflammasome pathway to induce interleukin-1&#946; production</article-title>. <source>BMC Immunol</source> (<year>2018</year>) <volume>19</volume>:<elocation-id>28</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1186/s12865-018-0265-9</pub-id><pub-id pub-id-type="pmid">30217146</pub-id><pub-id pub-id-type="pmcid">PMC6137923</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Gao</surname><given-names>X</given-names></name><name name-style="western"><surname>Miao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>H</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>NLRP3 regulates macrophage M2 polarization through up-regulation of IL-4 in asthma</article-title>. <source>Biochem J</source> (<year>2018</year>) <volume>475</volume>:<fpage>1995</fpage>&#8211;<lpage>2008</lpage>. &#160;<pub-id pub-id-type="doi">10.1042/BCJ20180086</pub-id><pub-id pub-id-type="pmid">29626160</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Delaney</surname><given-names>MK</given-names></name><name name-style="western"><surname>O&#8217;Brien</surname><given-names>KA</given-names></name><name name-style="western"><surname>Du</surname><given-names>X</given-names></name></person-group><article-title>Signaling during platelet adhesion and activation</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2010</year>) <volume>30</volume>:<page-range>2341&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/ATVBAHA.110.207522</pub-id><pub-id pub-id-type="pmcid">PMC3085271</pub-id><pub-id pub-id-type="pmid">21071698</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaplanski</surname><given-names>G</given-names></name><name name-style="western"><surname>Porat</surname><given-names>R</given-names></name><name name-style="western"><surname>Aiura</surname><given-names>K</given-names></name><name name-style="western"><surname>Erban</surname><given-names>JK</given-names></name><name name-style="western"><surname>Gelfand</surname><given-names>JA</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title>Activated platelets induce endothelial secretion of interleukin-8 in vitro via an interleukin-1-mediated event</article-title>. <source>Blood</source> (<year>1993</year>) <volume>81</volume>:<page-range>2492&#8211;5</page-range>.<pub-id pub-id-type="pmid">8490165</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Boilard</surname><given-names>E</given-names></name><name name-style="western"><surname>Nigrovic</surname><given-names>PA</given-names></name><name name-style="western"><surname>Larabee</surname><given-names>K</given-names></name><name name-style="western"><surname>Watts</surname><given-names>GF</given-names></name><name name-style="western"><surname>Coblyn</surname><given-names>JS</given-names></name><name name-style="western"><surname>Weinblatt</surname><given-names>ME</given-names></name><etal/></person-group><article-title>Platelets amplify inflammation in arthritis via collagen-dependent microparticle production</article-title>. <source>Science (80)</source> (<year>2010</year>) <volume>327</volume>:<page-range>580&#8211;3</page-range>. &#160;<pub-id pub-id-type="doi">10.1126/science.1181928</pub-id><pub-id pub-id-type="pmcid">PMC2927861</pub-id><pub-id pub-id-type="pmid">20110505</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornton</surname><given-names>P</given-names></name><name name-style="western"><surname>McColl</surname><given-names>BW</given-names></name><name name-style="western"><surname>Greenhalgh</surname><given-names>A</given-names></name><name name-style="western"><surname>Denes</surname><given-names>A</given-names></name><name name-style="western"><surname>Allan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Rothwell</surname><given-names>NJ</given-names></name></person-group><article-title>Platelet interleukin-1alpha drives cerebrovascular inflammation</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>:<page-range>3632&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2009-11-252643</pub-id><pub-id pub-id-type="pmid">20200351</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vats</surname><given-names>R</given-names></name><name name-style="western"><surname>Brzoska</surname><given-names>T</given-names></name><name name-style="western"><surname>Bennewitz</surname><given-names>MF</given-names></name><name name-style="western"><surname>Jimenez</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pradhan-Sundd</surname><given-names>T</given-names></name><name name-style="western"><surname>Tutuncuoglu</surname><given-names>E</given-names></name><etal/></person-group><article-title>Platelet Extracellular Vesicles Drive Inflammasome-IL-1&#946;-Dependent Lung Injury in Sickle Cell Disease</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2020</year>) <volume>201</volume>:<fpage>33</fpage>&#8211;<lpage>46</lpage>. &#160;<pub-id pub-id-type="doi">10.1164/rccm.201807-1370OC</pub-id><pub-id pub-id-type="pmid">31498653</pub-id><pub-id pub-id-type="pmcid">PMC6938158</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rolfes</surname><given-names>V</given-names></name><name name-style="western"><surname>Ribeiro</surname><given-names>LS</given-names></name><name name-style="western"><surname>Hawwari</surname><given-names>I</given-names></name><name name-style="western"><surname>B&#246;ttcher</surname><given-names>L</given-names></name><name name-style="western"><surname>Rosero</surname><given-names>N</given-names></name><name name-style="western"><surname>Maasewerd</surname><given-names>S</given-names></name><etal/></person-group><article-title>Platelets Fuel the Inflammasome Activation of Innate Immune Cells</article-title>. <source>Cell Rep</source> (<year>2020</year>) <volume>31</volume>:<elocation-id>107615</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1016/j.celrep.2020.107615</pub-id><pub-id pub-id-type="pmid">32402278</pub-id><pub-id pub-id-type="pmcid">PMC7225754</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beaulieu</surname><given-names>LM</given-names></name><name name-style="western"><surname>Lin</surname><given-names>E</given-names></name><name name-style="western"><surname>Mick</surname><given-names>E</given-names></name><name name-style="western"><surname>Koupenova</surname><given-names>M</given-names></name><name name-style="western"><surname>Weinberg</surname><given-names>EO</given-names></name><name name-style="western"><surname>Kramer</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Interleukin 1 receptor 1 and interleukin 1&#946; regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2014</year>) <volume>34</volume>:<page-range>552&#8211;64</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/ATVBAHA.113.302700</pub-id><pub-id pub-id-type="pmcid">PMC4070375</pub-id><pub-id pub-id-type="pmid">24458711</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GT</given-names></name><name name-style="western"><surname>Narayanan</surname><given-names>P</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Silverstein</surname><given-names>RL</given-names></name><name name-style="western"><surname>McIntyre</surname><given-names>TM</given-names></name></person-group><article-title>Lipopolysaccharide stimulates platelets through an IL-1&#946; autocrine loop</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<page-range>5196&#8211;203</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1300354</pub-id><pub-id pub-id-type="pmcid">PMC3818355</pub-id><pub-id pub-id-type="pmid">24081990</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>MCH</given-names></name><name name-style="western"><surname>Savill</surname><given-names>J</given-names></name><name name-style="western"><surname>Jones</surname><given-names>DB</given-names></name><name name-style="western"><surname>Noble</surname><given-names>BS</given-names></name><name name-style="western"><surname>Brown</surname><given-names>SB</given-names></name></person-group><article-title>Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death</article-title>. <source>J Cell Biol</source> (<year>2003</year>) <volume>160</volume>:<page-range>577&#8211;87</page-range>. &#160;<pub-id pub-id-type="doi">10.1083/jcb.200210111</pub-id><pub-id pub-id-type="pmcid">PMC2173731</pub-id><pub-id pub-id-type="pmid">12591916</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Botton</surname><given-names>S</given-names></name><name name-style="western"><surname>Sabri</surname><given-names>S</given-names></name><name name-style="western"><surname>Daugas</surname><given-names>E</given-names></name><name name-style="western"><surname>Zermati</surname><given-names>Y</given-names></name><name name-style="western"><surname>Guidotti</surname><given-names>JE</given-names></name><name name-style="western"><surname>Hermine</surname><given-names>O</given-names></name><etal/></person-group><article-title>Platelet formation is the consequence of caspase activation within megakaryocytes</article-title>. <source>Blood</source> (<year>2002</year>) <volume>100</volume>:<page-range>1310&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2002-03-0686</pub-id><pub-id pub-id-type="pmid">12149212</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nishimura</surname><given-names>S</given-names></name><name name-style="western"><surname>Nagasaki</surname><given-names>M</given-names></name><name name-style="western"><surname>Kunishima</surname><given-names>S</given-names></name><name name-style="western"><surname>Sawaguchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sakata</surname><given-names>A</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>H</given-names></name><etal/></person-group><article-title>IL-1alpha induces thrombopoiesis through megakaryocyte rupture in response to acute platelet needs</article-title>. <source>J Cell Biol</source> (<year>2015</year>) <volume>209</volume>:<page-range>453&#8211;66</page-range>. &#160;<pub-id pub-id-type="doi">10.1083/jcb.201410052</pub-id><pub-id pub-id-type="pmcid">PMC4427781</pub-id><pub-id pub-id-type="pmid">25963822</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gery</surname><given-names>I</given-names></name><name name-style="western"><surname>Handschumacher</surname><given-names>RE</given-names></name></person-group><article-title>Potentiation of the T lymphocyte response to mitogens. III. Properties of the mediator(s) from adherent cells</article-title>. <source>Cell Immunol</source> (<year>1974</year>) <volume>11</volume>:<page-range>162&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/0008-8749(74)90016-1</pub-id><pub-id pub-id-type="pmid">4549027</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aarden</surname><given-names>LA</given-names></name><name name-style="western"><surname>Brunner</surname><given-names>TK</given-names></name><name name-style="western"><surname>Cerottini</surname><given-names>J-C</given-names></name><name name-style="western"><surname>Dayer</surname><given-names>J-M</given-names></name><name name-style="western"><surname>de Weck</surname><given-names>AL</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Revised Nomenclature for Antigen-Nonspecific T Cell Proliferation and Helper Factors</article-title>. <source>J Immunol</source> (<year>1979</year>) <volume>123</volume>:<page-range>2928&#8211;9</page-range>.<pub-id pub-id-type="pmid">91646</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>KA</given-names></name><name name-style="western"><surname>Lachman</surname><given-names>LB</given-names></name><name name-style="western"><surname>Oppenheim</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Favata</surname><given-names>MF</given-names></name></person-group><article-title>The functional relationship of the interleukins</article-title>. <source>J Exp Med</source> (<year>1980</year>) <volume>151</volume>:<page-range>1551&#8211;6</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.151.6.1551</pub-id><pub-id pub-id-type="pmcid">PMC2185867</pub-id><pub-id pub-id-type="pmid">6770028</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shibuya</surname><given-names>K</given-names></name><name name-style="western"><surname>Robinson</surname><given-names>D</given-names></name><name name-style="western"><surname>Zonin</surname><given-names>F</given-names></name><name name-style="western"><surname>Hartley</surname><given-names>SB</given-names></name><name name-style="western"><surname>Macatonia</surname><given-names>SE</given-names></name><name name-style="western"><surname>Somoza</surname><given-names>C</given-names></name><etal/></person-group><article-title>IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>160</volume>:<page-range>1708&#8211;16</page-range>.<pub-id pub-id-type="pmid">9469428</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Sasson</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Quiel</surname><given-names>J</given-names></name><name name-style="western"><surname>Cauchetaux</surname><given-names>S</given-names></name><name name-style="western"><surname>Ratner</surname><given-names>M</given-names></name><name name-style="western"><surname>Shapira</surname><given-names>I</given-names></name><etal/></person-group><article-title>IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>:<page-range>7119&#8211;24</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.0902745106</pub-id><pub-id pub-id-type="pmcid">PMC2678417</pub-id><pub-id pub-id-type="pmid">19359475</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huber</surname><given-names>M</given-names></name><name name-style="western"><surname>Beuscher</surname><given-names>HU</given-names></name><name name-style="western"><surname>Rohwer</surname><given-names>P</given-names></name><name name-style="western"><surname>Kurrle</surname><given-names>R</given-names></name><name name-style="western"><surname>Rollinghoff</surname><given-names>M</given-names></name><name name-style="western"><surname>Lowoff</surname><given-names>M</given-names></name></person-group><article-title>Costimulation via TCR and IL-1 reveals a novel autocrine pathway of T helper type 2 cell proliferation</article-title>. <source>Immunobiology</source> (<year>1998</year>) <volume>160</volume>:<page-range>4242 LP &#8211;4247</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/s0165-2478(97)87026-5</pub-id><pub-id pub-id-type="pmid">9574525</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schenten</surname><given-names>D</given-names></name><name name-style="western"><surname>Nish</surname><given-names>SA</given-names></name><name name-style="western"><surname>Yu</surname><given-names>S</given-names></name><name name-style="western"><surname>Yan</surname><given-names>X</given-names></name><name name-style="western"><surname>Lee</surname><given-names>HK</given-names></name><name name-style="western"><surname>Brodsky</surname><given-names>I</given-names></name><etal/></person-group><article-title>Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>:<fpage>78</fpage>&#8211;<lpage>90</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2013.10.023</pub-id><pub-id pub-id-type="pmid">24439266</pub-id><pub-id pub-id-type="pmcid">PMC4445716</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ben-Sasson</surname><given-names>SZ</given-names></name><name name-style="western"><surname>Hogg</surname><given-names>A</given-names></name><name name-style="western"><surname>Hu-Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Wingfield</surname><given-names>P</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Crank</surname><given-names>M</given-names></name><etal/></person-group><article-title>IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<fpage>491</fpage>&#8211;<lpage>502</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20122006</pub-id><pub-id pub-id-type="pmid">23460726</pub-id><pub-id pub-id-type="pmcid">PMC3600912</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Acosta-Rodriguez</surname><given-names>EV</given-names></name><name name-style="western"><surname>Napolitani</surname><given-names>G</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name></person-group><article-title>Interleukins 1&#946; and 6 but not transforming growth factor-&#946; are essential for the differentiation of interleukin 17-producing human T helper cells</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<page-range>942&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni1496</pub-id><pub-id pub-id-type="pmid">17676045</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Boniface</surname><given-names>K</given-names></name><name name-style="western"><surname>Chan</surname><given-names>JR</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>BS</given-names></name><name name-style="western"><surname>Blumenschein</surname><given-names>WM</given-names></name><name name-style="western"><surname>Mattson</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Development, cytokine profile and function of human interleukin 17-producing helper T cells</article-title>. <source>Nat Immunol</source> (<year>2007</year>) <volume>8</volume>:<page-range>950&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni1497</pub-id><pub-id pub-id-type="pmid">17676044</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>L</given-names></name><name name-style="western"><surname>Wei</surname><given-names>G</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liao</surname><given-names>W</given-names></name><name name-style="western"><surname>Leonard</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>K</given-names></name><etal/></person-group><article-title>IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>:<page-range>13463&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.0906988106</pub-id><pub-id pub-id-type="pmcid">PMC2726336</pub-id><pub-id pub-id-type="pmid">19666510</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horka</surname><given-names>H</given-names></name><name name-style="western"><surname>Staudt</surname><given-names>V</given-names></name><name name-style="western"><surname>Klein</surname><given-names>M</given-names></name><name name-style="western"><surname>Taube</surname><given-names>C</given-names></name><name name-style="western"><surname>Reuter</surname><given-names>S</given-names></name><name name-style="western"><surname>Dehzad</surname><given-names>N</given-names></name><etal/></person-group><article-title>The Tick Salivary Protein Sialostatin L Inhibits the Th9-Derived Production of the Asthma-Promoting Cytokine IL-9 and Is Effective in the Prevention of Experimental Asthma</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<page-range>2669&#8211;76</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1100529</pub-id><pub-id pub-id-type="pmcid">PMC3523721</pub-id><pub-id pub-id-type="pmid">22327077</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>V&#233;gran</surname><given-names>F</given-names></name><name name-style="western"><surname>Berger</surname><given-names>H</given-names></name><name name-style="western"><surname>Boidot</surname><given-names>R</given-names></name><name name-style="western"><surname>Mignot</surname><given-names>G</given-names></name><name name-style="western"><surname>Bruchard</surname><given-names>M</given-names></name><name name-style="western"><surname>Dosset</surname><given-names>M</given-names></name><etal/></person-group><article-title>The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of T H9 cells</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>:<page-range>758&#8211;66</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni.2925</pub-id><pub-id pub-id-type="pmid">24973819</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lichtman</surname><given-names>AH</given-names></name><name name-style="western"><surname>Chin</surname><given-names>J</given-names></name><name name-style="western"><surname>Schmidt</surname><given-names>JA</given-names></name><name name-style="western"><surname>Abbas</surname><given-names>AK</given-names></name></person-group><article-title>Role of interleukin 1 in the activation of T lymphocytes</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1988</year>) <volume>85</volume>:<page-range>9699&#8211;703</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.85.24.9699</pub-id><pub-id pub-id-type="pmcid">PMC282842</pub-id><pub-id pub-id-type="pmid">3264404</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Taylor-Robinson</surname><given-names>AW</given-names></name><name name-style="western"><surname>Phillips</surname><given-names>RS</given-names></name></person-group><article-title>Expression of the IL-1 receptor discriminates Th2 from Th1 cloned CD4+ T cells specific for Plasmodium chabaudi</article-title>. <source>Immunology</source> (<year>1994</year>) <volume>81</volume>:<page-range>216&#8211;21</page-range>.<pub-id pub-id-type="pmcid">PMC1422306</pub-id><pub-id pub-id-type="pmid">7512528</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cosmi</surname><given-names>L</given-names></name><name name-style="western"><surname>Maggi</surname><given-names>L</given-names></name><name name-style="western"><surname>Santarlasci</surname><given-names>V</given-names></name><name name-style="western"><surname>Capone</surname><given-names>M</given-names></name><name name-style="western"><surname>Cardilicchia</surname><given-names>E</given-names></name><name name-style="western"><surname>Frosali</surname><given-names>F</given-names></name><etal/></person-group><article-title>Identification of a novel subset of human circulating memory CD4+ T cells that produce both IL-17A and IL-4</article-title>. <source>J Allergy Clin Immunol</source> (<year>2010</year>) <volume>125</volume>:<page-range>222&#8211;30</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.jaci.2009.10.012</pub-id><pub-id pub-id-type="pmid">20109749</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>YH</given-names></name><name name-style="western"><surname>Voo</surname><given-names>KS</given-names></name><name name-style="western"><surname>Liu</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CY</given-names></name><name name-style="western"><surname>Uygungil</surname><given-names>B</given-names></name><name name-style="western"><surname>Spoede</surname><given-names>W</given-names></name><etal/></person-group><article-title>A novel subset of CD4+ TH2 memory/ effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<page-range>2479&#8211;91</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20101376</pub-id><pub-id pub-id-type="pmcid">PMC2964570</pub-id><pub-id pub-id-type="pmid">20921287</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>W-WW</given-names></name><name name-style="western"><surname>Kang</surname><given-names>SW</given-names></name><name name-style="western"><surname>Choi</surname><given-names>J</given-names></name><name name-style="western"><surname>Lee</surname><given-names>S-HH</given-names></name><name name-style="western"><surname>Shah</surname><given-names>K</given-names></name><name name-style="western"><surname>Eynon</surname><given-names>EE</given-names></name><etal/></person-group><article-title>Regulating human Th17 cells via differential expression of IL-1 receptor</article-title>. <source>Blood</source> (<year>2010</year>) <volume>115</volume>:<page-range>530&#8211;40</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2009-08-236521</pub-id><pub-id pub-id-type="pmcid">PMC2810985</pub-id><pub-id pub-id-type="pmid">19965648</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wesche</surname><given-names>H</given-names></name><name name-style="western"><surname>Korherr</surname><given-names>C</given-names></name><name name-style="western"><surname>Kracht</surname><given-names>M</given-names></name><name name-style="western"><surname>Falk</surname><given-names>W</given-names></name><name name-style="western"><surname>Resch</surname><given-names>K</given-names></name><name name-style="western"><surname>Martin</surname><given-names>MU</given-names></name></person-group><article-title>The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)</article-title>. <source>J Biol Chem</source> (<year>1997</year>) <volume>272</volume>:<page-range>7727&#8211;31</page-range>. &#160;<pub-id pub-id-type="doi">10.1074/jbc.272.12.7727</pub-id><pub-id pub-id-type="pmid">9065432</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korherr</surname><given-names>C</given-names></name><name name-style="western"><surname>Hofmeister</surname><given-names>R</given-names></name><name name-style="western"><surname>Wesche</surname><given-names>H</given-names></name><name name-style="western"><surname>Falk</surname><given-names>W</given-names></name></person-group><article-title>A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling</article-title>. <source>Eur J Immunol</source> (<year>1997</year>) <volume>27</volume>:<page-range>262&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/eji.1830270139</pub-id><pub-id pub-id-type="pmid">9022028</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mansur</surname><given-names>IG</given-names></name><name name-style="western"><surname>Schiavon</surname><given-names>V</given-names></name><name name-style="western"><surname>Giustiniani</surname><given-names>J</given-names></name><name name-style="western"><surname>Bagot</surname><given-names>M</given-names></name><name name-style="western"><surname>Bensussan</surname><given-names>A</given-names></name><name name-style="western"><surname>Marie-Cardine</surname><given-names>A</given-names></name></person-group><article-title>Engagement of IL-1 receptor accessory protein (IL-1RAcP) with the monoclonal antibody AY19 provides co-activating signals and prolongs the CD2-induced proliferation of peripheral blood lymphocytes</article-title>. <source>Immunol Lett</source> (<year>2011</year>) <volume>139</volume>:<page-range>52&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.imlet.2011.04.015</pub-id><pub-id pub-id-type="pmid">21600927</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Chan</surname><given-names>WL</given-names></name><name name-style="western"><surname>Leung</surname><given-names>BP</given-names></name><name name-style="western"><surname>Huang</surname><given-names>FP</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>R</given-names></name><name name-style="western"><surname>Piedrafita</surname><given-names>D</given-names></name><etal/></person-group><article-title>Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells</article-title>. <source>J Exp Med</source> (<year>1998</year>) <volume>187</volume>:<page-range>787&#8211;94</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.187.5.787</pub-id><pub-id pub-id-type="pmcid">PMC2212173</pub-id><pub-id pub-id-type="pmid">9480988</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmitz</surname><given-names>J</given-names></name><name name-style="western"><surname>Owyang</surname><given-names>A</given-names></name><name name-style="western"><surname>Oldham</surname><given-names>E</given-names></name><name name-style="western"><surname>Song</surname><given-names>Y</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>E</given-names></name><name name-style="western"><surname>McClanahan</surname><given-names>TK</given-names></name><etal/></person-group><article-title>IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines</article-title>. <source>Immunity</source> (<year>2005</year>) <volume>23</volume>:<page-range>479&#8211;90</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2005.09.015</pub-id><pub-id pub-id-type="pmid">16286016</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ritvo</surname><given-names>P-GG</given-names></name><name name-style="western"><surname>Churlaud</surname><given-names>G</given-names></name><name name-style="western"><surname>Quiniou</surname><given-names>V</given-names></name><name name-style="western"><surname>Florez</surname><given-names>L</given-names></name><name name-style="western"><surname>Brimaud</surname><given-names>F</given-names></name><name name-style="western"><surname>Fourcade</surname><given-names>G</given-names></name><etal/></person-group><article-title>T <sub>fr</sub> cells lack IL-2R&#945; but express decoy IL-1R2 and IL-1Ra and suppress the IL-1&#8211;dependent activation of T <sub>fh</sub> cells</article-title>. <source>Sci Immunol</source> (<year>2017</year>) <volume>2</volume>:<fpage>eaan0368</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/sciimmunol.aan0368</pub-id><pub-id pub-id-type="pmid">28887367</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>CG</given-names></name><name name-style="western"><surname>Linterman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Yu</surname><given-names>D</given-names></name><name name-style="western"><surname>Maclennan</surname><given-names>ICM</given-names></name></person-group><article-title>Follicular Helper T Cells</article-title>. <source>Annu Rev Immunol</source> (<year>2016</year>) <volume>34</volume>:<page-range>335&#8211;68</page-range>. &#160;<pub-id pub-id-type="doi">10.1146/annurev-immunol-041015-055605</pub-id><pub-id pub-id-type="pmid">26907215</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>D</given-names></name><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><name name-style="western"><surname>Shih</surname><given-names>C</given-names></name><name name-style="western"><surname>Wan</surname><given-names>Z</given-names></name><name name-style="western"><surname>Ma</surname><given-names>X</given-names></name><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><etal/></person-group><article-title>T-B-cell entanglement and ICOSL-driven feed-forward regulation of germinal centre reaction</article-title>. <source>Nature</source> (<year>2015</year>) <volume>517</volume>:<page-range>214&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature13803</pub-id><pub-id pub-id-type="pmid">25317561</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shulman</surname><given-names>Z</given-names></name><name name-style="western"><surname>Gitlin</surname><given-names>AD</given-names></name><name name-style="western"><surname>Weinstein</surname><given-names>JS</given-names></name><name name-style="western"><surname>Lainez</surname><given-names>B</given-names></name><name name-style="western"><surname>Esplugues</surname><given-names>E</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Germinal centers: Dynamic signaling by T follicular helper cells during germinal center B cell selection</article-title>. <source>Science (80)</source> (<year>2014</year>) <volume>345</volume>:<page-range>1058&#8211;62</page-range>. &#160;<pub-id pub-id-type="doi">10.1126/science.1257861</pub-id><pub-id pub-id-type="pmcid">PMC4519234</pub-id><pub-id pub-id-type="pmid">25170154</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-Wolf</surname><given-names>N</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name></person-group><article-title>A Guide to IL-1 family cytokines in adjuvanticity</article-title>. <source>FEBS J</source> (<year>2018</year>) <volume>285</volume>:<page-range>2377&#8211;401</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/febs.14467</pub-id><pub-id pub-id-type="pmid">29656546</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinuesa</surname><given-names>CG</given-names></name><name name-style="western"><surname>Cook</surname><given-names>MC</given-names></name><name name-style="western"><surname>Angelucci</surname><given-names>C</given-names></name><name name-style="western"><surname>Athanasopoulos</surname><given-names>V</given-names></name><name name-style="western"><surname>Rui</surname><given-names>L</given-names></name><name name-style="western"><surname>Hill</surname><given-names>KM</given-names></name><etal/></person-group><article-title>A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity</article-title>. <source>Nature</source> (<year>2005</year>) <volume>435</volume>:<page-range>452&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature03555</pub-id><pub-id pub-id-type="pmid">15917799</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Baumjohann</surname><given-names>D</given-names></name><name name-style="western"><surname>Preite</surname><given-names>S</given-names></name><name name-style="western"><surname>Reboldi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ronchi</surname><given-names>F</given-names></name><name name-style="western"><surname>Ansel</surname><given-names>KM</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name><etal/></person-group><article-title>Persistent Antigen and Germinal Center B Cells Sustain T Follicular Helper Cell Responses and Phenotype</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>:<fpage>596</fpage>&#8211;<lpage>605</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2012.11.020</pub-id><pub-id pub-id-type="pmid">23499493</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miyara</surname><given-names>M</given-names></name><name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name></person-group><article-title>Natural regulatory T cells: mechanisms of suppression</article-title>. <source>Trends Mol Med</source> (<year>2007</year>) <volume>13</volume>:<page-range>108&#8211;16</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.molmed.2007.01.003</pub-id><pub-id pub-id-type="pmid">17257897</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sakaguchi</surname><given-names>S</given-names></name><name name-style="western"><surname>Wing</surname><given-names>K</given-names></name><name name-style="western"><surname>Onishi</surname><given-names>A</given-names></name><name name-style="western"><surname>Prieto-Martin</surname><given-names>P</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>T</given-names></name></person-group><article-title>Regulatory T cells: how do they suppress immune responses</article-title>? <source>Int Immunol</source> (<year>2009</year>) <volume>21</volume>:<page-range>1105&#8211;11</page-range>. &#160;<pub-id pub-id-type="doi">10.1093/intimm/dxp095</pub-id><pub-id pub-id-type="pmid">19737784</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Linterman</surname><given-names>MA</given-names></name><name name-style="western"><surname>Pierson</surname><given-names>W</given-names></name><name name-style="western"><surname>Lee</surname><given-names>SK</given-names></name><name name-style="western"><surname>Kallies</surname><given-names>A</given-names></name><name name-style="western"><surname>Kawamoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Rayner</surname><given-names>TF</given-names></name><etal/></person-group><article-title>Foxp3+ follicular regulatory T cells control the germinal center response</article-title>. <source>Nat Med</source> (<year>2011</year>) <volume>17</volume>:<page-range>975&#8211;82</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nm.2425</pub-id><pub-id pub-id-type="pmcid">PMC3182542</pub-id><pub-id pub-id-type="pmid">21785433</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>S</given-names></name><name name-style="western"><surname>Chu</surname><given-names>F</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>RI</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Rawal</surname><given-names>S</given-names></name><etal/></person-group><article-title>Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions</article-title>. <source>Nat Med</source> (<year>2011</year>) <volume>17</volume>:<page-range>983&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nm.2426</pub-id><pub-id pub-id-type="pmcid">PMC3151340</pub-id><pub-id pub-id-type="pmid">21785430</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plitas</surname><given-names>G</given-names></name><name name-style="western"><surname>Konopacki</surname><given-names>C</given-names></name><name name-style="western"><surname>Wu</surname><given-names>K</given-names></name><name name-style="western"><surname>Bos</surname><given-names>PD</given-names></name><name name-style="western"><surname>Morrow</surname><given-names>M</given-names></name><name name-style="western"><surname>Putintseva</surname><given-names>EV</given-names></name><etal/></person-group><article-title>Regulatory T Cells Exhibit Distinct Features in Human Breast Cancer</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>:<page-range>1122&#8211;34</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.032</pub-id><pub-id pub-id-type="pmcid">PMC5134901</pub-id><pub-id pub-id-type="pmid">27851913</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Simone</surname><given-names>M</given-names></name><name name-style="western"><surname>Arrigoni</surname><given-names>A</given-names></name><name name-style="western"><surname>Rossetti</surname><given-names>G</given-names></name><name name-style="western"><surname>Gruarin</surname><given-names>P</given-names></name><name name-style="western"><surname>Ranzani</surname><given-names>V</given-names></name><name name-style="western"><surname>Politano</surname><given-names>C</given-names></name><etal/></person-group><article-title>Transcriptional Landscape of Human Tissue Lymphocytes Unveils Uniqueness of Tumor-Infiltrating T Regulatory Cells</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>45</volume>:<page-range>1135&#8211;47</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.10.021</pub-id><pub-id pub-id-type="pmcid">PMC5119953</pub-id><pub-id pub-id-type="pmid">27851914</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ghiringhelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Apetoh</surname><given-names>L</given-names></name><name name-style="western"><surname>Tesniere</surname><given-names>A</given-names></name><name name-style="western"><surname>Aymeric</surname><given-names>L</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y</given-names></name><name name-style="western"><surname>Ortiz</surname><given-names>C</given-names></name><etal/></person-group><article-title>Activation of the NLRP3 inflammasome in dendritic cells induces IL-1|[beta]||[ndash]|dependent adaptive immunity against tumors</article-title>. <source>Nat Med Publ</source> (<year>2009</year>) <volume>15</volume>:<fpage>1170</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/nm.2028</pub-id>. online 20 Sept 2009; | 101038/nm2028<pub-id pub-id-type="pmid">19767732</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michelini</surname><given-names>S</given-names></name><name name-style="western"><surname>Sarajlic</surname><given-names>M</given-names></name><name name-style="western"><surname>Duschl</surname><given-names>A</given-names></name><name name-style="western"><surname>Horejs-Hoeck</surname><given-names>J</given-names></name></person-group><article-title>IL-1&#946; induces expression of costimulatory molecules and cytokines but not immune feedback regulators in dendritic cells</article-title>. <source>Hum Immunol</source> (<year>2018</year>) <volume>79</volume>:<page-range>610&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.humimm.2018.06.002</pub-id><pub-id pub-id-type="pmid">29886260</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luft</surname><given-names>T</given-names></name><name name-style="western"><surname>Jefford</surname><given-names>M</given-names></name><name name-style="western"><surname>Luetjens</surname><given-names>P</given-names></name><name name-style="western"><surname>Hochrein</surname><given-names>H</given-names></name><name name-style="western"><surname>Masterman</surname><given-names>K-A</given-names></name><name name-style="western"><surname>Maliszewski</surname><given-names>C</given-names></name><etal/></person-group><article-title>IL-1&#946; Enhances CD40 Ligand-Mediated Cytokine Secretion by Human Dendritic Cells (DC): A Mechanism for T Cell-Independent DC Activation</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume>:<page-range>713&#8211;22</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.168.2.713</pub-id><pub-id pub-id-type="pmid">11777965</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matjeka</surname><given-names>T</given-names></name><name name-style="western"><surname>Summerfield</surname><given-names>V</given-names></name><name name-style="western"><surname>Noursadeghi</surname><given-names>M</given-names></name><name name-style="western"><surname>Chain</surname><given-names>BM</given-names></name></person-group><article-title>Chemical toxicity to keratinocytes triggers dendritic cell activation via an IL-1&#945; path</article-title>. <source>J Allergy Clin Immunol</source> (<year>2012</year>) <volume>129</volume>:<page-range>247&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.jaci.2011.08.018</pub-id><pub-id pub-id-type="pmid">21943942</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wesa</surname><given-names>AK</given-names></name><name name-style="western"><surname>Galy</surname><given-names>A</given-names></name></person-group><article-title>IL-1&#946; induces dendritic cells to produce IL-12</article-title>. <source>Int Immunol</source> (<year>2001</year>) <volume>13</volume>:<page-range>1053&#8211;61</page-range>. &#160;<pub-id pub-id-type="doi">10.1093/intimm/13.8.1053</pub-id><pub-id pub-id-type="pmid">11470775</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sallusto</surname><given-names>F</given-names></name><name name-style="western"><surname>Cella</surname><given-names>M</given-names></name><name name-style="western"><surname>Danieli</surname><given-names>C</given-names></name><name name-style="western"><surname>Lanzavecchia</surname><given-names>A</given-names></name></person-group><article-title>Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products</article-title>. <source>J Exp Med</source> (<year>1995</year>) <volume>182</volume>:<fpage>389</fpage>&#8211;<lpage>400</lpage>. &#160;<pub-id pub-id-type="doi">10.1084/jem.182.2.389</pub-id><pub-id pub-id-type="pmid">7629501</pub-id><pub-id pub-id-type="pmcid">PMC2192110</pub-id></mixed-citation></ref><ref id="B138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anttila</surname><given-names>HS</given-names></name><name name-style="western"><surname>Reitamo</surname><given-names>S</given-names></name><name name-style="western"><surname>Erkko</surname><given-names>P</given-names></name><name name-style="western"><surname>Miettinen</surname><given-names>A</given-names></name><name name-style="western"><surname>Didierjean</surname><given-names>L</given-names></name><name name-style="western"><surname>Saurat</surname><given-names>JH</given-names></name></person-group><article-title>Membrane and cytosolic interleukin-1 alpha and beta in normal human epidermal cells: variability of epitope exposure in immunohistochemistry</article-title>. <source>J Invest Dermatol</source> (<year>1990</year>) <volume>95</volume>:<page-range>31&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/1523-1747.ep12873278</pub-id><pub-id pub-id-type="pmid">1694889</pub-id></mixed-citation></ref><ref id="B139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palazon-Riquelme</surname><given-names>P</given-names></name><name name-style="western"><surname>Lopez-Castejon</surname><given-names>G</given-names></name></person-group><article-title>The inflammasomes, immune guardians at defence barriers</article-title>. <source>Immunology</source> (<year>2018</year>) <volume>155</volume>:<page-range>320&#8211;30</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/imm.12989</pub-id><pub-id pub-id-type="pmcid">PMC6187212</pub-id><pub-id pub-id-type="pmid">30098204</pub-id></mixed-citation></ref><ref id="B140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feldmeyer</surname><given-names>L</given-names></name><name name-style="western"><surname>Keller</surname><given-names>M</given-names></name><name name-style="western"><surname>Niklaus</surname><given-names>G</given-names></name><name name-style="western"><surname>Hohl</surname><given-names>D</given-names></name><name name-style="western"><surname>Werner</surname><given-names>S</given-names></name><name name-style="western"><surname>Beer</surname><given-names>HD</given-names></name></person-group><article-title>The inflammasome mediates UVB-induced activation and secretion of interleukin-1beta by keratinocytes</article-title>. <source>Curr Biol</source> (<year>2007</year>) <volume>17</volume>:<page-range>1140&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.cub.2007.05.074</pub-id><pub-id pub-id-type="pmid">17600714</pub-id></mixed-citation></ref><ref id="B141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dai</surname><given-names>X</given-names></name><name name-style="western"><surname>Tohyama</surname><given-names>M</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>M</given-names></name><name name-style="western"><surname>Sayama</surname><given-names>K</given-names></name></person-group><article-title>Epidermal keratinocytes sense dsRNA via the NLRP3 inflammasome, mediating interleukin (IL)-1&#946; and IL-18 release</article-title>. <source>Exp Dermatol</source> (<year>2017</year>) <volume>26</volume>:<page-range>904&#8211;11</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/exd.13334</pub-id><pub-id pub-id-type="pmid">28266737</pub-id></mixed-citation></ref><ref id="B142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orzalli</surname><given-names>MH</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Jurado</surname><given-names>KA</given-names></name><name name-style="western"><surname>Iwasaki</surname><given-names>A</given-names></name><name name-style="western"><surname>Garlick</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kagan</surname><given-names>JC</given-names></name></person-group><article-title>An Antiviral Branch of the IL-1 Signaling Pathway Restricts Immune-Evasive Virus Replication</article-title>. <source>Mol Cell</source> (<year>2018</year>) <volume>71</volume>:<page-range>825&#8211;40</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.molcel.2018.07.009</pub-id><pub-id pub-id-type="pmcid">PMC6411291</pub-id><pub-id pub-id-type="pmid">30100266</pub-id></mixed-citation></ref><ref id="B143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beales</surname><given-names>IL</given-names></name><name name-style="western"><surname>Calam</surname><given-names>J</given-names></name></person-group><article-title>Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways</article-title>. <source>Gut</source> (<year>1998</year>) <volume>42</volume>:<page-range>227&#8211;34</page-range>. &#160;<pub-id pub-id-type="doi">10.1136/gut.42.2.227</pub-id><pub-id pub-id-type="pmcid">PMC1726991</pub-id><pub-id pub-id-type="pmid">9536948</pub-id></mixed-citation></ref><ref id="B144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>JL</given-names></name><name name-style="western"><surname>Cucala</surname><given-names>M</given-names></name><name name-style="western"><surname>Mugridge</surname><given-names>K</given-names></name><name name-style="western"><surname>Parente</surname><given-names>L</given-names></name></person-group><article-title>Secretagogue-specific effects of interleukin-1 on gastric acid secretion</article-title>. <source>Am J Physiol</source> (<year>1991</year>) <volume>261</volume>:<page-range>G559&#8211;64</page-range>. &#160;<pub-id pub-id-type="doi">10.1152/ajpgi.1991.261.4.G559</pub-id><pub-id pub-id-type="pmid">1681735</pub-id></mixed-citation></ref><ref id="B145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uehara</surname><given-names>A</given-names></name><name name-style="western"><surname>Okumura</surname><given-names>T</given-names></name><name name-style="western"><surname>Sekiya</surname><given-names>C</given-names></name><name name-style="western"><surname>Okamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Takasugi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Namiki</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin</article-title>. <source>Biochem Biophys Res Commun</source> (<year>1989</year>) <volume>162</volume>:<page-range>1578&#8211;84</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/0006-291x(89)90855-3</pub-id><pub-id pub-id-type="pmid">2788416</pub-id></mixed-citation></ref><ref id="B146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>JL</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>CM</given-names></name><name name-style="western"><surname>Cucala</surname><given-names>M</given-names></name><name name-style="western"><surname>Mugridge</surname><given-names>KG</given-names></name><name name-style="western"><surname>Parente</surname><given-names>L</given-names></name></person-group><article-title>Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy</article-title>. <source>Gastroenterology</source> (<year>1992</year>) <volume>102</volume>:<page-range>1176&#8211;85</page-range>.<pub-id pub-id-type="pmid">1348040</pub-id></mixed-citation></ref><ref id="B147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wallace</surname><given-names>JL</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mugridge</surname><given-names>KG</given-names></name><name name-style="western"><surname>Parente</surname><given-names>L</given-names></name></person-group><article-title>Reduction of the severity of experimental gastric and duodenal ulceration by interleukin-1 beta</article-title>. <source>Eur J Pharmacol</source> (<year>1990</year>) <volume>186</volume>:<page-range>279&#8211;84</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/0014-2999(90)90444-b</pub-id><pub-id pub-id-type="pmid">2289528</pub-id></mixed-citation></ref><ref id="B148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohan</surname><given-names>VL</given-names></name><name name-style="western"><surname>Scott</surname><given-names>AL</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Prendergast</surname><given-names>RA</given-names></name></person-group><article-title>Interleukin-1 is a mucus secretagogue</article-title>. <source>Cell Immunol</source> (<year>1991</year>) <volume>136</volume>:<page-range>425&#8211;34</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/0008-8749(91)90364-h</pub-id><pub-id pub-id-type="pmid">1873825</pub-id></mixed-citation></ref><ref id="B149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>V</given-names></name><name name-style="western"><surname>Resau</surname><given-names>J</given-names></name><name name-style="western"><surname>Prendergast</surname><given-names>R</given-names></name><name name-style="western"><surname>Scott</surname><given-names>A</given-names></name><name name-style="western"><surname>Levy</surname><given-names>DA</given-names></name></person-group><article-title>Interleukin-1 induces mucus secretion from mouse intestinal explants</article-title>. <source>Int Arch Allergy Appl Immunol</source> (<year>1987</year>) <volume>82</volume>:<page-range>364&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1159/000234228</pub-id><pub-id pub-id-type="pmid">3494680</pub-id></mixed-citation></ref><ref id="B150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>S</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>E</given-names></name><name name-style="western"><surname>Okabe</surname><given-names>S</given-names></name></person-group><article-title>Effects of cytokines, without and with Helicobacter pylori components, on mucus secretion by cultured gastric epithelial cells</article-title>. <source>Dig Dis Sci</source> (<year>1998</year>) <volume>43</volume>:<page-range>2301&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1023/a:1026635110099</pub-id><pub-id pub-id-type="pmid">9790469</pub-id></mixed-citation></ref><ref id="B151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Sadi</surname><given-names>R</given-names></name><name name-style="western"><surname>Ye</surname><given-names>D</given-names></name><name name-style="western"><surname>Dokladny</surname><given-names>K</given-names></name><name name-style="western"><surname>Ma</surname><given-names>TY</given-names></name></person-group><article-title>Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<page-range>5653&#8211;61</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.180.8.5653</pub-id><pub-id pub-id-type="pmcid">PMC3035485</pub-id><pub-id pub-id-type="pmid">18390750</pub-id></mixed-citation></ref><ref id="B152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Al-Sadi</surname><given-names>R</given-names></name><name name-style="western"><surname>Ye</surname><given-names>D</given-names></name><name name-style="western"><surname>Said</surname><given-names>HM</given-names></name><name name-style="western"><surname>Ma</surname><given-names>TY</given-names></name></person-group><article-title>Cellular and molecular mechanism of interleukin-1&#946; modulation of Caco-2 intestinal epithelial tight junction barrier</article-title>. <source>J Cell Mol Med</source> (<year>2011</year>) <volume>15</volume>:<page-range>970&#8211;82</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/j.1582-4934.2010.01065.x</pub-id><pub-id pub-id-type="pmcid">PMC3922681</pub-id><pub-id pub-id-type="pmid">20406328</pub-id></mixed-citation></ref><ref id="B153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vi&#241;uales</surname><given-names>C</given-names></name><name name-style="western"><surname>Gasc&#243;n</surname><given-names>S</given-names></name><name name-style="western"><surname>Barranquero</surname><given-names>C</given-names></name><name name-style="western"><surname>Osada</surname><given-names>J</given-names></name><name name-style="western"><surname>Rodr&#237;guez-Yoldi</surname><given-names>MJ</given-names></name></person-group><article-title>Inhibitory effect of IL-1&#946; on galactose intestinal absorption in rabbits</article-title>. <source>Cell Physiol Biochem</source> (<year>2012</year>) <volume>30</volume>:<page-range>173&#8211;86</page-range>. &#160;<pub-id pub-id-type="doi">10.1159/000339056</pub-id><pub-id pub-id-type="pmid">22759965</pub-id></mixed-citation></ref><ref id="B154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Garc&#237;a-Barrios</surname><given-names>A</given-names></name><name name-style="western"><surname>Guill&#233;n</surname><given-names>N</given-names></name><name name-style="western"><surname>Gasc&#243;n</surname><given-names>S</given-names></name><name name-style="western"><surname>Osada</surname><given-names>J</given-names></name><name name-style="western"><surname>Vazquez</surname><given-names>CM</given-names></name><name name-style="western"><surname>Miguel-Carrasco</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Nitric oxide involved in the IL-1&#946;-induced inhibition of fructose intestinal transport</article-title>. <source>J Cell Biochem</source> (<year>2010</year>) <volume>111</volume>:<page-range>1321&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/jcb.22859</pub-id><pub-id pub-id-type="pmid">20803526</pub-id></mixed-citation></ref><ref id="B155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodr&#237;guez-Yoldi</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Gasc&#243;n</surname><given-names>S</given-names></name><name name-style="western"><surname>Barranquero</surname><given-names>C</given-names></name><name name-style="western"><surname>Garc&#237;a-Barrios</surname><given-names>A</given-names></name><name name-style="western"><surname>Osada</surname><given-names>J</given-names></name></person-group><article-title>Involvement of intracellular signaling in the IL-1&#946; inhibitory effect on fructose intestinal absorption</article-title>. <source>J Cell Physiol</source> (<year>2015</year>) <volume>230</volume>:<fpage>896</fpage>&#8211;<lpage>902</lpage>. &#160;<pub-id pub-id-type="doi">10.1002/jcp.24820</pub-id><pub-id pub-id-type="pmid">25216359</pub-id></mixed-citation></ref><ref id="B156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dmitrieva-Posocco</surname><given-names>O</given-names></name><name name-style="western"><surname>Dzutsev</surname><given-names>A</given-names></name><name name-style="western"><surname>Posocco</surname><given-names>DF</given-names></name><name name-style="western"><surname>Hou</surname><given-names>V</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>W</given-names></name><name name-style="western"><surname>Thovarai</surname><given-names>V</given-names></name><etal/></person-group><article-title>Cell-Type-Specific Responses to Interleukin-1 Control Microbial Invasion and Tumor-Elicited Inflammation in Colorectal Cancer</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>:<fpage>166</fpage>&#8211;<lpage>80.e7</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2018.11.015</pub-id><pub-id pub-id-type="pmid">30650375</pub-id><pub-id pub-id-type="pmcid">PMC6490968</pub-id></mixed-citation></ref><ref id="B157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knight</surname><given-names>DA</given-names></name><name name-style="western"><surname>Holgate</surname><given-names>ST</given-names></name></person-group><article-title>The airway epithelium: structural and functional properties in health and disease</article-title>. <source>Respirology</source> (<year>2003</year>) <volume>8</volume>:<page-range>432&#8211;46</page-range>. &#160;<pub-id pub-id-type="doi">10.1046/j.1440-1843.2003.00493.x</pub-id><pub-id pub-id-type="pmid">14708552</pub-id></mixed-citation></ref><ref id="B158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>T</given-names></name><name name-style="western"><surname>Coakley</surname><given-names>R</given-names></name><name name-style="western"><surname>Hirsh</surname><given-names>A</given-names></name><name name-style="western"><surname>Thornton</surname><given-names>D</given-names></name><name name-style="western"><surname>Kirkham</surname><given-names>S</given-names></name><name name-style="western"><surname>Koo</surname><given-names>JS</given-names></name><etal/></person-group><article-title>Regulation of MUC5AC mucin secretion and airway surface liquid metabolism by IL-1beta in human bronchial epithelia</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source> (<year>2004</year>) <volume>286</volume>:<page-range>L320&#8211;30</page-range>. &#160;<pub-id pub-id-type="doi">10.1152/ajplung.00440.2002</pub-id><pub-id pub-id-type="pmid">14527933</pub-id></mixed-citation></ref><ref id="B159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>G</given-names></name><name name-style="western"><surname>Sun</surname><given-names>L</given-names></name><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name><name name-style="western"><surname>Okuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Martino</surname><given-names>MB</given-names></name><name name-style="western"><surname>Abzhanova</surname><given-names>A</given-names></name><etal/></person-group><article-title>IL-1&#946; dominates the promucin secretory cytokine profile in cystic fibrosis</article-title>. <source>J Clin Invest</source> (<year>2019</year>) <volume>129</volume>:<page-range>4433&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/jci125669</pub-id><pub-id pub-id-type="pmcid">PMC6763234</pub-id><pub-id pub-id-type="pmid">31524632</pub-id></mixed-citation></ref><ref id="B160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Katsura</surname><given-names>H</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Tata</surname><given-names>PR</given-names></name><name name-style="western"><surname>Hogan</surname><given-names>BLM</given-names></name></person-group><article-title>IL-1 and TNF&#945; Contribute to the Inflammatory Niche to Enhance Alveolar Regeneration</article-title>. <source>Stem Cell Rep</source> (<year>2019</year>) <volume>12</volume>:<page-range>657&#8211;66</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.stemcr.2019.02.013</pub-id><pub-id pub-id-type="pmcid">PMC6450459</pub-id><pub-id pub-id-type="pmid">30930244</pub-id></mixed-citation></ref><ref id="B161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>XJ</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>PG</given-names></name></person-group><article-title>New fronts emerge in the influenza cytokine storm</article-title>. <source>Semin Immunopathol</source> (<year>2017</year>) <volume>39</volume>:<page-range>541&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1007/s00281-017-0636-y</pub-id><pub-id pub-id-type="pmcid">PMC5580809</pub-id><pub-id pub-id-type="pmid">28555383</pub-id></mixed-citation></ref><ref id="B162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michiels</surname><given-names>C</given-names></name></person-group><article-title>Endothelial cell functions</article-title>. <source>J Cell Physiol</source> (<year>2003</year>) <volume>196</volume>:<page-range>430&#8211;43</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/jcp.10333</pub-id><pub-id pub-id-type="pmid">12891700</pub-id></mixed-citation></ref><ref id="B163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Erdei</surname><given-names>J</given-names></name><name name-style="western"><surname>T&#243;th</surname><given-names>A</given-names></name><name name-style="western"><surname>Balogh</surname><given-names>E</given-names></name><name name-style="western"><surname>Nyakundi</surname><given-names>BB</given-names></name><name name-style="western"><surname>B&#225;nyai</surname><given-names>E</given-names></name><name name-style="western"><surname>Ryffel</surname><given-names>B</given-names></name><etal/></person-group><article-title>Induction of NLRP3 Inflammasome Activation by Heme in Human Endothelial Cells</article-title>. <source>Oxid Med Cell Longev</source> (<year>2018</year>) <volume>2018</volume>:<elocation-id>4310816</elocation-id>. &#160;<pub-id pub-id-type="doi">10.1155/2018/4310816</pub-id><pub-id pub-id-type="pmid">29743981</pub-id><pub-id pub-id-type="pmcid">PMC5883980</pub-id></mixed-citation></ref><ref id="B164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bevilacqua</surname><given-names>MP</given-names></name><name name-style="western"><surname>Pober</surname><given-names>JS</given-names></name><name name-style="western"><surname>Majeau</surname><given-names>GR</given-names></name><name name-style="western"><surname>Cotran</surname><given-names>RS</given-names></name><name name-style="western"><surname>Gimbrone</surname><given-names>MA</given-names><suffix>Jr.</suffix></name></person-group><article-title>Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells</article-title>. <source>J Exp Med</source> (<year>1984</year>) <volume>160</volume>:<page-range>618&#8211;23</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.160.2.618</pub-id><pub-id pub-id-type="pmcid">PMC2187463</pub-id><pub-id pub-id-type="pmid">6332168</pub-id></mixed-citation></ref><ref id="B165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bevilacqua</surname><given-names>MP</given-names></name><name name-style="western"><surname>Pober</surname><given-names>JS</given-names></name><name name-style="western"><surname>Wheeler</surname><given-names>ME</given-names></name><name name-style="western"><surname>Cotran</surname><given-names>RS</given-names></name><name name-style="western"><surname>Gimbrone</surname><given-names>MA</given-names><suffix>Jr.</suffix></name></person-group><article-title>Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines</article-title>. <source>J Clin Invest</source> (<year>1985</year>) <volume>76</volume>:<page-range>2003&#8211;11</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/jci112200</pub-id><pub-id pub-id-type="pmcid">PMC424265</pub-id><pub-id pub-id-type="pmid">3877078</pub-id></mixed-citation></ref><ref id="B166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Woodfin</surname><given-names>A</given-names></name><name name-style="western"><surname>Reichel</surname><given-names>CA</given-names></name><name name-style="western"><surname>Khandoga</surname><given-names>A</given-names></name><name name-style="western"><surname>Corada</surname><given-names>M</given-names></name><name name-style="western"><surname>Voisin</surname><given-names>MB</given-names></name><name name-style="western"><surname>Scheiermann</surname><given-names>C</given-names></name><etal/></person-group><article-title>JAM-A mediates neutrophil transmigration in a stimulus-specific manner in vivo: evidence for sequential roles for JAM-A and PECAM-1 in neutrophil transmigration</article-title>. <source>Blood</source> (<year>2007</year>) <volume>110</volume>:<page-range>1848&#8211;56</page-range>. &#160;<pub-id pub-id-type="doi">10.1182/blood-2006-09-047431</pub-id><pub-id pub-id-type="pmid">17505016</pub-id></mixed-citation></ref><ref id="B167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>AM</given-names></name><name name-style="western"><surname>McNeil</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Stallaert</surname><given-names>KM</given-names></name><name name-style="western"><surname>Rogers</surname><given-names>KA</given-names></name><name name-style="western"><surname>Sandig</surname><given-names>M</given-names></name></person-group><article-title>Interleukin-1beta reduces transcellular monocyte diapedesis and compromises endothelial adherens junction integrity</article-title>. <source>Microcirculation</source> (<year>2005</year>) <volume>12</volume>:<page-range>563&#8211;79</page-range>. &#160;<pub-id pub-id-type="doi">10.1080/10739680500253493</pub-id><pub-id pub-id-type="pmid">16207629</pub-id></mixed-citation></ref><ref id="B168"><label>168</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Labus</surname><given-names>J</given-names></name><name name-style="western"><surname>W&#246;ltje</surname><given-names>K</given-names></name><name name-style="western"><surname>Stolte</surname><given-names>KN</given-names></name><name name-style="western"><surname>H&#228;ckel</surname><given-names>S</given-names></name><name name-style="western"><surname>Kim</surname><given-names>KS</given-names></name><name name-style="western"><surname>Hildmann</surname><given-names>A</given-names></name><etal/></person-group><article-title>IL-1&#946; promotes transendothelial migration of PBMCs by upregulation of the FN/&#945;(5)&#946;(1) signalling pathway in immortalised human brain microvascular endothelial cells</article-title>. <source>Exp Cell Res</source> (<year>2018</year>) <volume>373</volume>:<fpage>99</fpage>&#8211;<lpage>111</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.yexcr.2018.10.002</pub-id><pub-id pub-id-type="pmid">30342992</pub-id></mixed-citation></ref><ref id="B169"><label>169</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ebisawa</surname><given-names>M</given-names></name><name name-style="western"><surname>Bochner</surname><given-names>BS</given-names></name><name name-style="western"><surname>Georas</surname><given-names>SN</given-names></name><name name-style="western"><surname>Schleimer</surname><given-names>RP</given-names></name></person-group><article-title>Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration</article-title>. <source>J Immunol</source> (<year>1992</year>) <volume>149</volume>:<page-range>4021&#8211;8</page-range>.<pub-id pub-id-type="pmid">1460288</pub-id></mixed-citation></ref><ref id="B170"><label>170</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dangerfield</surname><given-names>J</given-names></name><name name-style="western"><surname>Larbi</surname><given-names>KY</given-names></name><name name-style="western"><surname>Huang</surname><given-names>MT</given-names></name><name name-style="western"><surname>Dewar</surname><given-names>A</given-names></name><name name-style="western"><surname>Nourshargh</surname><given-names>S</given-names></name></person-group><article-title>PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane</article-title>. <source>J Exp Med</source> (<year>2002</year>) <volume>196</volume>:<page-range>1201&#8211;11</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20020324</pub-id><pub-id pub-id-type="pmcid">PMC2194111</pub-id><pub-id pub-id-type="pmid">12417630</pub-id></mixed-citation></ref><ref id="B171"><label>171</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Voronov</surname><given-names>E</given-names></name><name name-style="western"><surname>Dotan</surname><given-names>S</given-names></name><name name-style="western"><surname>Lahat</surname><given-names>N</given-names></name><name name-style="western"><surname>Rahat</surname><given-names>MA</given-names></name><name name-style="western"><surname>Fogel</surname><given-names>M</given-names></name><etal/></person-group><article-title>The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>:<page-range>4705&#8211;14</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.0901511</pub-id><pub-id pub-id-type="pmid">19752225</pub-id></mixed-citation></ref><ref id="B172"><label>172</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carmi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Dotan</surname><given-names>S</given-names></name><name name-style="western"><surname>Rider</surname><given-names>P</given-names></name><name name-style="western"><surname>Kaplanov</surname><given-names>I</given-names></name><name name-style="western"><surname>White</surname><given-names>MR</given-names></name><name name-style="western"><surname>Baron</surname><given-names>R</given-names></name><etal/></person-group><article-title>The role of IL-1&#946; in the early tumor cell-induced angiogenic response</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>190</volume>:<page-range>3500&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.1202769</pub-id><pub-id pub-id-type="pmid">23475218</pub-id></mixed-citation></ref><ref id="B173"><label>173</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voronov</surname><given-names>E</given-names></name><name name-style="western"><surname>Shouval</surname><given-names>DS</given-names></name><name name-style="western"><surname>Krelin</surname><given-names>Y</given-names></name><name name-style="western"><surname>Cagnano</surname><given-names>E</given-names></name><name name-style="western"><surname>Benharroch</surname><given-names>D</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><etal/></person-group><article-title>IL-1 is required for tumor invasiveness and angiogenesis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>:<page-range>2645&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.0437939100</pub-id><pub-id pub-id-type="pmcid">PMC151394</pub-id><pub-id pub-id-type="pmid">12598651</pub-id></mixed-citation></ref><ref id="B174"><label>174</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bar</surname><given-names>D</given-names></name><name name-style="western"><surname>Apte</surname><given-names>RN</given-names></name><name name-style="western"><surname>Voronov</surname><given-names>E</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>S</given-names></name></person-group><article-title>A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development</article-title>. <source>FASEB J</source> (<year>2004</year>) <volume>18</volume>:<page-range>161&#8211;3</page-range>. &#160;<pub-id pub-id-type="doi">10.1096/fj.03-0483fje</pub-id><pub-id pub-id-type="pmid">14597552</pub-id></mixed-citation></ref><ref id="B175"><label>175</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Simon</surname><given-names>A</given-names></name><name name-style="western"><surname>van der Meer</surname><given-names>JW</given-names></name></person-group><article-title>Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases</article-title>. <source>Nat Rev Drug Discov</source> (<year>2012</year>) <volume>11</volume>:<page-range>633&#8211;52</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nrd3800</pub-id><pub-id pub-id-type="pmcid">PMC3644509</pub-id><pub-id pub-id-type="pmid">22850787</pub-id></mixed-citation></ref><ref id="B176"><label>176</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>R</given-names></name><name name-style="western"><surname>Liang</surname><given-names>H</given-names></name><name name-style="western"><surname>Clarke</surname><given-names>E</given-names></name><name name-style="western"><surname>Jackson</surname><given-names>C</given-names></name><name name-style="western"><surname>Xue</surname><given-names>M</given-names></name></person-group><article-title>Inflammation in Chronic Wounds</article-title>. <source>Int J Mol Sci</source> (<year>2016</year>) <volume>17</volume>:<fpage>2085</fpage>. &#160;<pub-id pub-id-type="doi">10.3390/ijms17122085</pub-id><pub-id pub-id-type="pmcid">PMC5187885</pub-id><pub-id pub-id-type="pmid">27973441</pub-id></mixed-citation></ref><ref id="B177"><label>177</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lippi</surname><given-names>G</given-names></name><name name-style="western"><surname>Franchini</surname><given-names>M</given-names></name><name name-style="western"><surname>Targher</surname><given-names>G</given-names></name></person-group><article-title>Arterial thrombus formation in cardiovascular disease</article-title>. <source>Nat Rev Cardiol</source> (<year>2011</year>) <volume>8</volume>:<page-range>502&#8211;12</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nrcardio.2011.91</pub-id><pub-id pub-id-type="pmid">21727917</pub-id></mixed-citation></ref><ref id="B178"><label>178</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weinheimer-Haus</surname><given-names>EM</given-names></name><name name-style="western"><surname>Mirza</surname><given-names>RE</given-names></name><name name-style="western"><surname>Koh</surname><given-names>TJ</given-names></name></person-group><article-title>Nod-like receptor protein-3 inflammasome plays an important role during early stages of wound healing</article-title>. <source>PLoS One</source> (<year>2015</year>) <volume>10</volume>:<fpage>e0119106</fpage>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0119106</pub-id><pub-id pub-id-type="pmid">25793779</pub-id><pub-id pub-id-type="pmcid">PMC4368510</pub-id></mixed-citation></ref><ref id="B179"><label>179</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ito</surname><given-names>H</given-names></name><name name-style="western"><surname>Kanbe</surname><given-names>A</given-names></name><name name-style="western"><surname>Sakai</surname><given-names>H</given-names></name><name name-style="western"><surname>Seishima</surname><given-names>M</given-names></name></person-group><article-title>Activation of NLRP3 signalling accelerates skin wound healing</article-title>. <source>Exp Dermatol</source> (<year>2018</year>) <volume>27</volume>:<page-range>80&#8211;6</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/exd.13441</pub-id><pub-id pub-id-type="pmid">28887870</pub-id></mixed-citation></ref><ref id="B180"><label>180</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brauweiler</surname><given-names>AM</given-names></name><name name-style="western"><surname>Goleva</surname><given-names>E</given-names></name><name name-style="western"><surname>Leung</surname><given-names>DYM</given-names></name></person-group><article-title>Staphylococcus aureus Lipoteichoic Acid Damages the Skin Barrier through an IL-1-Mediated Pathway</article-title>. <source>J Invest Dermatol</source> (<year>2019</year>) <volume>139</volume>:<fpage>1753</fpage>&#8211;<lpage>1761.e4</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.jid.2019.02.006</pub-id><pub-id pub-id-type="pmid">30779913</pub-id><pub-id pub-id-type="pmcid">PMC6650368</pub-id></mixed-citation></ref><ref id="B181"><label>181</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinaik</surname><given-names>R</given-names></name><name name-style="western"><surname>Abdullahi</surname><given-names>A</given-names></name><name name-style="western"><surname>Barayan</surname><given-names>D</given-names></name><name name-style="western"><surname>Jeschke</surname><given-names>MG</given-names></name></person-group><article-title>NLRP3 inflammasome activity is required for wound healing after burns</article-title>. <source>Transl Res</source> (<year>2020</year>) <volume>217</volume>:<fpage>47</fpage>&#8211;<lpage>60</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.trsl.2019.11.002</pub-id><pub-id pub-id-type="pmid">31843468</pub-id><pub-id pub-id-type="pmcid">PMC7036017</pub-id></mixed-citation></ref><ref id="B182"><label>182</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mirza</surname><given-names>RE</given-names></name><name name-style="western"><surname>Fang</surname><given-names>MM</given-names></name><name name-style="western"><surname>Weinheimer-Haus</surname><given-names>EM</given-names></name><name name-style="western"><surname>Ennis</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Koh</surname><given-names>TJ</given-names></name></person-group><article-title>Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice</article-title>. <source>Diabetes</source> (<year>2014</year>) <volume>63</volume>:<page-range>1103&#8211;14</page-range>. &#160;<pub-id pub-id-type="doi">10.2337/db13-0927</pub-id><pub-id pub-id-type="pmcid">PMC3931398</pub-id><pub-id pub-id-type="pmid">24194505</pub-id></mixed-citation></ref><ref id="B183"><label>183</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bitto</surname><given-names>A</given-names></name><name name-style="western"><surname>Altavilla</surname><given-names>D</given-names></name><name name-style="western"><surname>Pizzino</surname><given-names>G</given-names></name><name name-style="western"><surname>Irrera</surname><given-names>N</given-names></name><name name-style="western"><surname>Pallio</surname><given-names>G</given-names></name><name name-style="western"><surname>Colonna</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice</article-title>. <source>Br J Pharmacol</source> (<year>2014</year>) <volume>171</volume>:<page-range>2300&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1111/bph.12557</pub-id><pub-id pub-id-type="pmcid">PMC3997271</pub-id><pub-id pub-id-type="pmid">24329484</pub-id></mixed-citation></ref><ref id="B184"><label>184</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thomay</surname><given-names>AA</given-names></name><name name-style="western"><surname>Daley</surname><given-names>JM</given-names></name><name name-style="western"><surname>Sabo</surname><given-names>E</given-names></name><name name-style="western"><surname>Worth</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Shelton</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Harty</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Disruption of interleukin-1 signaling improves the quality of wound healing</article-title>. <source>Am J Pathol</source> (<year>2009</year>) <volume>174</volume>:<page-range>2129&#8211;36</page-range>. &#160;<pub-id pub-id-type="doi">10.2353/ajpath.2009.080765</pub-id><pub-id pub-id-type="pmcid">PMC2684178</pub-id><pub-id pub-id-type="pmid">19389930</pub-id></mixed-citation></ref><ref id="B185"><label>185</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perrault</surname><given-names>DP</given-names></name><name name-style="western"><surname>Bramos</surname><given-names>A</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Shi</surname><given-names>S</given-names></name><name name-style="western"><surname>Wong</surname><given-names>AK</given-names></name></person-group><article-title>Local Administration of Interleukin-1 Receptor Antagonist Improves Diabetic Wound Healing</article-title>. <source>Ann Plast Surg</source> (<year>2018</year>) <volume>80</volume>:<fpage>S317</fpage>&#8211;<lpage>s321</lpage>. &#160;<pub-id pub-id-type="doi">10.1097/sap.0000000000001417</pub-id><pub-id pub-id-type="pmid">29553981</pub-id><pub-id pub-id-type="pmcid">PMC5929157</pub-id></mixed-citation></ref><ref id="B186"><label>186</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ridker</surname><given-names>PM</given-names></name><name name-style="western"><surname>Everett</surname><given-names>BM</given-names></name><name name-style="western"><surname>Thuren</surname><given-names>T</given-names></name><name name-style="western"><surname>MacFadyen</surname><given-names>JG</given-names></name><name name-style="western"><surname>Chang</surname><given-names>WH</given-names></name><name name-style="western"><surname>Ballantyne</surname><given-names>C</given-names></name><etal/></person-group><article-title>Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease</article-title>. <source>N Engl J Med</source> (<year>2017</year>) <volume>377</volume>:<page-range>1119&#8211;31</page-range>. &#160;<pub-id pub-id-type="doi">10.1056/NEJMoa1707914</pub-id><pub-id pub-id-type="pmid">28845751</pub-id></mixed-citation></ref><ref id="B187"><label>187</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yadav</surname><given-names>V</given-names></name><name name-style="western"><surname>Chi</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>R</given-names></name><name name-style="western"><surname>Tourdot</surname><given-names>BE</given-names></name><name name-style="western"><surname>Yalavarthi</surname><given-names>S</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>BN</given-names></name><etal/></person-group><article-title>Ectonucleotidase tri(di)phosphohydrolase-1 (ENTPD-1) disrupts inflammasome/interleukin 1&#946;-driven venous thrombosis</article-title>. <source>J Clin Invest</source> (<year>2019</year>) <volume>129</volume>:<page-range>2872&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/jci124804</pub-id><pub-id pub-id-type="pmcid">PMC6597243</pub-id><pub-id pub-id-type="pmid">30990798</pub-id></mixed-citation></ref><ref id="B188"><label>188</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Mitroulis</surname><given-names>I</given-names></name><name name-style="western"><surname>Apostolidou</surname><given-names>E</given-names></name><name name-style="western"><surname>Girod</surname><given-names>A</given-names></name><name name-style="western"><surname>Chrysanthopoulou</surname><given-names>A</given-names></name><name name-style="western"><surname>Pneumatikos</surname><given-names>I</given-names></name><etal/></person-group><article-title>Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e45427</fpage>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0045427</pub-id><pub-id pub-id-type="pmid">23029002</pub-id><pub-id pub-id-type="pmcid">PMC3446899</pub-id></mixed-citation></ref><ref id="B189"><label>189</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fuchs</surname><given-names>TA</given-names></name><name name-style="western"><surname>Brill</surname><given-names>A</given-names></name><name name-style="western"><surname>Duerschmied</surname><given-names>D</given-names></name><name name-style="western"><surname>Schatzberg</surname><given-names>D</given-names></name><name name-style="western"><surname>Monestier</surname><given-names>M</given-names></name><name name-style="western"><surname>Myers</surname><given-names>DD</given-names></name><etal/></person-group><article-title>Extracellular DNA traps promote thrombosis</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2010</year>) <volume>107</volume>:<page-range>15880&#8211;5</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1005743107</pub-id><pub-id pub-id-type="pmcid">PMC2936604</pub-id><pub-id pub-id-type="pmid">20798043</pub-id></mixed-citation></ref><ref id="B190"><label>190</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Mitroulis</surname><given-names>I</given-names></name><name name-style="western"><surname>Ritis</surname><given-names>K</given-names></name></person-group><article-title>The emerging role of neutrophils in thrombosis-the journey of TF through NETs</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<elocation-id>385</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fimmu.2012.00385</pub-id><pub-id pub-id-type="pmid">23264778</pub-id><pub-id pub-id-type="pmcid">PMC3524512</pub-id></mixed-citation></ref><ref id="B191"><label>191</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Markiewski</surname><given-names>MM</given-names></name><name name-style="western"><surname>Pneumatikos</surname><given-names>IA</given-names></name><name name-style="western"><surname>Rafail</surname><given-names>SS</given-names></name><name name-style="western"><surname>Theodorou</surname><given-names>V</given-names></name><name name-style="western"><surname>Konstantonis</surname><given-names>D</given-names></name><etal/></person-group><article-title>C5a and TNF-alpha up-regulate the expression of tissue factor in intra-alveolar neutrophils of patients with the acute respiratory distress syndrome</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>180</volume>:<page-range>7368&#8211;75</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.180.11.7368</pub-id><pub-id pub-id-type="pmcid">PMC2673518</pub-id><pub-id pub-id-type="pmid">18490736</pub-id></mixed-citation></ref><ref id="B192"><label>192</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stakos</surname><given-names>DA</given-names></name><name name-style="western"><surname>Kambas</surname><given-names>K</given-names></name><name name-style="western"><surname>Konstantinidis</surname><given-names>T</given-names></name><name name-style="western"><surname>Mitroulis</surname><given-names>I</given-names></name><name name-style="western"><surname>Apostolidou</surname><given-names>E</given-names></name><name name-style="western"><surname>Arelaki</surname><given-names>S</given-names></name><etal/></person-group><article-title>Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction</article-title>. <source>Eur Hear J</source> (<year>2015</year>) <volume>36</volume>:<page-range>1405&#8211;14</page-range>. &#160;<pub-id pub-id-type="doi">10.1093/eurheartj/ehv007</pub-id><pub-id pub-id-type="pmcid">PMC4458286</pub-id><pub-id pub-id-type="pmid">25660055</pub-id></mixed-citation></ref><ref id="B193"><label>193</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liberale</surname><given-names>L</given-names></name><name name-style="western"><surname>Holy</surname><given-names>EW</given-names></name><name name-style="western"><surname>Akhmedov</surname><given-names>A</given-names></name><name name-style="western"><surname>Bonetti</surname><given-names>NR</given-names></name><name name-style="western"><surname>Nietlispach</surname><given-names>F</given-names></name><name name-style="western"><surname>Matter</surname><given-names>CM</given-names></name><etal/></person-group><article-title>Interleukin-1&#946; Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor</article-title>. <source>J Clin Med</source> (<year>2019</year>) <volume>8</volume>:<fpage>2072</fpage>. &#160;<pub-id pub-id-type="doi">10.3390/jcm8122072</pub-id><pub-id pub-id-type="pmcid">PMC6947515</pub-id><pub-id pub-id-type="pmid">31779200</pub-id></mixed-citation></ref><ref id="B194"><label>194</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gomes</surname><given-names>T</given-names></name><name name-style="western"><surname>V&#225;rady</surname><given-names>CBS</given-names></name><name name-style="western"><surname>Louren&#231;o</surname><given-names>AL</given-names></name><name name-style="western"><surname>Mizurini</surname><given-names>DM</given-names></name><name name-style="western"><surname>Rondon</surname><given-names>AMR</given-names></name><name name-style="western"><surname>Leal</surname><given-names>AC</given-names></name><etal/></person-group><article-title>IL-1&#946; Blockade Attenuates Thrombosis in a Neutrophil Extracellular Trap-Dependent Breast Cancer Model</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>2088</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02088</pub-id><pub-id pub-id-type="pmid">31552036</pub-id><pub-id pub-id-type="pmcid">PMC6737452</pub-id></mixed-citation></ref><ref id="B195"><label>195</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C</given-names></name><name name-style="western"><surname>Lu</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>G</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Hisada</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>50</volume>:<fpage>1401</fpage>&#8211;<lpage>1411.e4</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.04.003</pub-id><pub-id pub-id-type="pmid">31076358</pub-id><pub-id pub-id-type="pmcid">PMC6791531</pub-id></mixed-citation></ref><ref id="B196"><label>196</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>X</given-names></name><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kang</surname><given-names>H</given-names></name><etal/></person-group><article-title>Bacterial Endotoxin Activates the Coagulation Cascade through Gasdermin D-Dependent Phosphatidylserine Exposure</article-title>. <source>Immunity</source> (<year>2019</year>) <volume>51</volume>:<page-range>983&#8211;96</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2019.11.005</pub-id><pub-id pub-id-type="pmid">31836429</pub-id></mixed-citation></ref><ref id="B197"><label>197</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>SC</given-names></name><name name-style="western"><surname>van der Meer</surname><given-names>JWM</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>Innate immune memory: Towards a better understanding of host defense mechanisms</article-title>. <source>Curr Opin Immunol</source> (<year>2014</year>) <volume>29</volume>:<fpage>1</fpage>&#8211;<lpage>7</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.coi.2014.02.006</pub-id><pub-id pub-id-type="pmid">24637148</pub-id></mixed-citation></ref><ref id="B198"><label>198</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saeed</surname><given-names>S</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Kerstens</surname><given-names>HHD</given-names></name><name name-style="western"><surname>Rao</surname><given-names>NA</given-names></name><name name-style="western"><surname>Aghajanirefah</surname><given-names>A</given-names></name><name name-style="western"><surname>Matarese</surname><given-names>F</given-names></name><etal/></person-group><article-title>Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity</article-title>. <source>Science (80)</source> (<year>2014</year>) <volume>345</volume>:<fpage>1251086</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/science.1251086</pub-id><pub-id pub-id-type="pmcid">PMC4242194</pub-id><pub-id pub-id-type="pmid">25258085</pub-id></mixed-citation></ref><ref id="B199"><label>199</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arts</surname><given-names>RJW</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>LAB</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name></person-group><article-title>Immunometabolic circuits in trained immunity</article-title>. <source>Semin Immunol</source> (<year>2016</year>) <volume>28</volume>:<page-range>425&#8211;30</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.smim.2016.09.002</pub-id><pub-id pub-id-type="pmid">27686054</pub-id></mixed-citation></ref><ref id="B200"><label>200</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>J</given-names></name><name name-style="western"><surname>Miller</surname><given-names>M</given-names></name><name name-style="western"><surname>Stojanovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Garbi</surname><given-names>N</given-names></name><name name-style="western"><surname>Cerwenka</surname><given-names>A</given-names></name></person-group><article-title>Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors</article-title>. <source>J Exp Med</source> (<year>2012</year>) <volume>209</volume>:<page-range>2351&#8211;65</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.20120944</pub-id><pub-id pub-id-type="pmcid">PMC3526364</pub-id><pub-id pub-id-type="pmid">23209317</pub-id></mixed-citation></ref><ref id="B201"><label>201</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cooper</surname><given-names>MA</given-names></name><name name-style="western"><surname>Elliott</surname><given-names>JM</given-names></name><name name-style="western"><surname>Keyel</surname><given-names>PA</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name><name name-style="western"><surname>Carrero</surname><given-names>JA</given-names></name><name name-style="western"><surname>Yokoyama</surname><given-names>WM</given-names></name></person-group><article-title>Cytokine-induced memory-like natural killer cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2009</year>) <volume>106</volume>:<page-range>1915&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.0813192106</pub-id><pub-id pub-id-type="pmcid">PMC2644138</pub-id><pub-id pub-id-type="pmid">19181844</pub-id></mixed-citation></ref><ref id="B202"><label>202</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van den Boorn</surname><given-names>JG</given-names></name><name name-style="western"><surname>Jakobs</surname><given-names>C</given-names></name><name name-style="western"><surname>Hagen</surname><given-names>C</given-names></name><name name-style="western"><surname>Renn</surname><given-names>M</given-names></name><name name-style="western"><surname>Luiten</surname><given-names>RM</given-names></name><name name-style="western"><surname>Melief</surname><given-names>CJM</given-names></name><etal/></person-group><article-title>Inflammasome-Dependent Induction of Adaptive NK Cell Memory</article-title>. <source>Immunity</source> (<year>2016</year>) <volume>44</volume>:<page-range>1406&#8211;21</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2016.05.008</pub-id><pub-id pub-id-type="pmid">27287410</pub-id></mixed-citation></ref><ref id="B203"><label>203</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Preijers</surname><given-names>F</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>LAB</given-names></name><name name-style="western"><surname>Ifrim</surname><given-names>DC</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>S</given-names></name><etal/></person-group><article-title>Bacille Calmette-Gu&#233;rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2012</year>) <volume>109</volume>:<page-range>17537&#8211;42</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1202870109</pub-id><pub-id pub-id-type="pmcid">PMC3491454</pub-id><pub-id pub-id-type="pmid">22988082</pub-id></mixed-citation></ref><ref id="B204"><label>204</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>SC</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Cramer</surname><given-names>RA</given-names></name><name name-style="western"><surname>Shepardson</surname><given-names>KM</given-names></name><name name-style="western"><surname>Saeed</surname><given-names>S</given-names></name><name name-style="western"><surname>Kumar</surname><given-names>V</given-names></name><etal/></person-group><article-title>MTOR- and HIF-1&#945;-mediated aerobic glycolysis as metabolic basis for trained immunity</article-title>. <source>Science (80)</source> (<year>2014</year>) <volume>345</volume>:<fpage>1250684</fpage>. &#160;<pub-id pub-id-type="doi">10.1126/science.1250684</pub-id><pub-id pub-id-type="pmcid">PMC4226238</pub-id><pub-id pub-id-type="pmid">25258083</pub-id></mixed-citation></ref><ref id="B205"><label>205</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dom&#237;nguez-Andr&#233;s</surname><given-names>J</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Scicluna</surname><given-names>BP</given-names></name><name name-style="western"><surname>Gresnigt</surname><given-names>MS</given-names></name><name name-style="western"><surname>Arts</surname><given-names>RJW</given-names></name><etal/></person-group><article-title>The Itaconate Pathway Is a Central Regulatory Node Linking Innate Immune Tolerance and Trained Immunity</article-title>. <source>Cell Metab</source> (<year>2019</year>) <volume>29</volume>:<fpage>211</fpage>&#8211;<lpage>220.e5</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cmet.2018.09.003</pub-id><pub-id pub-id-type="pmid">30293776</pub-id></mixed-citation></ref><ref id="B206"><label>206</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bekkering</surname><given-names>S</given-names></name><name name-style="western"><surname>Arts</surname><given-names>RJW</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>B</given-names></name><name name-style="western"><surname>Kourtzelis</surname><given-names>I</given-names></name><name name-style="western"><surname>van der Heijden</surname><given-names>CDCC</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Metabolic Induction of Trained Immunity through the Mevalonate Pathway</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>135</fpage>&#8211;<lpage>146.e9</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cell.2017.11.025</pub-id><pub-id pub-id-type="pmid">29328908</pub-id></mixed-citation></ref><ref id="B207"><label>207</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arts</surname><given-names>RJW</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>B</given-names></name><name name-style="western"><surname>ter Horst</surname><given-names>R</given-names></name><name name-style="western"><surname>Carvalho</surname><given-names>A</given-names></name><name name-style="western"><surname>Bekkering</surname><given-names>S</given-names></name><name name-style="western"><surname>Lachmandas</surname><given-names>E</given-names></name><etal/></person-group><article-title>Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity</article-title>. <source>Cell Metab</source> (<year>2016</year>) <volume>24</volume>:<page-range>807&#8211;19</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.cmet.2016.10.008</pub-id><pub-id pub-id-type="pmcid">PMC5742541</pub-id><pub-id pub-id-type="pmid">27866838</pub-id></mixed-citation></ref><ref id="B208"><label>208</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tannahill</surname><given-names>GM</given-names></name><name name-style="western"><surname>Curtis</surname><given-names>AM</given-names></name><name name-style="western"><surname>Adamik</surname><given-names>J</given-names></name><name name-style="western"><surname>Palsson-Mcdermott</surname><given-names>EM</given-names></name><name name-style="western"><surname>McGettrick</surname><given-names>AF</given-names></name><name name-style="western"><surname>Goel</surname><given-names>G</given-names></name><etal/></person-group><article-title>Succinate is an inflammatory signal that induces IL-1&#946; through HIF-1&#945;</article-title>. <source>Nature</source> (<year>2013</year>) <volume>496</volume>:<page-range>238&#8211;42</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature11986</pub-id><pub-id pub-id-type="pmcid">PMC4031686</pub-id><pub-id pub-id-type="pmid">23535595</pub-id></mixed-citation></ref><ref id="B209"><label>209</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitroulis</surname><given-names>I</given-names></name><name name-style="western"><surname>Ruppova</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>B</given-names></name><name name-style="western"><surname>Chen</surname><given-names>LS</given-names></name><name name-style="western"><surname>Grzybek</surname><given-names>M</given-names></name><name name-style="western"><surname>Grinenko</surname><given-names>T</given-names></name><etal/></person-group><article-title>Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>147</fpage>&#8211;<lpage>61.e12</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cell.2017.11.034</pub-id><pub-id pub-id-type="pmid">29328910</pub-id><pub-id pub-id-type="pmcid">PMC5766828</pub-id></mixed-citation></ref><ref id="B210"><label>210</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kaufmann</surname><given-names>E</given-names></name><name name-style="western"><surname>Sanz</surname><given-names>J</given-names></name><name name-style="western"><surname>Dunn</surname><given-names>JL</given-names></name><name name-style="western"><surname>Khan</surname><given-names>N</given-names></name><name name-style="western"><surname>Mendon&#231;a</surname><given-names>LE</given-names></name><name name-style="western"><surname>Pacis</surname><given-names>A</given-names></name><etal/></person-group><article-title>BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>176</fpage>&#8211;<lpage>90.e19</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cell.2017.12.031</pub-id><pub-id pub-id-type="pmid">29328912</pub-id></mixed-citation></ref><ref id="B211"><label>211</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arts</surname><given-names>RJW</given-names></name><name name-style="western"><surname>Moorlag</surname><given-names>SJCFM</given-names></name><name name-style="western"><surname>Novakovic</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wang</surname><given-names>SY</given-names></name><name name-style="western"><surname>Oosting</surname><given-names>M</given-names></name><etal/></person-group><article-title>BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity</article-title>. <source>Cell Host Microbe</source> (<year>2018</year>) <volume>23</volume>:<fpage>89</fpage>&#8211;<lpage>100.e5</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.chom.2017.12.010</pub-id><pub-id pub-id-type="pmid">29324233</pub-id></mixed-citation></ref><ref id="B212"><label>212</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Christ</surname><given-names>A</given-names></name><name name-style="western"><surname>G&#252;nther</surname><given-names>P</given-names></name><name name-style="western"><surname>Lauterbach</surname><given-names>MAR</given-names></name><name name-style="western"><surname>Duewell</surname><given-names>P</given-names></name><name name-style="western"><surname>Biswas</surname><given-names>D</given-names></name><name name-style="western"><surname>Pelka</surname><given-names>K</given-names></name><etal/></person-group><article-title>Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming</article-title>. <source>Cell</source> (<year>2018</year>) <volume>172</volume>:<fpage>162</fpage>&#8211;<lpage>175.e14</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cell.2017.12.013</pub-id><pub-id pub-id-type="pmid">29328911</pub-id><pub-id pub-id-type="pmcid">PMC6324559</pub-id></mixed-citation></ref><ref id="B213"><label>213</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bekkering</surname><given-names>S</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Joosten</surname><given-names>LAB</given-names></name><name name-style="western"><surname>Van Der Meer</surname><given-names>JWM</given-names></name><name name-style="western"><surname>Netea</surname><given-names>MG</given-names></name><name name-style="western"><surname>Riksen</surname><given-names>NP</given-names></name></person-group><article-title>Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2014</year>) <volume>34</volume>:<page-range>1731&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1161/ATVBAHA.114.303887</pub-id><pub-id pub-id-type="pmid">24903093</pub-id></mixed-citation></ref><ref id="B214"><label>214</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pietras</surname><given-names>EM</given-names></name><name name-style="western"><surname>Mirantes-Barbeito</surname><given-names>C</given-names></name><name name-style="western"><surname>Fong</surname><given-names>S</given-names></name><name name-style="western"><surname>Loeffler</surname><given-names>D</given-names></name><name name-style="western"><surname>Kovtonyuk</surname><given-names>LV</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Chronic interleukin-1 exposure drives haematopoietic stem cells towards precocious myeloid differentiation at the expense of self-renewal</article-title>. <source>Nat Cell Biol</source> (<year>2016</year>) <volume>18</volume>:<page-range>607&#8211;18</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ncb3346</pub-id><pub-id pub-id-type="pmcid">PMC4884136</pub-id><pub-id pub-id-type="pmid">27111842</pub-id></mixed-citation></ref><ref id="B215"><label>215</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mills</surname><given-names>EL</given-names></name><name name-style="western"><surname>Ryan</surname><given-names>DG</given-names></name><name name-style="western"><surname>Prag</surname><given-names>HA</given-names></name><name name-style="western"><surname>Dikovskaya</surname><given-names>D</given-names></name><name name-style="western"><surname>Menon</surname><given-names>D</given-names></name><name name-style="western"><surname>Zaslona</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1</article-title>. <source>Nature</source> (<year>2018</year>) <volume>556</volume>:<page-range>113&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature25986</pub-id><pub-id pub-id-type="pmcid">PMC6047741</pub-id><pub-id pub-id-type="pmid">29590092</pub-id></mixed-citation></ref><ref id="B216"><label>216</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lampropoulou</surname><given-names>V</given-names></name><name name-style="western"><surname>Sergushichev</surname><given-names>A</given-names></name><name name-style="western"><surname>Bambouskova</surname><given-names>M</given-names></name><name name-style="western"><surname>Nair</surname><given-names>S</given-names></name><name name-style="western"><surname>Vincent</surname><given-names>EE</given-names></name><name name-style="western"><surname>Loginicheva</surname><given-names>E</given-names></name><etal/></person-group><article-title>Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation</article-title>. <source>Cell Metab</source> (<year>2016</year>) <volume>24</volume>:<page-range>158&#8211;66</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.cmet.2016.06.004</pub-id><pub-id pub-id-type="pmcid">PMC5108454</pub-id><pub-id pub-id-type="pmid">27374498</pub-id></mixed-citation></ref><ref id="B217"><label>217</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Neill</surname><given-names>LAJ</given-names></name><name name-style="western"><surname>Artyomov</surname><given-names>MN</given-names></name></person-group><article-title>Itaconate: the poster child of metabolic reprogramming in macrophage function</article-title>. <source>Nat Rev Immunol</source> (<year>2019</year>) <volume>19</volume>:<page-range>273&#8211;81</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/s41577-019-0128-5</pub-id><pub-id pub-id-type="pmid">30705422</pub-id></mixed-citation></ref><ref id="B218"><label>218</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Haley</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Brough</surname><given-names>D</given-names></name><name name-style="western"><surname>Quintin</surname><given-names>J</given-names></name><name name-style="western"><surname>Allan</surname><given-names>SM</given-names></name></person-group><article-title>Microglial Priming as Trained Immunity in the Brain</article-title>. <source>Neuroscience</source> (<year>2019</year>) <volume>405</volume>:<fpage>47</fpage>&#8211;<lpage>54</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.12.039</pub-id><pub-id pub-id-type="pmid">29292078</pub-id></mixed-citation></ref><ref id="B219"><label>219</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allan</surname><given-names>SM</given-names></name><name name-style="western"><surname>Tyrrell</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Rothwell</surname><given-names>NJ</given-names></name></person-group><article-title>Interleukin-1 and neuronal injury</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<page-range>629&#8211;40</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nri1664</pub-id><pub-id pub-id-type="pmid">16034365</pub-id></mixed-citation></ref><ref id="B220"><label>220</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vitkovic</surname><given-names>L</given-names></name><name name-style="western"><surname>Bockaert</surname><given-names>J</given-names></name><name name-style="western"><surname>Jacque</surname><given-names>C</given-names></name></person-group><article-title>&#8220;Inflammatory&#8221; cytokines&#8217; neuromodulators in normal brain</article-title>? <source>J Neurochem</source> (<year>2000</year>) <volume>74</volume>:<page-range>457&#8211;71</page-range>. &#160;<pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.740457.x</pub-id><pub-id pub-id-type="pmid">10646496</pub-id></mixed-citation></ref><ref id="B221"><label>221</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ching</surname><given-names>S</given-names></name><name name-style="western"><surname>He</surname><given-names>L</given-names></name><name name-style="western"><surname>Lai</surname><given-names>W</given-names></name><name name-style="western"><surname>Quan</surname><given-names>N</given-names></name></person-group><article-title>IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system</article-title>. <source>Brain Behav Immun</source> (<year>2005</year>) <volume>19</volume>:<page-range>127&#8211;37</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.bbi.2004.06.001</pub-id><pub-id pub-id-type="pmid">15664785</pub-id></mixed-citation></ref><ref id="B222"><label>222</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>A</given-names></name><name name-style="western"><surname>Song</surname><given-names>R</given-names></name><name name-style="western"><surname>Wakeland</surname><given-names>EK</given-names></name><name name-style="western"><surname>Pasare</surname><given-names>C</given-names></name></person-group><article-title>T cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T cells</article-title>. <source>Nat Commun</source> (<year>2018</year>) <volume>9</volume>:<fpage>1</fpage>&#8211;<lpage>13</lpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41467-018-05489-7</pub-id><pub-id pub-id-type="pmid">30093707</pub-id><pub-id pub-id-type="pmcid">PMC6085393</pub-id></mixed-citation></ref><ref id="B223"><label>223</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>CE</given-names></name><name name-style="western"><surname>Lalor</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Sweeney</surname><given-names>CM</given-names></name><name name-style="western"><surname>Brereton</surname><given-names>CF</given-names></name><name name-style="western"><surname>Lavelle</surname><given-names>EC</given-names></name><name name-style="western"><surname>Mills</surname><given-names>KHG</given-names></name></person-group><article-title>Interleukin-1 and IL-23 Induce Innate IL-17 Production from &#947;&#948; T Cells, Amplifying Th17 Responses and Autoimmunity</article-title>. <source>Immunity</source> (<year>2009</year>) <volume>31</volume>:<page-range>331&#8211;41</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.08.001</pub-id><pub-id pub-id-type="pmid">19682929</pub-id></mixed-citation></ref><ref id="B224"><label>224</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakae</surname><given-names>S</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Horai</surname><given-names>R</given-names></name><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Mori</surname><given-names>S</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name></person-group><article-title>IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>:<page-range>5986&#8211;90</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.1035999100</pub-id><pub-id pub-id-type="pmcid">PMC156313</pub-id><pub-id pub-id-type="pmid">12721360</pub-id></mixed-citation></ref><ref id="B225"><label>225</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsuki</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakae</surname><given-names>S</given-names></name><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Horai</surname><given-names>R</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name></person-group><article-title>Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis</article-title>. <source>Int Immunol</source> (<year>2006</year>) <volume>18</volume>:<fpage>399</fpage>&#8211;<lpage>407</lpage>. &#160;<pub-id pub-id-type="doi">10.1093/intimm/dxh379</pub-id><pub-id pub-id-type="pmid">16415102</pub-id></mixed-citation></ref><ref id="B226"><label>226</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aksentijevich</surname><given-names>I</given-names></name><name name-style="western"><surname>Masters</surname><given-names>SL</given-names></name><name name-style="western"><surname>Ferguson</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Dancey</surname><given-names>P</given-names></name><name name-style="western"><surname>Frenkel</surname><given-names>J</given-names></name><name name-style="western"><surname>van Royen-Kerkhoff</surname><given-names>A</given-names></name><etal/></person-group><article-title>An Autoinflammatory Disease with Deficiency of the Interleukin-1&#8211;Receptor Antagonist</article-title>. <source>N Engl J Med</source> (<year>2009</year>) <volume>360</volume>:<page-range>2426&#8211;37</page-range>. &#160;<pub-id pub-id-type="doi">10.1056/nejmoa0807865</pub-id><pub-id pub-id-type="pmcid">PMC2876877</pub-id><pub-id pub-id-type="pmid">19494218</pub-id></mixed-citation></ref><ref id="B227"><label>227</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gulen</surname><given-names>MF</given-names></name><name name-style="western"><surname>Kang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Bulek</surname><given-names>K</given-names></name><name name-style="western"><surname>Youzhong</surname><given-names>W</given-names></name><name name-style="western"><surname>Kim</surname><given-names>TW</given-names></name><name name-style="western"><surname>Chen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>The Receptor SIGIRR Suppresses Th17 Cell Proliferation via Inhibition of the Interleukin-1 Receptor Pathway and mTOR Kinase Activation</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>32</volume>:<fpage>54</fpage>&#8211;<lpage>66</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2009.12.003</pub-id><pub-id pub-id-type="pmid">20060329</pub-id><pub-id pub-id-type="pmcid">PMC3015141</pub-id></mixed-citation></ref><ref id="B228"><label>228</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comabella</surname><given-names>M</given-names></name><name name-style="western"><surname>Juli&#224;</surname><given-names>E</given-names></name><name name-style="western"><surname>Tintor&#233;</surname><given-names>M</given-names></name><name name-style="western"><surname>Brieva</surname><given-names>L</given-names></name><name name-style="western"><surname>T&#233;llez</surname><given-names>N</given-names></name><name name-style="western"><surname>R&#237;o</surname><given-names>J</given-names></name><etal/></person-group><article-title>Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis</article-title>. <source>J Neurol</source> (<year>2008</year>) <volume>255</volume>:<page-range>1136&#8211;41</page-range>. &#160;<pub-id pub-id-type="doi">10.1007/s00415-008-0855-1</pub-id><pub-id pub-id-type="pmid">18484235</pub-id></mixed-citation></ref><ref id="B229"><label>229</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nicoletti</surname><given-names>F</given-names></name><name name-style="western"><surname>Patti</surname><given-names>F</given-names></name><name name-style="western"><surname>Di Marco</surname><given-names>R</given-names></name><name name-style="western"><surname>Zaccone</surname><given-names>P</given-names></name><name name-style="western"><surname>Nicoletti</surname><given-names>A</given-names></name><name name-style="western"><surname>Meroni</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Circulating serum levels of IL-1ra in patients with relapsing remitting multiple sclerosis are normal during remission phases but significantly increased either during exacerbations or in response to IFN-&#946; treatment</article-title>. <source>Cytokine</source> (<year>1996</year>) <volume>8</volume>:<fpage>395</fpage>&#8211;<lpage>400</lpage>. &#160;<pub-id pub-id-type="doi">10.1006/cyto.1996.0054</pub-id><pub-id pub-id-type="pmid">8726668</pub-id></mixed-citation></ref><ref id="B230"><label>230</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dujmovic</surname><given-names>I</given-names></name><name name-style="western"><surname>Mangano</surname><given-names>K</given-names></name><name name-style="western"><surname>Pekmezovic</surname><given-names>T</given-names></name><name name-style="western"><surname>Quattrocchi</surname><given-names>C</given-names></name><name name-style="western"><surname>Mesaros</surname><given-names>S</given-names></name><name name-style="western"><surname>Stojsavljevic</surname><given-names>N</given-names></name><etal/></person-group><article-title>The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy</article-title>. <source>J Neuroimmunol</source> (<year>2009</year>) <volume>207</volume>:<page-range>101&#8211;6</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.jneuroim.2008.11.004</pub-id><pub-id pub-id-type="pmid">19162335</pub-id></mixed-citation></ref><ref id="B231"><label>231</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Jong</surname><given-names>BA</given-names></name><name name-style="western"><surname>Huizinga</surname><given-names>TWJ</given-names></name><name name-style="western"><surname>Bollen</surname><given-names>ELEM</given-names></name><name name-style="western"><surname>Uitdehaag</surname><given-names>BMJ</given-names></name><name name-style="western"><surname>Bosma</surname><given-names>GPT</given-names></name><name name-style="western"><surname>Van Buchem</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Production of IL-1&#946; and IL-1Ra as risk factors for susceptibility and progression of relapse-onset multiple sclerosis</article-title>. <source>J Neuroimmunol</source> (<year>2002</year>) <volume>126</volume>:<page-range>172&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/S0165-5728(02)00056-5</pub-id><pub-id pub-id-type="pmid">12020968</pub-id></mixed-citation></ref><ref id="B232"><label>232</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jha</surname><given-names>S</given-names></name><name name-style="western"><surname>Srivastava</surname><given-names>SY</given-names></name><name name-style="western"><surname>Brickey</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Iocca</surname><given-names>H</given-names></name><name name-style="western"><surname>Toews</surname><given-names>A</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18</article-title>. <source>J Neurosci</source> (<year>2010</year>) <volume>30</volume>:<page-range>15811&#8211;20</page-range>. &#160;<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4088-10.2010</pub-id><pub-id pub-id-type="pmcid">PMC6633756</pub-id><pub-id pub-id-type="pmid">21106820</pub-id></mixed-citation></ref><ref id="B233"><label>233</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gris</surname><given-names>D</given-names></name><name name-style="western"><surname>Ye</surname><given-names>Z</given-names></name><name name-style="western"><surname>Iocca</surname><given-names>HA</given-names></name><name name-style="western"><surname>Wen</surname><given-names>H</given-names></name><name name-style="western"><surname>Craven</surname><given-names>RR</given-names></name><name name-style="western"><surname>Gris</surname><given-names>P</given-names></name><etal/></person-group><article-title>NLRP3 Plays a Critical Role in the Development of Experimental Autoimmune Encephalomyelitis by Mediating Th1 and Th17 Responses</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<page-range>974&#8211;81</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.0904145</pub-id><pub-id pub-id-type="pmcid">PMC3593010</pub-id><pub-id pub-id-type="pmid">20574004</pub-id></mixed-citation></ref><ref id="B234"><label>234</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hisahara</surname><given-names>S</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>J</given-names></name><name name-style="western"><surname>Momoi</surname><given-names>T</given-names></name><name name-style="western"><surname>Okano</surname><given-names>H</given-names></name><name name-style="western"><surname>Miura</surname><given-names>M</given-names></name></person-group><article-title>Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination</article-title>. <source>J Exp Med</source> (<year>2001</year>) <volume>193</volume>:<page-range>111&#8211;22</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.193.1.111</pub-id><pub-id pub-id-type="pmcid">PMC2195881</pub-id><pub-id pub-id-type="pmid">11136825</pub-id></mixed-citation></ref><ref id="B235"><label>235</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Furlan</surname><given-names>R</given-names></name><name name-style="western"><surname>Martino</surname><given-names>G</given-names></name><name name-style="western"><surname>Galbiati</surname><given-names>F</given-names></name><name name-style="western"><surname>Poliani</surname><given-names>PL</given-names></name><name name-style="western"><surname>Smiroldo</surname><given-names>S</given-names></name><name name-style="western"><surname>Bergami</surname><given-names>A</given-names></name><etal/></person-group><article-title>Caspase-1 regulates the inflammatory process leading to autoimmune demyelination</article-title>. <source>J Immunol</source> (<year>1999</year>) <volume>163</volume>:<page-range>2403&#8211;9</page-range>.<pub-id pub-id-type="pmid">10452974</pub-id></mixed-citation></ref><ref id="B236"><label>236</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jain</surname><given-names>A</given-names></name><name name-style="western"><surname>Irizarry-Caro</surname><given-names>RA</given-names></name><name name-style="western"><surname>McDaniel</surname><given-names>MM</given-names></name><name name-style="western"><surname>Chawla</surname><given-names>AS</given-names></name><name name-style="western"><surname>Carroll</surname><given-names>KR</given-names></name><name name-style="western"><surname>Overcast</surname><given-names>GR</given-names></name><etal/></person-group><article-title>T cells instruct myeloid cells to produce inflammasome-independent IL-1&#946; and cause autoimmunity</article-title>. <source>Nat Immunol</source> (<year>2020</year>) <volume>21</volume>:<fpage>69</fpage>. &#160;<pub-id pub-id-type="doi">10.1038/s41590-019-0559-y</pub-id><pub-id pub-id-type="pmcid">PMC6927526</pub-id><pub-id pub-id-type="pmid">31848486</pub-id></mixed-citation></ref><ref id="B237"><label>237</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>XO</given-names></name><name name-style="western"><surname>Nurieva</surname><given-names>R</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Kang</surname><given-names>HS</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Pappu</surname><given-names>BP</given-names></name><etal/></person-group><article-title>Molecular Antagonism and Plasticity of Regulatory and Inflammatory T Cell Programs</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>29</volume>:<fpage>44</fpage>&#8211;<lpage>56</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.immuni.2008.05.007</pub-id><pub-id pub-id-type="pmid">18585065</pub-id><pub-id pub-id-type="pmcid">PMC2630532</pub-id></mixed-citation></ref><ref id="B238"><label>238</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wan</surname><given-names>YY</given-names></name><name name-style="western"><surname>Flavell</surname><given-names>RA</given-names></name></person-group><article-title>Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression</article-title>. <source>Nature</source> (<year>2007</year>) <volume>445</volume>:<page-range>766&#8211;70</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nature05479</pub-id><pub-id pub-id-type="pmid">17220876</pub-id></mixed-citation></ref><ref id="B239"><label>239</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name><name name-style="western"><surname>Bailey-Bucktrout</surname><given-names>SL</given-names></name><name name-style="western"><surname>Jeker</surname><given-names>LT</given-names></name><name name-style="western"><surname>Penaranda</surname><given-names>C</given-names></name><name name-style="western"><surname>Mart&#237;nez-Llordella</surname><given-names>M</given-names></name><name name-style="western"><surname>Ashby</surname><given-names>M</given-names></name><etal/></person-group><article-title>Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo</article-title>. <source>Nat Immunol</source> (<year>2009</year>) <volume>10</volume>:<page-range>1000&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/ni.1774</pub-id><pub-id pub-id-type="pmcid">PMC2729804</pub-id><pub-id pub-id-type="pmid">19633673</pub-id></mixed-citation></ref><ref id="B240"><label>240</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Sullivan</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Thomas</surname><given-names>HE</given-names></name><name name-style="western"><surname>Pai</surname><given-names>S</given-names></name><name name-style="western"><surname>Santamaria</surname><given-names>P</given-names></name><name name-style="western"><surname>Iwakura</surname><given-names>Y</given-names></name><name name-style="western"><surname>Steptoe</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>IL-1&#946; Breaks Tolerance through Expansion of CD25 + Effector T Cells</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<page-range>7278&#8211;87</page-range>. &#160;<pub-id pub-id-type="doi">10.4049/jimmunol.176.12.7278</pub-id><pub-id pub-id-type="pmid">16751371</pub-id></mixed-citation></ref><ref id="B241"><label>241</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atkinson</surname><given-names>MA</given-names></name><name name-style="western"><surname>Eisenbarth</surname><given-names>GS</given-names></name></person-group><article-title>Type 1 diabetes: New perspectives on disease pathogenesis and treatment</article-title>. <source>Lancet</source> (<year>2001</year>) <volume>358</volume>:<page-range>221&#8211;9</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/S0140-6736(01)05415-0</pub-id><pub-id pub-id-type="pmid">11476858</pub-id></mixed-citation></ref><ref id="B242"><label>242</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donath</surname><given-names>MY</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Mandrup-Poulsen</surname><given-names>T</given-names></name></person-group><article-title>Targeting innate immune mediators in type 1 and type 2 diabetes</article-title>. <source>Nat Rev Immunol</source> (<year>2019</year>) <volume>19</volume>:<page-range>734&#8211;46</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/s41577-019-0213-9</pub-id><pub-id pub-id-type="pmid">31501536</pub-id></mixed-citation></ref><ref id="B243"><label>243</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>B&#246;ni-Schnetzler</surname><given-names>M</given-names></name><name name-style="western"><surname>Boller</surname><given-names>S</given-names></name><name name-style="western"><surname>Debray</surname><given-names>S</given-names></name><name name-style="western"><surname>Bouzakri</surname><given-names>K</given-names></name><name name-style="western"><surname>Meier</surname><given-names>DT</given-names></name><name name-style="western"><surname>Prazak</surname><given-names>R</given-names></name><etal/></person-group><article-title>Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I</article-title>. <source>Endocrinology</source> (<year>2009</year>) <volume>150</volume>:<page-range>5218&#8211;29</page-range>. &#160;<pub-id pub-id-type="doi">10.1210/en.2009-0543</pub-id><pub-id pub-id-type="pmid">19819943</pub-id></mixed-citation></ref><ref id="B244"><label>244</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Donath</surname><given-names>MY</given-names></name><name name-style="western"><surname>St&#248;rling</surname><given-names>J</given-names></name><name name-style="western"><surname>Berchtold</surname><given-names>LA</given-names></name><name name-style="western"><surname>Billestrup</surname><given-names>N</given-names></name><name name-style="western"><surname>Mandrup-Poulsen</surname><given-names>T</given-names></name></person-group><article-title>Cytokines and &#946;-cell biology: From concept to clinical translation</article-title>. <source>Endocr Rev</source> (<year>2008</year>) <volume>29</volume>:<page-range>334&#8211;50</page-range>. &#160;<pub-id pub-id-type="doi">10.1210/er.2007-0033</pub-id><pub-id pub-id-type="pmid">18048762</pub-id></mixed-citation></ref><ref id="B245"><label>245</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ehses</surname><given-names>JA</given-names></name><name name-style="western"><surname>Perren</surname><given-names>A</given-names></name><name name-style="western"><surname>Eppler</surname><given-names>E</given-names></name><name name-style="western"><surname>Ribaux</surname><given-names>P</given-names></name><name name-style="western"><surname>Pospisilik</surname><given-names>JA</given-names></name><name name-style="western"><surname>Maor-Cahn</surname><given-names>R</given-names></name><etal/></person-group><article-title>Increased number of islet-associated macrophages in type 2 diabetes</article-title>. <source>Diabetes</source> (<year>2007</year>) <volume>56</volume>:<page-range>2356&#8211;70</page-range>. &#160;<pub-id pub-id-type="doi">10.2337/db06-1650</pub-id><pub-id pub-id-type="pmid">17579207</pub-id></mixed-citation></ref><ref id="B246"><label>246</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dotson</surname><given-names>AL</given-names></name><name name-style="western"><surname>Novikova</surname><given-names>L</given-names></name><name name-style="western"><surname>Stehno-Bittel</surname><given-names>L</given-names></name><name name-style="western"><surname>Benedict</surname><given-names>SH</given-names></name></person-group><article-title>Elimination of T cell reactivity to pancreatic &#946; cells and partial preservation of &#946; cell activity by peptide blockade of LFA-1: ICAM-1 interaction in the NOD mouse model</article-title>. <source>Clin Immunol</source> (<year>2013</year>) <volume>148</volume>:<page-range>149&#8211;61</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.clim.2013.04.016</pub-id><pub-id pub-id-type="pmcid">PMC3770271</pub-id><pub-id pub-id-type="pmid">23770626</pub-id></mixed-citation></ref><ref id="B247"><label>247</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bendtzen</surname><given-names>K</given-names></name><name name-style="western"><surname>Mandrup-Poulsen</surname><given-names>T</given-names></name><name name-style="western"><surname>Nerup</surname><given-names>J</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><name name-style="western"><surname>Svenson</surname><given-names>M</given-names></name></person-group><article-title>Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans</article-title>. <source>Science (80)</source> (<year>1986</year>) <volume>232</volume>:<page-range>1545&#8211;7</page-range>. &#160;<pub-id pub-id-type="doi">10.1126/science.3086977</pub-id><pub-id pub-id-type="pmid">3086977</pub-id></mixed-citation></ref><ref id="B248"><label>248</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maedler</surname><given-names>K</given-names></name><name name-style="western"><surname>Sergeev</surname><given-names>P</given-names></name><name name-style="western"><surname>Ris</surname><given-names>F</given-names></name><name name-style="western"><surname>Oberholzer</surname><given-names>J</given-names></name><name name-style="western"><surname>Joller-Jemelka</surname><given-names>HI</given-names></name><name name-style="western"><surname>Spinas</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Glucose-induced &#946; cell production of IL-1&#946; contributes to glucotoxicity in human pancreatic islets</article-title>. <source>J Clin Invest</source> (<year>2002</year>) <volume>110</volume>:<page-range>851&#8211;60</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/jci15318</pub-id><pub-id pub-id-type="pmcid">PMC151125</pub-id><pub-id pub-id-type="pmid">12235117</pub-id></mixed-citation></ref><ref id="B249"><label>249</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arnush</surname><given-names>M</given-names></name><name name-style="western"><surname>Scarim</surname><given-names>AL</given-names></name><name name-style="western"><surname>Heitmeier</surname><given-names>MR</given-names></name><name name-style="western"><surname>Kelly</surname><given-names>CB</given-names></name><name name-style="western"><surname>Corbett</surname><given-names>JA</given-names></name></person-group><article-title>Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>160</volume>:<page-range>2684&#8211;91</page-range>.<pub-id pub-id-type="pmid">9510167</pub-id></mixed-citation></ref><ref id="B250"><label>250</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corbett</surname><given-names>JA</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>G</given-names></name><name name-style="western"><surname>Misko</surname><given-names>TP</given-names></name><name name-style="western"><surname>Rodi</surname><given-names>CP</given-names></name><name name-style="western"><surname>McDaniel</surname><given-names>ML</given-names></name></person-group><article-title>Tyrosine kinase involvement in IL-1&#946;-induced expression of iNOS by &#946;- cells purified from islets of Langerhans</article-title>. <source>Am J Physiol Cell Physiol</source> (<year>1994</year>) <volume>267</volume>:<fpage>48</fpage>&#8211;<lpage>54</lpage>. &#160;<pub-id pub-id-type="doi">10.1152/ajpcell.1994.267.1.c48</pub-id><pub-id pub-id-type="pmid">7519400</pub-id></mixed-citation></ref><ref id="B251"><label>251</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meyerovich</surname><given-names>K</given-names></name><name name-style="western"><surname>Fukaya</surname><given-names>M</given-names></name><name name-style="western"><surname>Terra</surname><given-names>LF</given-names></name><name name-style="western"><surname>Ortis</surname><given-names>F</given-names></name><name name-style="western"><surname>Eizirik</surname><given-names>DL</given-names></name><name name-style="western"><surname>Cardozo</surname><given-names>AK</given-names></name></person-group><article-title>The non-canonical NF-&#954;B pathway is induced by cytokines in pancreatic beta cells and contributes to cell death and proinflammatory responses in vitro</article-title>. <source>Diabetologia</source> (<year>2016</year>) <volume>59</volume>:<page-range>512&#8211;21</page-range>. &#160;<pub-id pub-id-type="doi">10.1007/s00125-015-3817-z</pub-id><pub-id pub-id-type="pmid">26634571</pub-id></mixed-citation></ref><ref id="B252"><label>252</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>CM</given-names></name><name name-style="western"><surname>Faulenbach</surname><given-names>M</given-names></name><name name-style="western"><surname>Vaag</surname><given-names>A</given-names></name><name name-style="western"><surname>V&#248;lund</surname><given-names>A</given-names></name><name name-style="western"><surname>Ehses</surname><given-names>JA</given-names></name><name name-style="western"><surname>Seifert</surname><given-names>B</given-names></name><etal/></person-group><article-title>Interleukin-1-receptor antagonist in type 2 diabetes mellitus</article-title>. <source>N Engl J Med</source> (<year>2007</year>) <volume>356</volume>:<page-range>1517&#8211;26</page-range>. &#160;<pub-id pub-id-type="doi">10.1056/NEJMoa065213</pub-id><pub-id pub-id-type="pmid">17429083</pub-id></mixed-citation></ref><ref id="B253"><label>253</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abramson</surname><given-names>SB</given-names></name><name name-style="western"><surname>Amin</surname><given-names>A</given-names></name></person-group><article-title>Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage</article-title>. <source>Rheumatology</source> (<year>2002</year>) <volume>41</volume>:<page-range>972&#8211;80</page-range>. &#160;<pub-id pub-id-type="doi">10.1093/rheumatology/41.9.972</pub-id><pub-id pub-id-type="pmid">12209029</pub-id></mixed-citation></ref><ref id="B254"><label>254</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horai</surname><given-names>R</given-names></name><name name-style="western"><surname>Saijo</surname><given-names>S</given-names></name><name name-style="western"><surname>Tanioka</surname><given-names>H</given-names></name><name name-style="western"><surname>Nakae</surname><given-names>S</given-names></name><name name-style="western"><surname>Sudo</surname><given-names>K</given-names></name><name name-style="western"><surname>Okahara</surname><given-names>A</given-names></name><etal/></person-group><article-title>Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin I receptor antagonist-deficient mice</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>191</volume>:<page-range>313&#8211;20</page-range>. &#160;<pub-id pub-id-type="doi">10.1084/jem.191.2.313</pub-id><pub-id pub-id-type="pmcid">PMC2195765</pub-id><pub-id pub-id-type="pmid">10637275</pub-id></mixed-citation></ref><ref id="B255"><label>255</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bau</surname><given-names>B</given-names></name><name name-style="western"><surname>Gebhard</surname><given-names>PM</given-names></name><name name-style="western"><surname>Haag</surname><given-names>J</given-names></name><name name-style="western"><surname>Knorr</surname><given-names>T</given-names></name><name name-style="western"><surname>Bartnik</surname><given-names>E</given-names></name><name name-style="western"><surname>Aigner</surname><given-names>T</given-names></name></person-group><article-title>Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro</article-title>. <source>Arthritis Rheum</source> (<year>2002</year>) <volume>46</volume>:<page-range>2648&#8211;57</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/art.10531</pub-id><pub-id pub-id-type="pmid">12384923</pub-id></mixed-citation></ref><ref id="B256"><label>256</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mengshol</surname><given-names>JA</given-names></name><name name-style="western"><surname>Vincenti</surname><given-names>MP</given-names></name><name name-style="western"><surname>Coon</surname><given-names>CI</given-names></name><name name-style="western"><surname>Barchowsky</surname><given-names>A</given-names></name><name name-style="western"><surname>Brinckerhoff</surname><given-names>CE</given-names></name></person-group><article-title>Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor &#954;B: Differential regulation of collagenase 1 and collagenase 3</article-title>. <source>Arthritis Rheum</source> (<year>2000</year>) <volume>43</volume>:<page-range>801&#8211;11</page-range>. &#160;<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1529-0131(200004)43:4&amp;#x0003c;801::AID-ANR10&amp;#x0003e;3.0.CO;2-4</pub-id><pub-id pub-id-type="pmid">10765924</pub-id></mixed-citation></ref><ref id="B257"><label>257</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fan</surname><given-names>Z</given-names></name><name name-style="western"><surname>S&#246;der</surname><given-names>S</given-names></name><name name-style="western"><surname>Oehler</surname><given-names>S</given-names></name><name name-style="western"><surname>Fundel</surname><given-names>K</given-names></name><name name-style="western"><surname>Aigner</surname><given-names>T</given-names></name></person-group><article-title>Activation of interleukin-1 signaling cascades in normal and osteoarthritis articular cartilage</article-title>. <source>Am J Pathol</source> (<year>2007</year>) <volume>171</volume>:<page-range>938&#8211;46</page-range>. &#160;<pub-id pub-id-type="doi">10.2353/ajpath.2007.061083</pub-id><pub-id pub-id-type="pmcid">PMC1959501</pub-id><pub-id pub-id-type="pmid">17640966</pub-id></mixed-citation></ref><ref id="B258"><label>258</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theill</surname><given-names>LE</given-names></name><name name-style="western"><surname>Boyle</surname><given-names>WJ</given-names></name><name name-style="western"><surname>Penninger</surname><given-names>JM</given-names></name></person-group><article-title>RANK-L and RANK: T cells, bone loss, and mammalian evolution</article-title>. <source>Annu Rev Immunol</source> (<year>2002</year>) <volume>20</volume>:<fpage>795</fpage>&#8211;<lpage>823</lpage>. &#160;<pub-id pub-id-type="doi">10.1146/annurev.immunol.20.100301.064753</pub-id><pub-id pub-id-type="pmid">11861618</pub-id></mixed-citation></ref><ref id="B259"><label>259</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bessis</surname><given-names>N</given-names></name><name name-style="western"><surname>Gu&#233;ry</surname><given-names>L</given-names></name><name name-style="western"><surname>Mantovani</surname><given-names>A</given-names></name><name name-style="western"><surname>Vecchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Sims</surname><given-names>JE</given-names></name><name name-style="western"><surname>Fradelizi</surname><given-names>D</given-names></name><etal/></person-group><article-title>The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis</article-title>. <source>Eur J Immunol</source> (<year>2000</year>) <volume>30</volume>:<page-range>867&#8211;75</page-range>. &#160;<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1521-4141(200003)30:3&amp;#x0003c;867::AID-IMMU867&amp;#x0003e;3.0.CO;2-M</pub-id><pub-id pub-id-type="pmid">10741403</pub-id></mixed-citation></ref><ref id="B260"><label>260</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Makarov</surname><given-names>SS</given-names></name><name name-style="western"><surname>Olsen</surname><given-names>JC</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>WN</given-names></name><name name-style="western"><surname>Anderle</surname><given-names>SK</given-names></name><name name-style="western"><surname>Brown</surname><given-names>RR</given-names></name><name name-style="western"><surname>Baldwin</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1996</year>) <volume>93</volume>:<page-range>402&#8211;6</page-range>. &#160;<pub-id pub-id-type="doi">10.1073/pnas.93.1.402</pub-id><pub-id pub-id-type="pmcid">PMC40246</pub-id><pub-id pub-id-type="pmid">8552648</pub-id></mixed-citation></ref><ref id="B261"><label>261</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fleischmann</surname><given-names>R</given-names></name><name name-style="western"><surname>Tesser</surname><given-names>J</given-names></name><name name-style="western"><surname>Schiff</surname><given-names>MH</given-names></name><name name-style="western"><surname>Schechtman</surname><given-names>J</given-names></name><name name-style="western"><surname>Burmester</surname><given-names>GR</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>R</given-names></name><etal/></person-group><article-title>Safety of extended treatment with anakinra in patients with rheumatoid arthritis</article-title>. <source>Ann Rheum Dis</source> (<year>2006</year>) <volume>65</volume>:<page-range>1006&#8211;12</page-range>. &#160;<pub-id pub-id-type="doi">10.1136/ard.2005.048371</pub-id><pub-id pub-id-type="pmcid">PMC1798263</pub-id><pub-id pub-id-type="pmid">16396977</pub-id></mixed-citation></ref><ref id="B262"><label>262</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Mu</surname><given-names>R</given-names></name><name name-style="western"><surname>Wei</surname><given-names>X</given-names></name></person-group><article-title>The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>:<elocation-id>2025</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fimmu.2019.02025</pub-id><pub-id pub-id-type="pmid">31572353</pub-id><pub-id pub-id-type="pmcid">PMC6753625</pub-id></mixed-citation></ref><ref id="B263"><label>263</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hara</surname><given-names>M</given-names></name><name name-style="western"><surname>Wright</surname><given-names>TM</given-names></name></person-group><article-title>Endogenous IL-1&#945; from systemic sclerosis fibroblasts induces IL-6 and PDGF-A</article-title>. <source>J Clin Invest</source> (<year>1999</year>) <volume>103</volume>:<page-range>1253&#8211;60</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/JCI4304</pub-id><pub-id pub-id-type="pmcid">PMC408350</pub-id><pub-id pub-id-type="pmid">10225968</pub-id></mixed-citation></ref><ref id="B264"><label>264</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maleszewska</surname><given-names>M</given-names></name><name name-style="western"><surname>Moonen</surname><given-names>JRAJ</given-names></name><name name-style="western"><surname>Huijkman</surname><given-names>N</given-names></name><name name-style="western"><surname>van de Sluis</surname><given-names>B</given-names></name><name name-style="western"><surname>Krenning</surname><given-names>G</given-names></name><name name-style="western"><surname>Harmsen</surname><given-names>MC</given-names></name></person-group><article-title>IL-1&#946; and TGF&#946;2 synergistically induce endothelial to mesenchymal transition in an NF&#954;B-dependent manner</article-title>. <source>Immunobiology</source> (<year>2013</year>) <volume>218</volume>:<page-range>443&#8211;54</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.imbio.2012.05.026</pub-id><pub-id pub-id-type="pmid">22739237</pub-id></mixed-citation></ref><ref id="B265"><label>265</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>McCarthy</surname><given-names>SA</given-names></name><name name-style="western"><surname>Watkins</surname><given-names>SC</given-names></name><name name-style="western"><surname>Wright</surname><given-names>TM</given-names></name></person-group><article-title>Autocrine activation by interleukin 1&#945; induces the fibrogenic phenotype of systemic sclerosis fibroblasts</article-title>. <source>J Rheumatol</source> (<year>2004</year>) <volume>31</volume>:<page-range>1946&#8211;54</page-range>.<pub-id pub-id-type="pmid">15468358</pub-id></mixed-citation></ref><ref id="B266"><label>266</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wynn</surname><given-names>TA</given-names></name><name name-style="western"><surname>Ramalingam</surname><given-names>TR</given-names></name></person-group><article-title>Mechanisms of fibrosis: Therapeutic translation for fibrotic disease</article-title>. <source>Nat Med</source> (<year>2012</year>) <volume>18</volume>:<page-range>1028&#8211;40</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nm.2807</pub-id><pub-id pub-id-type="pmcid">PMC3405917</pub-id><pub-id pub-id-type="pmid">22772564</pub-id></mixed-citation></ref><ref id="B267"><label>267</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirk</surname><given-names>TZ</given-names></name><name name-style="western"><surname>Mayes</surname><given-names>MD</given-names></name></person-group><article-title>IL-1 rescues scleroderma myofibroblasts from serum-starvation-induced cell death</article-title>. <source>Biochem Biophys Res Commun</source> (<year>1999</year>) <volume>255</volume>:<page-range>129&#8211;32</page-range>. &#160;<pub-id pub-id-type="doi">10.1006/bbrc.1999.0155</pub-id><pub-id pub-id-type="pmid">10082667</pub-id></mixed-citation></ref><ref id="B268"><label>268</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artlett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sassi-Gaha</surname><given-names>S</given-names></name><name name-style="western"><surname>Hope</surname><given-names>JL</given-names></name><name name-style="western"><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name><name name-style="western"><surname>Katsikis</surname><given-names>PD</given-names></name></person-group><article-title>Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis</article-title>. <source>Arthritis Res Ther</source> (<year>2017</year>) <volume>19</volume>:<fpage>144</fpage>. &#160;<pub-id pub-id-type="doi">10.1186/s13075-017-1331-z</pub-id><pub-id pub-id-type="pmid">28623945</pub-id><pub-id pub-id-type="pmcid">PMC5473986</pub-id></mixed-citation></ref><ref id="B269"><label>269</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Artlett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Sassi-Gaha</surname><given-names>S</given-names></name><name name-style="western"><surname>Rieger</surname><given-names>JL</given-names></name><name name-style="western"><surname>Boesteanu</surname><given-names>AC</given-names></name><name name-style="western"><surname>Feghali-Bostwick</surname><given-names>CA</given-names></name><name name-style="western"><surname>Katsikis</surname><given-names>PD</given-names></name></person-group><article-title>The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis</article-title>. <source>Arthritis Rheum</source> (<year>2011</year>) <volume>63</volume>:<page-range>3563&#8211;74</page-range>. &#160;<pub-id pub-id-type="doi">10.1002/art.30568</pub-id><pub-id pub-id-type="pmid">21792841</pub-id></mixed-citation></ref><ref id="B270"><label>270</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pottier</surname><given-names>N</given-names></name><name name-style="western"><surname>Maurin</surname><given-names>T</given-names></name><name name-style="western"><surname>Chevalier</surname><given-names>B</given-names></name><name name-style="western"><surname>Puiss&#233;gur</surname><given-names>MP</given-names></name><name name-style="western"><surname>Lebrigand</surname><given-names>K</given-names></name><name name-style="western"><surname>Robbe-Sermesant</surname><given-names>K</given-names></name><etal/></person-group><article-title>Identification of keratinocyte growth factor as a target of microRNA-155 in lung fibroblasts: Implication in epithelial-mesenchymal interactions</article-title>. <source>PLoS One</source> (<year>2009</year>) <volume>4</volume>:<fpage>e6718</fpage>. &#160;<pub-id pub-id-type="doi">10.1371/journal.pone.0006718</pub-id><pub-id pub-id-type="pmid">19701459</pub-id><pub-id pub-id-type="pmcid">PMC2726943</pub-id></mixed-citation></ref><ref id="B271"><label>271</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coperchini</surname><given-names>F</given-names></name><name name-style="western"><surname>Chiovato</surname><given-names>L</given-names></name><name name-style="western"><surname>Croce</surname><given-names>L</given-names></name><name name-style="western"><surname>Magri</surname><given-names>F</given-names></name><name name-style="western"><surname>Rotondi</surname><given-names>M</given-names></name></person-group><article-title>The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system</article-title>. <source>Cytokine Growth Factor Rev</source> (<year>2020</year>) <volume>53</volume>:<fpage>25</fpage>&#8211;<lpage>32</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/j.cytogfr.2020.05.003</pub-id><pub-id pub-id-type="pmid">32446778</pub-id><pub-id pub-id-type="pmcid">PMC7211650</pub-id></mixed-citation></ref><ref id="B272"><label>272</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruan</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>W</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>L</given-names></name><name name-style="western"><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China</article-title>. <source>Intens Care Med</source> (<year>2020</year>) <volume>46</volume>:<page-range>846&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1007/s00134-020-05991-x</pub-id><pub-id pub-id-type="pmcid">PMC7080116</pub-id><pub-id pub-id-type="pmid">32125452</pub-id></mixed-citation></ref><ref id="B273"><label>273</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>IH</given-names></name><name name-style="western"><surname>Burckhardt</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Yakimovich</surname><given-names>A</given-names></name><name name-style="western"><surname>Greber</surname><given-names>UF</given-names></name></person-group><article-title>Imaging, Tracking and Computational Analyses of Virus Entry and Egress with the Cytoskeleton</article-title>. <source>Viruses</source> (<year>2018</year>) <volume>10</volume>:<elocation-id>166</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3390/v10040166</pub-id><pub-id pub-id-type="pmcid">PMC5923460</pub-id><pub-id pub-id-type="pmid">29614729</pub-id></mixed-citation></ref><ref id="B274"><label>274</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravindran</surname><given-names>MS</given-names></name><name name-style="western"><surname>Bagchi</surname><given-names>P</given-names></name><name name-style="western"><surname>Cunningham</surname><given-names>CN</given-names></name><name name-style="western"><surname>Tsai</surname><given-names>B</given-names></name></person-group><article-title>Opportunistic intruders: how viruses orchestrate ER functions to infect cells</article-title>. <source>Nat Rev Microbiol</source> (<year>2016</year>) <volume>14</volume>:<page-range>407&#8211;20</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nrmicro.2016.60</pub-id><pub-id pub-id-type="pmcid">PMC5272919</pub-id><pub-id pub-id-type="pmid">27265768</pub-id></mixed-citation></ref><ref id="B275"><label>275</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoeman</surname><given-names>D</given-names></name><name name-style="western"><surname>Fielding</surname><given-names>BC</given-names></name></person-group><article-title>Coronavirus envelope protein: current knowledge</article-title>. <source>Virol J</source> (<year>2019</year>) <volume>16</volume>:<fpage>69</fpage>. &#160;<pub-id pub-id-type="doi">10.1186/s12985-019-1182-0</pub-id><pub-id pub-id-type="pmid">31133031</pub-id><pub-id pub-id-type="pmcid">PMC6537279</pub-id></mixed-citation></ref><ref id="B276"><label>276</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nieva</surname><given-names>JL</given-names></name><name name-style="western"><surname>Madan</surname><given-names>V</given-names></name><name name-style="western"><surname>Carrasco</surname><given-names>L</given-names></name></person-group><article-title>Viroporins: structure and biological functions</article-title>. <source>Nat Rev Microbiol</source> (<year>2012</year>) <volume>10</volume>:<page-range>563&#8211;74</page-range>. &#160;<pub-id pub-id-type="doi">10.1038/nrmicro2820</pub-id><pub-id pub-id-type="pmcid">PMC7097105</pub-id><pub-id pub-id-type="pmid">22751485</pub-id></mixed-citation></ref><ref id="B277"><label>277</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Lescar</surname><given-names>J</given-names></name><name name-style="western"><surname>Tam</surname><given-names>JP</given-names></name><name name-style="western"><surname>Liu</surname><given-names>DX</given-names></name></person-group><article-title>Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2004</year>) <volume>325</volume>:<page-range>374&#8211;80</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/j.bbrc.2004.10.050</pub-id><pub-id pub-id-type="pmcid">PMC7092894</pub-id><pub-id pub-id-type="pmid">15522242</pub-id></mixed-citation></ref><ref id="B278"><label>278</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>CH</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Anderson</surname><given-names>R</given-names></name></person-group><article-title>Activation of vascular endothelial cells by IL-1alpha released by epithelial cells infected with respiratory syncytial virus</article-title>. <source>Cell Immunol</source> (<year>2003</year>) <volume>221</volume>:<fpage>37</fpage>&#8211;<lpage>41</lpage>. &#160;<pub-id pub-id-type="doi">10.1016/s0008-8749(03)00058-3</pub-id><pub-id pub-id-type="pmid">12742380</pub-id></mixed-citation></ref><ref id="B279"><label>279</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tisoncik</surname><given-names>JR</given-names></name><name name-style="western"><surname>Korth</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>CP</given-names></name><name name-style="western"><surname>Farrar</surname><given-names>J</given-names></name><name name-style="western"><surname>Martin</surname><given-names>TR</given-names></name><name name-style="western"><surname>Katze</surname><given-names>MG</given-names></name></person-group><article-title>Into the eye of the cytokine storm</article-title>. <source>Microbiol Mol Biol Rev</source> (<year>2012</year>) <volume>76</volume>:<fpage>16</fpage>&#8211;<lpage>32</lpage>. &#160;<pub-id pub-id-type="doi">10.1128/mmbr.05015-11</pub-id><pub-id pub-id-type="pmid">22390970</pub-id><pub-id pub-id-type="pmcid">PMC3294426</pub-id></mixed-citation></ref><ref id="B280"><label>280</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Shi</surname><given-names>L</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>C</given-names></name><etal/></person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title>. <source>Lancet Respir Med</source> (<year>2020</year>) <volume>8</volume>:<page-range>420&#8211;2</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmcid">PMC7164771</pub-id><pub-id pub-id-type="pmid">32085846</pub-id></mixed-citation></ref><ref id="B281"><label>281</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGonagle</surname><given-names>D</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>JS</given-names></name><name name-style="western"><surname>Sharif</surname><given-names>K</given-names></name><name name-style="western"><surname>Emery</surname><given-names>P</given-names></name><name name-style="western"><surname>Bridgewood</surname><given-names>C</given-names></name></person-group><article-title>Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia</article-title>. <source>Lancet Rheumatol</source> (<year>2020</year>) <volume>2</volume>:<page-range>e437&#8211;e45</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/S2665-9913(20)30121-1</pub-id><pub-id pub-id-type="pmcid">PMC7252093</pub-id><pub-id pub-id-type="pmid">32835247</pub-id></mixed-citation></ref><ref id="B282"><label>282</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shakoory</surname><given-names>B</given-names></name><name name-style="western"><surname>Carcillo</surname><given-names>JA</given-names></name><name name-style="western"><surname>Chatham</surname><given-names>WW</given-names></name><name name-style="western"><surname>Amdur</surname><given-names>RL</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>H</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name><etal/></person-group><article-title>Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial</article-title>. <source>Crit Care Med</source> (<year>2016</year>) <volume>44</volume>:<page-range>275&#8211;81</page-range>. &#160;<pub-id pub-id-type="doi">10.1097/ccm.0000000000001402</pub-id><pub-id pub-id-type="pmcid">PMC5378312</pub-id><pub-id pub-id-type="pmid">26584195</pub-id></mixed-citation></ref><ref id="B283"><label>283</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Slotman</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Opal</surname><given-names>SM</given-names></name><name name-style="western"><surname>Pribble</surname><given-names>JP</given-names></name><name name-style="western"><surname>Bone</surname><given-names>RC</given-names></name><name name-style="western"><surname>Emmanuel</surname><given-names>G</given-names></name><etal/></person-group><article-title>Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial</article-title>. <source>Crit Care Med</source> (<year>1994</year>) <volume>22</volume>:<fpage>12</fpage>&#8211;<lpage>21</lpage>. &#160;<pub-id pub-id-type="doi">10.1097/00003246-199401000-00008</pub-id><pub-id pub-id-type="pmid">8124953</pub-id></mixed-citation></ref><ref id="B284"><label>284</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rajasekaran</surname><given-names>S</given-names></name><name name-style="western"><surname>Kruse</surname><given-names>K</given-names></name><name name-style="western"><surname>Kovey</surname><given-names>K</given-names></name><name name-style="western"><surname>Davis</surname><given-names>AT</given-names></name><name name-style="western"><surname>Hassan</surname><given-names>NE</given-names></name><name name-style="western"><surname>Ndika</surname><given-names>AN</given-names></name><etal/></person-group><article-title>Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction/macrophage activating syndrome in critically ill children*</article-title>. <source>Pediatr Crit Care Med</source> (<year>2014</year>) <volume>15</volume>:<page-range>401&#8211;8</page-range>. &#160;<pub-id pub-id-type="doi">10.1097/pcc.0000000000000078</pub-id><pub-id pub-id-type="pmid">24583503</pub-id></mixed-citation></ref><ref id="B285"><label>285</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cavalli</surname><given-names>G</given-names></name><name name-style="western"><surname>Dinarello</surname><given-names>CA</given-names></name></person-group><article-title>Anakinra Therapy for Non-cancer Inflammatory Diseases</article-title>. <source>Front Pharmacol</source> (<year>2018</year>) <volume>9</volume>:<elocation-id>1157</elocation-id>. &#160;<pub-id pub-id-type="doi">10.3389/fphar.2018.01157</pub-id><pub-id pub-id-type="pmid">30459597</pub-id><pub-id pub-id-type="pmcid">PMC6232613</pub-id></mixed-citation></ref><ref id="B286"><label>286</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>King</surname><given-names>A</given-names></name><name name-style="western"><surname>Vail</surname><given-names>A</given-names></name><name name-style="western"><surname>O&#8217;Leary</surname><given-names>C</given-names></name><name name-style="western"><surname>Hannan</surname><given-names>C</given-names></name><name name-style="western"><surname>Brough</surname><given-names>D</given-names></name><name name-style="western"><surname>Patel</surname><given-names>H</given-names></name><etal/></person-group><article-title>Anakinra in COVID-19: important considerations for clinical trials</article-title>. <source>Lancet Rheumatol</source> (<year>2020</year>) <volume>2</volume>:<page-range>e379&#8211;81</page-range>. &#160;<pub-id pub-id-type="doi">10.1016/S2665-9913(20)30160-0</pub-id><pub-id pub-id-type="pmcid">PMC7241987</pub-id><pub-id pub-id-type="pmid">32835233</pub-id></mixed-citation></ref><ref id="B287"><label>287</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Horby</surname><given-names>P</given-names></name><name name-style="western"><surname>Lim</surname><given-names>WS</given-names></name><name name-style="western"><surname>Emberson</surname><given-names>JR</given-names></name><name name-style="western"><surname>Mafham</surname><given-names>M</given-names></name><name name-style="western"><surname>Bell</surname><given-names>JL</given-names></name><name name-style="western"><surname>Linsell</surname><given-names>L</given-names></name><etal/></person-group><article-title>Dexamethasone in Hospitalized Patients with Covid-19 &#8212; Preliminary Report</article-title>. <source>N Engl J Med</source> (<year>2020</year>) NEJMoa2021436. &#160;<pub-id pub-id-type="doi">10.1056/nejmoa2021436</pub-id></mixed-citation></ref><ref id="B288"><label>288</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kern</surname><given-names>JA</given-names></name><name name-style="western"><surname>Lamb</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Reed</surname><given-names>JC</given-names></name><name name-style="western"><surname>Daniele</surname><given-names>RP</given-names></name><name name-style="western"><surname>Nowell</surname><given-names>PC</given-names></name></person-group><article-title>Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms</article-title>. <source>J Clin Invest</source> (<year>1988</year>) <volume>81</volume>:<page-range>237&#8211;44</page-range>. &#160;<pub-id pub-id-type="doi">10.1172/jci113301</pub-id><pub-id pub-id-type="pmcid">PMC442499</pub-id><pub-id pub-id-type="pmid">3257219</pub-id></mixed-citation></ref><ref id="B289"><label>289</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bochner</surname><given-names>BS</given-names></name><name name-style="western"><surname>Rutledge</surname><given-names>BK</given-names></name><name name-style="western"><surname>Schleimer</surname><given-names>RP</given-names></name></person-group><article-title>Interleukin 1 production by human lung tissue. II. Inhibition by anti-inflammatory steroids</article-title>. <source>J Immunol</source> (<year>1987</year>) <volume>139</volume>:<fpage>2303</fpage>.<pub-id pub-id-type="pmid">3498758</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>